BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696-699. [PMID: 7560864 DOI: 10.1016/0168-8278(95)80226-6] [Cited by in Crossref: 3222] [Cited by in F6Publishing: 3305] [Article Influence: 119.3] [Reference Citation Analysis]
Number Citing Articles
1 Jocius D, Vajauskas D, Mikelis K, Jokubauskiene S, Jakutiene J, Strupas K, Tamosiunas AE. Quantitative Assessment of Liver Impairment in Chronic Viral Hepatitis with [99mTc]Tc-Mebrofenin: A Noninvasive Attempt to Stage Viral Hepatitis-Associated Liver Fibrosis. Medicina 2022;58:1333. [DOI: 10.3390/medicina58101333] [Reference Citation Analysis]
2 Zacharias M, Kashofer K, Wurm P, Regitnig P, Schütte M, Neger M, Ehmann S, Marsh LM, Kwapiszewska G, Loibner M, Birnhuber A, Leitner E, Thüringer A, Winter E, Sauer S, Pollheimer MJ, Vagena FR, Lackner C, Jelusic B, Ogilvie L, Durdevic M, Timmermann B, Lehrach H, Zatloukal K, Gorkiewicz G. Host and microbiome features of secondary infections in lethal covid-19. iScience 2022;25:104926. [PMID: 35992303 DOI: 10.1016/j.isci.2022.104926] [Reference Citation Analysis]
3 Xu L, Dai F, Wang P, Li L, Zhang M, Xu M. Novel postoperative nomograms for predicting individual prognoses of hepatitis B-related hepatocellular carcinoma with cirrhosis. BMC Surg 2022;22. [DOI: 10.1186/s12893-022-01789-4] [Reference Citation Analysis]
4 Soares GA, Pereira GM, Romualdo GR, Biasotti GGA, Stoppa EG, Bakuzis AF, Baffa O, Barbisan LF, Miranda JRA. Biodistribution Profile of Magnetic Nanoparticles in Cirrhosis-Associated Hepatocarcinogenesis in Rats by AC Biosusceptometry. Pharmaceutics 2022;14:1907. [DOI: 10.3390/pharmaceutics14091907] [Reference Citation Analysis]
5 Padula A, Petruzzelli R, Philbert SA, Church SJ, Esposito F, Campione S, Monti M, Capolongo F, Perna C, Nusco E, Schmidt HH, Auricchio A, Cooper GJ, Polishchuk R, Piccolo P. Full-length ATP7B reconstituted through protein trans-splicing corrects Wilson disease in mice. Molecular Therapy - Methods & Clinical Development 2022;26:495-504. [DOI: 10.1016/j.omtm.2022.08.004] [Reference Citation Analysis]
6 Santarone S, Angelini S, Natale A, Vaddinelli D, Spadano R, Casciani P, Papola F, Di Lembo E, Iannetti G, Di Bartolomeo P. Survival and late effects of hematopoietic cell transplantation in patients with thalassemia major. Bone Marrow Transplant 2022. [PMID: 36002533 DOI: 10.1038/s41409-022-01786-4] [Reference Citation Analysis]
7 Fang C, Rafailidis V, Konstantatou E, Yusuf GT, Barrow I, Pagkalidou E, Romanos O, Agarwal K, Quaglia A, Sidhu PS. Comparison Between Different Manufacturers' 2-D and Point Shear Wave Elastography Techniques in Staging Liver Fibrosis in Chronic Liver Disease Using Liver Biopsy as the Reference Standard: A Prospective Study. Ultrasound Med Biol 2022:S0301-5629(22)00461-6. [PMID: 36008215 DOI: 10.1016/j.ultrasmedbio.2022.06.009] [Reference Citation Analysis]
8 Ji D, Chen Y, Bi J, Shang Q, Liu H, Wang JB, Tan L, Wang J, Chen Y, Li Q, Long Q, Song L, Jiang L, Xiao G, Yu Z, Chen L, Wang X, Chen D, Li Z, Dong Z, Yang Y. Entecavir plus Biejia-Ruangan compound reduces the risk of hepatocellular carcinoma in Chinese patients with chronic hepatitis B. J Hepatol 2022:S0168-8278(22)02982-8. [PMID: 35985545 DOI: 10.1016/j.jhep.2022.07.018] [Reference Citation Analysis]
9 Aljawdah HMA, Abdel-gaber R, Al-shaebi EM, Thagfan FA, Al-quraishy S, Qasem MAA, Murshed M, Mares MM, Al-otaibi T, Hawsah MA, Dkhil MA. Hepatoprotective activity of Eucalyptus camaldulensis extract in murine malaria mediated by suppression of oxidative and inflammatory processes. Front Cell Infect Microbiol 2022;12:955042. [DOI: 10.3389/fcimb.2022.955042] [Reference Citation Analysis]
10 Elsisi AE, Elmarhoumy EH, Osman EY. Protective effect of cilostazol and verapamil against thioacetamide-induced hepatotoxicity in rats may involve Nrf2/GSK-3β/NF-κB signaling pathway. Toxicology Research 2022. [DOI: 10.1093/toxres/tfac045] [Reference Citation Analysis]
11 Dong SC, Bai DS, Wang FA, Jin SJ, Zhang C, Zhou BH, Jiang GQ. Radiofrequency ablation is an inferior option to liver resection for solitary hepatocellular carcinoma ≤ 5 cm without cirrhosis: A population-based study with stratification by tumor size. Hepatobiliary Pancreat Dis Int 2022:S1499-3872(22)00187-4. [PMID: 35977873 DOI: 10.1016/j.hbpd.2022.08.001] [Reference Citation Analysis]
12 Li H, Xu L, Yi P, Li L, Yan T, Xie L, Zhu Z. High-throughput circular RNA sequencing reveals the profiles of circular RNA in non-cirrhotic hepatocellular carcinoma. BMC Cancer 2022;22:857. [PMID: 35931993 DOI: 10.1186/s12885-022-09909-2] [Reference Citation Analysis]
13 Serai S, Tsitsiou Y, Wilkins B, Ghosh A, Cahill A, Biko D, Rychik J, Rand E, Goldberg D. MR elastography-based staging of liver fibrosis in Fontan procedure associated liver disease is confounded by effects of venous congestion. Clinical Radiology 2022. [DOI: 10.1016/j.crad.2022.06.016] [Reference Citation Analysis]
14 Zhang H, Du X, Dong H, Xu W, Zhou P, Liu S, Qing X, Zhang Y, Yang M, Zhang Y. Risk factors and predictive nomograms for early death of patients with advanced hepatocellular carcinoma: a large retrospective study based on the SEER database. BMC Gastroenterol 2022;22:348. [PMID: 35854221 DOI: 10.1186/s12876-022-02424-5] [Reference Citation Analysis]
15 Wang Y, Hu Y, Zhang X, Luo Y, Ma L, Lu J, Liang Q, Xu C, Zhao C, Pan CQ. IP-10 Interferes With the Antiviral Response of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection. Front Public Health 2022;10:911551. [DOI: 10.3389/fpubh.2022.911551] [Reference Citation Analysis]
16 Inuzuka R, Nii M, Inai K, Shimada E, Shinohara T, Kogiso T, Ono H, Otsuki SI, Kurita Y, Takeda A, Hirono K, Takei K, Yasukohchi S, Yoshikawa T, Furutani Y, Shinozaki T, Matsuyama Y, Senzaki H, Tokushige K, Nakanishi T. Predictors of liver cirrhosis and hepatocellular carcinoma among perioperative survivors of the Fontan operation. Heart 2022:heartjnl-2022-320940. [PMID: 35768191 DOI: 10.1136/heartjnl-2022-320940] [Reference Citation Analysis]
17 Ozdemir YE, Sahin Ozdemir M, Bayramlar OF, Surme S, Yildiz Kaya S, Karaali R, Balkan II, Mete B, Saltoglu N, Tabak F. Long-term follow-up of treatment-naïve HBeAg-negative patients with chronic hepatitis B. Ir J Med Sci 2022. [PMID: 35715665 DOI: 10.1007/s11845-022-03066-y] [Reference Citation Analysis]
18 Chen PM, Katsuyama E, Satyam A, Li H, Rubio J, Jung S, Andrzejewski S, Becherer JD, Tsokos MG, Abdi R, Tsokos GC. CD38 reduces mitochondrial fitness and cytotoxic T cell response against viral infection in lupus patients by suppressing mitophagy. Sci Adv 2022;8:eabo4271. [PMID: 35704572 DOI: 10.1126/sciadv.abo4271] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Dong Y, Wang WP, Lee WJ, Meloni MF, Clevert DA, Chammas MC, Tannapfel A, Forgione A, Piscaglia F, Dietrich CF. Contrast-Enhanced Ultrasound Features of Histopathologically Proven Hepatocellular Carcinoma in the Non-cirrhotic Liver: A Multicenter Study. Ultrasound Med Biol 2022:S0301-5629(22)00393-3. [PMID: 35710501 DOI: 10.1016/j.ultrasmedbio.2022.05.005] [Reference Citation Analysis]
20 Qiao L, Guo Z, Liu H, Liu J, Lin X, Deng H, Liu X, Zhao Y, Xiao X, Lei J, Han J. Protective Effect of Mitophagy Regulated by mTOR Signaling Pathway in Liver Fibrosis Associated with Selenium. Nutrients 2022;14:2410. [PMID: 35745140 DOI: 10.3390/nu14122410] [Reference Citation Analysis]
21 Gori E, Pierini A, Tulone F, Abramo F, Marchetti V. Serum protein electrophoresis in 26 dogs with chronic hepatitis. J Vet Diagn Invest 2022;:10406387221101547. [PMID: 35686386 DOI: 10.1177/10406387221101547] [Reference Citation Analysis]
22 Umeshappa CS, Solé P, Yamanouchi J, Mohapatra S, Surewaard BGJ, Garnica J, Singha S, Mondal D, Cortés-vicente E, D’mello C, Mason A, Kubes P, Serra P, Yang Y, Santamaria P. Re-programming mouse liver-resident invariant natural killer T cells for suppressing hepatic and diabetogenic autoimmunity. Nat Commun 2022;13. [DOI: 10.1038/s41467-022-30759-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Ogaly HA, Abdel-Rahman RF, Mohamed MAE, O A AF, Khattab MS, Abd-Elsalam RM. Thymol ameliorated neurotoxicity and cognitive deterioration in a thioacetamide-induced hepatic encephalopathy rat model; involvement of the BDNF/CREB signaling pathway. Food Funct 2022;13:6180-94. [PMID: 35583008 DOI: 10.1039/d1fo04292k] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Wang CY, Deng Y, Li P, Zheng S, Chen G, Zhou G, Xu J, Chen YP, Wang Z, Jin X, Tang JM, Hu KP, Bi JF, Zhang P, Li CX, Huang A, Lv GJ, Xiao XH, Zou Z, Ji D. Prediction of biochemical nonresolution in patients with chronic drug-induced liver injury: A large multicenter study. Hepatology 2022;75:1373-85. [PMID: 34919746 DOI: 10.1002/hep.32283] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
25 Elrazik NAA, El-Mesery M, El-Shishtawy MM. Sesamol protects against liver fibrosis induced in rats by modulating lysophosphatidic acid receptor expression and TGF-β/Smad3 signaling pathway. Naunyn Schmiedebergs Arch Pharmacol 2022. [PMID: 35648193 DOI: 10.1007/s00210-022-02259-7] [Reference Citation Analysis]
26 Al-Noshokaty TM, Mesbah NM, Abo-Elmatty DM, Abulsoud AI, Abdel-Hamed AR. Selenium nanoparticles overcomes sorafenib resistance in thioacetamide induced hepatocellular carcinoma in rats by modulation of mTOR, NF-κB pathways and LncRNA-AF085935/GPC3 axis. Life Sci 2022;303:120675. [PMID: 35640776 DOI: 10.1016/j.lfs.2022.120675] [Reference Citation Analysis]
27 Al-abkal F, Abdel-wahab BA, El-kareem HFA, Moustafa YM, Khodeer DM. Protective Effect of Pycnogenol against Methotrexate-Induced Hepatic, Renal, and Cardiac Toxicity: An In Vivo Study. Pharmaceuticals 2022;15:674. [DOI: 10.3390/ph15060674] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Wei CT, Wang YW, Wu YC, Lin LW, Chen CC, Chen CY, Kuo SM. Reparative Efficacy of Liposome-Encapsulated Oleanolic Acid against Liver Inflammation Induced by Fine Ambient Particulate Matter and Alcohol in Mice. Pharmaceutics 2022;14:1108. [PMID: 35631694 DOI: 10.3390/pharmaceutics14051108] [Reference Citation Analysis]
29 Anstee QM, Castera L, Loomba R. Impact of non-invasive biomarkers on hepatology practice: Past, present and future. J Hepatol 2022;76:1362-78. [PMID: 35589256 DOI: 10.1016/j.jhep.2022.03.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
30 Magri A, Harris JM, D’arienzo V, Minisini R, Jühling F, Wing PAC, Rapetti R, Leutner M, Testoni B, Baumert TF, Zoulim F, Balfe P, Pirisi M, Mckeating JA. Inflammatory Gene Expression Associates with Hepatitis B Virus cccDNA- but Not Integrant-Derived Transcripts in HBeAg Negative Disease. Viruses 2022;14:1070. [DOI: 10.3390/v14051070] [Reference Citation Analysis]
31 Lee I, Bae J. Hepatic Protective Effects of Jujuboside B through the Modulation of Inflammatory Pathways. Biotechnol Bioproc E. [DOI: 10.1007/s12257-022-0049-1] [Reference Citation Analysis]
32 Ogaly HA, Aldulmani SAA, Al-Zahrani FAM, Abd-Elsalam RM. D-Carvone Attenuates CCl4-Induced Liver Fibrosis in Rats by Inhibiting Oxidative Stress and TGF-ß 1/SMAD3 Signaling Pathway. Biology (Basel) 2022;11:739. [PMID: 35625467 DOI: 10.3390/biology11050739] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
33 Zhang X, Thompkins-Johns A, Ziober A, Zhang PJ, Furth EE. Hepatic Macrophage Types Cluster with Disease Etiology in Chronic Liver Disease and Differ Compared to Normal Liver: Implications for Their Biologic and Diagnostic Role. Int J Surg Pathol 2022;:10668969221099630. [PMID: 35521912 DOI: 10.1177/10668969221099630] [Reference Citation Analysis]
34 Wilczynski E, Sasson E, Eliav U, Navon G, Nevo U. Quantitative Magnetization EXchange MRI Measurement of Liver Fibrosis Model in Rodents. J Magn Reson Imaging 2022. [PMID: 35521943 DOI: 10.1002/jmri.28228] [Reference Citation Analysis]
35 Dhingra S, Mahadik JD, Tarabishy Y, May SB, Vierling JM. Prevalence and clinical significance of portal inflammation, portal plasma cells, interface hepatitis and biliary injury in liver biopsies from patients with non-alcoholic steatohepatitis. Pathology 2022:S0031-3025(22)00123-4. [PMID: 35525796 DOI: 10.1016/j.pathol.2022.01.009] [Reference Citation Analysis]
36 Guth I, Matos-pardal C, Ferreira-lima R, Loureiro-rebouças R, Sobral A, Moraes-marques C, Kubrusly L. Caffeine attenuates liver damage and improves neurologic signs in a rat model of hepatic encephalopathy. Revista de Gastroenterología de México (English Edition) 2022. [DOI: 10.1016/j.rgmxen.2022.03.004] [Reference Citation Analysis]
37 Wang JB, Huang A, Wang Y, Ji D, Liang QS, Zhao J, Zhou G, Liu S, Niu M, Sun Y, Tian H, Teng GJ, Chang BX, Bi JF, Peng XX, Xin S, Xie H, Ma X, Mao YM, Liangpunsakul S, Saxena R, Aithal GP, Xiao XH, Zhao J, Zou Z. Corticosteroid plus glycyrrhizin therapy for chronic drug- or herb-induced liver injury achieves biochemical and histological improvements: a randomised open-label trial. Aliment Pharmacol Ther 2022;55:1297-310. [PMID: 35362188 DOI: 10.1111/apt.16902] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Yamkate P, Lidbury JA, Steiner JM, Suchodolski JS, Giaretta PR. Immunohistochemical Expression of Oxidative Stress and Apoptosis Markers in Archived Liver Specimens from Dogs with Chronic Hepatitis. Journal of Comparative Pathology 2022;193:25-36. [DOI: 10.1016/j.jcpa.2022.02.005] [Reference Citation Analysis]
39 Mieli-Vergani G, Zen Y, Vergani D. Reassessement of the histological features of autoimmune hepatitis. Liver Int 2022;42:954-6. [PMID: 35447009 DOI: 10.1111/liv.15219] [Reference Citation Analysis]
40 Akyüz F, Çavuş B, Nizam N, Göktürk S, Baran B, Yazıcı H, Evirgen S, Akyüz Ü, Öbekli T, Karaca Ç, Demir K, Beşışık F, Kaymakoğlu S. Evaluation of safety and efficacy of tenofovir disoproxil in hemodialysis and renal transplant patients monoinfected with hepatitis B virus based on real life data. Clin Exp Hepatol 2022;8:7-13. [PMID: 35415260 DOI: 10.5114/ceh.2022.114153] [Reference Citation Analysis]
41 Wang J, Qiu Y, Yang Y, Shen S, Zhi M, Zhang B, Wang W. Impact of cirrhosis on long-term survival outcomes of patients with intrahepatic cholangiocarcinoma. Cancer Med 2022. [PMID: 35415945 DOI: 10.1002/cam4.4740] [Reference Citation Analysis]
42 Mukherjee A, Kössler W, Marozzi M. A distribution‐free procedure for testing versatile alternative in medical multisample comparison studies. Statistics in Medicine. [DOI: 10.1002/sim.9397] [Reference Citation Analysis]
43 Bekki Y, Crismale JF, Myers B, Schiano TD, Florman S. Varying Utilization Rates but Superior Outcomes in Liver Transplantation From Hepatitis C−positive Donors in the US: An Analysis of the OPTN/UNOS Database. Transplantation 2022;Publish Ahead of Print. [DOI: 10.1097/tp.0000000000004116] [Reference Citation Analysis]
44 Kinzler MN, Klasen C, Schulze F, Herrmann E, Schnitzbauer AA, Trojan J, Zeuzem S, Wild PJ, Walter D. Impact of Liver Fibrosis on Survival of Patients with Intrahepatic Cholangiocarcinoma Receiving Gemcitabine-Based Chemotherapy. J Clin Med 2022;11:2057. [PMID: 35407665 DOI: 10.3390/jcm11072057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Saeki C, Matsuzaki J, Kuroda M, Fujita K, Ichikawa M, Takizawa S, Takano K, Oikawa T, Nakanuma Y, Saruta M, Ochiya T, Tsubota A. Identification of circulating microRNAs as potential biomarkers for hepatic necroinflammation in patients with autoimmune hepatitis. BMJ Open Gastroenterol 2022;9:e000879. [PMID: 35379653 DOI: 10.1136/bmjgast-2022-000879] [Reference Citation Analysis]
46 D’amico R, Cordaro M, Fusco R, Peritore AF, Genovese T, Gugliandolo E, Crupi R, Mandalari G, Caccamo D, Cuzzocrea S, Di Paola R, Siracusa R, Impellizzeri D. Consumption of Cashew (Anacardium occidentale L.) Nuts Counteracts Oxidative Stress and Tissue Inflammation in Mild Hyperhomocysteinemia in Rats. Nutrients 2022;14:1474. [DOI: 10.3390/nu14071474] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
47 Abd El Salam ASG, Samra YA, El-shishtawy MM. Cinnamaldehyde Relieves Induced Hepatocellular Carcinoma in Rat Model via Targeting Wnt/β-Catenin Pathway. Sci Pharm 2022;90:22. [DOI: 10.3390/scipharm90020022] [Reference Citation Analysis]
48 Su CH, Chung PC, Lin SF, Tsai HW, Yang TL, Su YC. Multi-Scale Attention Convolutional Network for Masson Stained Bile Duct Segmentation from Liver Pathology Images. Sensors (Basel) 2022;22:2679. [PMID: 35408293 DOI: 10.3390/s22072679] [Reference Citation Analysis]
49 Hui RW, Chan AC, Lo G, Lo R, Chan C, Kotewall CN, Mak L, She W, Au K, Ai V, Fung J, Yuen M, Seto W. Magnetic resonance elastography and proton density fat fraction predict adverse outcomes in hepatocellular carcinoma. Hepatol Int. [DOI: 10.1007/s12072-022-10305-y] [Reference Citation Analysis]
50 Pai RK, Jairath V, Hogan M, Zou G, Adeyi OA, Anstee QM, Aqel BA, Behling C, Carey EJ, Clouston AD, Corey K, Feagan BG, Kleiner DE, Ma C, McFarlane SC, Noureddin M, Ratziu V, Valasek MA, Younossi ZM, Harrison SA, Loomba R. Reliability of histologic assessment for NAFLD and development of an expanded NAFLD activity score. Hepatology 2022. [PMID: 35332569 DOI: 10.1002/hep.32475] [Reference Citation Analysis]
51 Zha H, Li Q, Chang K, Xia J, Li S, Tang R, Li L. Characterising the Intestinal Bacterial and Fungal Microbiome Associated With Different Cytokine Profiles in Two Bifidobacterium strains Pre-Treated Rats With D-Galactosamine-Induced Liver Injury. Front Immunol 2022;13:791152. [DOI: 10.3389/fimmu.2022.791152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Alshanwani AR, Hagar H, Shaheen S, Alhusaini AM, Arafah MM, Faddah LM, Alharbi FM, Sharma AK, Badr AM. A promising antifibrotic drug, pyridoxamine attenuates thioacetamide-induced liver fibrosis by combating oxidative stress, advanced glycation end products, and balancing matrix metalloproteinases. Eur J Pharmacol 2022;:174910. [PMID: 35339478 DOI: 10.1016/j.ejphar.2022.174910] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
53 Cardoso AC, Figueiredo-Mendes C, Villela-Nogueira CA, Marcellin P. Staging Fibrosis in Chronic Viral Hepatitis. Viruses 2022;14:660. [PMID: 35458391 DOI: 10.3390/v14040660] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Lee HA, Lee HW, Park Y, Kim HS, Seo YS. Hepatitis B Core-Related Antigen Is Useful for Predicting Phase and Prognosis of Hepatitis B e Antigen-Positive Patients. J Clin Med 2022;11:1729. [PMID: 35330053 DOI: 10.3390/jcm11061729] [Reference Citation Analysis]
55 Huang X, Zhuang J, Yang Y, Jian J, Ai W, Liu C, Tang W, Jiang C, He Y, Huang L, Peng S, Pan JS. Diagnostic Value of Serum Chitinase-3-Like Protein 1 for Liver Fibrosis: A Meta-analysis. BioMed Research International 2022;2022:1-13. [DOI: 10.1155/2022/3227957] [Reference Citation Analysis]
56 Hamberger F, Legchenko E, Chouvarine P, Mederacke YS, Taubert R, Meier M, Jonigk D, Hansmann G, Mederacke I. Pulmonary Arterial Hypertension and Consecutive Right Heart Failure Lead to Liver Fibrosis. Front Cardiovasc Med 2022;9:862330. [DOI: 10.3389/fcvm.2022.862330] [Reference Citation Analysis]
57 Venkatesh SK, Torbenson MS. Liver fibrosis quantification. Abdom Radiol (NY) 2022;47:1032-52. [PMID: 35022806 DOI: 10.1007/s00261-021-03396-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
58 Czernuszewicz TJ, Aji AM, Moore CJ, Montgomery SA, Velasco B, Torres G, Anand KS, Johnson KA, Deal AM, Zukić D, McCormick M, Schnabl B, Gallippi CM, Dayton PA, Gessner RC. Development of a Robotic Shear Wave Elastography System for Noninvasive Staging of Liver Disease in Murine Models. Hepatol Commun 2022. [PMID: 35202510 DOI: 10.1002/hep4.1912] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Chowdhury AB, Mehta KJ. Liver biopsy for assessment of chronic liver diseases: a synopsis. Clin Exp Med 2022. [PMID: 35192111 DOI: 10.1007/s10238-022-00799-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Mohamed AA, Zaghloul RA, Abdelghany AM, El Gayar AM. Selenium nanoparticles and quercetin suppress thioacetamide-induced hepatocellular carcinoma in rats: Attenuation of inflammation involvement. J Biochem Mol Toxicol 2022;:e22989. [PMID: 35179263 DOI: 10.1002/jbt.22989] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Dalla E, Bulfoni M, Cesselli D, Pravisani R, Hidaka M, Eguchi S, Baccarani U. Reinfection of Transplanted Livers in HCV- and HCV/HIV-Infected Patients Is Characterized by a Different MicroRNA Expression Profile. Cells 2022;11:690. [DOI: 10.3390/cells11040690] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
62 Wang T, Zhang C, Meng X, Zhu B, Wang S, Yuan W, Zhang S, Xu J, Zhang C. Long Noncoding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 in Extracellular Vesicles Promotes Hepatic Stellate Cell Activation, Liver Fibrosis and β-Catenin Signaling Pathway. Front Physiol 2022;13:792182. [DOI: 10.3389/fphys.2022.792182] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Gokcen P, Guzelbulut F, Adali G, Degirmenci Salturk AG, Ozturk O, Bahadir O, Kanatsiz E, Kiyak M, Ozdil K, Doganay HL. Validation of the PAGE-B score to predict hepatocellular carcinoma risk in caucasian chronic hepatitis B patients on treatment. World J Gastroenterol 2022; 28(6): 665-674 [DOI: 10.3748/wjg.v28.i6.665] [Reference Citation Analysis]
64 Nasehi Z, Kheiripour N, Taheri MA, Ardjmand A, Jozi F, Aghadavod E, Doustimotlagh AH, Shahaboddin ME, Siemianowicz K. The Protective Effects of Securigera securidaca Seed Extract on Liver Injury Induced by Bile Duct Ligation in Rats. BioMed Research International 2022;2022:1-12. [DOI: 10.1155/2022/6989963] [Reference Citation Analysis]
65 Sørensen MD, Thiele M, Krag A, Daniels SJ, Leeming DJ, Karsdal M, Detlefsen S. Stage-dependent expression of fibrogenic markers in alcohol-related liver disease. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.153798] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
66 Friedman SL, Pinzani M. Hepatic fibrosis 2022: Unmet needs and a blueprint for the future. Hepatology 2022;75:473-88. [PMID: 34923653 DOI: 10.1002/hep.32285] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 17.0] [Reference Citation Analysis]
67 Dimitrijević Stojanović MN, Franich AA, Jurišević MM, Gajović NM, Arsenijević NN, Jovanović IP, Stojanović BS, Mitrović SL, Kljun J, Rajković S, Živković MD. Platinum(II) complexes with malonic acids: Synthesis, characterization, in vitro and in vivo antitumor activity and interactions with biomolecules. Journal of Inorganic Biochemistry 2022. [DOI: 10.1016/j.jinorgbio.2022.111773] [Reference Citation Analysis]
68 Xie Y, Du D, Zhang L, Yang Y, Zou Z, Li Z, Zhou L, Shang R, Zhou P. TJ-M2010-5, A self-developed MyD88 inhibitor, attenuates liver fibrosis by inhibiting the NF-κB pathway. Chem Biol Interact 2022;354:109839. [PMID: 35101388 DOI: 10.1016/j.cbi.2022.109839] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Zha H, Si G, Wang C, Zhang H, Li L, Huang J. Multiple Intestinal Bacteria Associated with the Better Protective Effect of Bifidobacterium pseudocatenulatum LI09 against Rat Liver Injury. BioMed Research International 2022;2022:1-11. [DOI: 10.1155/2022/8647483] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
70 Donadei C, Angeletti A, Cappuccilli M, Conti M, Conte D, Zappulo F, De Giovanni A, Malvi D, Aldini R, Roda A, La Manna G. Adaptive Mechanisms of Renal Bile Acid Transporters in a Rat Model of Carbon Tetrachloride-Induced Liver Cirrhosis. J Clin Med 2022;11:636. [PMID: 35160088 DOI: 10.3390/jcm11030636] [Reference Citation Analysis]
71 Trailin A, Červenková L, Ambrozkiewicz F, Ali E, Kasi P, Pálek R, Hošek P, Třeška V, Daum O, Tonar Z, Liška V, Hemminki K. T- and B-Cells in the Inner Invasive Margin of Hepatocellular Carcinoma after Resection Associate with Favorable Prognosis. Cancers (Basel) 2022;14:604. [PMID: 35158872 DOI: 10.3390/cancers14030604] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Erken R, Loukachov V, van Dort K, van den Hurk A, Takkenberg RB, de Niet A, Jansen L, Willemse S, Reesink H, Kootstra N. Quantified integrated hepatitis B virus is related to viral activity in patients with chronic hepatitis B. Hepatology 2022. [PMID: 35073596 DOI: 10.1002/hep.32352] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
73 Krag A, Roskams T, Pinzani M, Mueller S. Diagnostic challenges in patients with alcohol-related liver disease. Z Gastroenterol 2022;60:45-57. [PMID: 35042253 DOI: 10.1055/a-1713-4372] [Reference Citation Analysis]
74 Ekin N, Ucmak F, Ebik B, Tugba Tuncel E, Kacmaz H, Arpa M, Engin Atay A. GPR, King's Score and S-Index are superior to other non-invasive fibrosis markers in predicting the liver fibrosis in chronic Hepatitis B patients. Acta Gastroenterol Belg 2022;85:62-8. [PMID: 35304995 DOI: 10.51821/85.1.9156] [Reference Citation Analysis]
75 Byrnes K, Vachharajani N, Doyle MM, Nalbantoglu I. Liver Allograft Findings of Donation After Cardiac Death versus Brain Death in Recipients with Hepatitis C Related Cirrhosis: A Matched Histologic Comparison. Human Pathology 2022. [DOI: 10.1016/j.humpath.2022.01.005] [Reference Citation Analysis]
76 Khedr MA, Adawy NM, Salim TA, Salem ME, Ghazy RM, Elharoun AS, Sultan MM, Ehsan NA. Kupffer Cell Hyaline Globules in Children With Autoimmune Hepatitis. Journal of Clinical and Experimental Hepatology 2022;12:20-8. [DOI: 10.1016/j.jceh.2021.04.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
77 Pape S, Snijders RJ, Gevers TJ, Chazouilleres O, Dalekos GN, Hirschfield GM, Lenzi M, Trauner M, Manns MP, Vierling JM, Montano-loza AJ, Lohse AW, Schramm C, Drenth JP, Heneghan MA, Almasio P, Alvarez F, Andrade R, Arikan C, Assis D, Bardou-jacquet E, Biewenga M, Cancado E, Cazzagon N, Chazouillères O, Colloredo G, Cuarterolo M, Dalekos G, Debray D, Robles-díaz M, Drenth J, Dyson J, Efe C, Engel B, Ferri S, Fontana R, Gatselis N, Gerussi A, Halilbasic E, Halliday N, Heneghan M, Hirschfield G, van Hoek B, Jørgensen MH, Indolfini G, Iorio R, Jeong S, Jones D, Kelly D, Kerkar N, Lacaille F, Lammert C, Leggett B, Lenzi M, Levy C, Liberal R, Lleo A, Lohse A, Lopez SI, de Martin E, Mclin V, Mieli-vergani G, Milkiewicz P, Mohan N, Muratori L, Nebbia G, van Nieuwkerk C, Oo Y, Ortega A, Páres A, Pop T, Pratt D, Purnak T, Ranucci G, Rushbrook S, Schramm C, Stättermayer A, Swain M, Tanaka A, Taubert R, Terrabuio D, Terziroli B, Trauner M, Valentino P, van den Brand F, Villamil A, Wahlin S, Ytting H, Zachou K, Zeniya M. Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group. Journal of Hepatology 2022. [DOI: 10.1016/j.jhep.2021.12.041] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
78 Mogahed E, El-Karaksy H, Zaki H, Abdullatif H. Autoimmune hepatitis in Egyptian children: A single center experience. Int J Immunopathol Pharmacol 2022;36:20587384211073265. [PMID: 35231187 DOI: 10.1177/20587384211073265] [Reference Citation Analysis]
79 Li A, Wu J, Cheng J, Feng C, Liu W, Li Y, Rao H, Huang R, Zhou G, Hong N, Wang Y. Gd-EOB-DTPA-enhanced MRI-a noninvasive and short-term assessment method for liver necroinflammation after direct-acting antiviral (DAA) therapy in patients with chronic hepatitis C. Abdom Radiol (NY) 2022;47:174-83. [PMID: 34664096 DOI: 10.1007/s00261-021-03316-0] [Reference Citation Analysis]
80 Westendorf J, Wobeser B, Epp T. IIB or not IIB, part 2: assessing inter-rater and intra-rater repeatability of the Kenney–Doig scale in equine endometrial biopsy evaluation. J VET Diagn Invest. [DOI: 10.1177/10406387211062866] [Reference Citation Analysis]
81 Liu F, Sun C, Chen Y, Du F, Yang Y, Wu G. Indole-3-propionic Acid-aggravated CCl4-induced Liver Fibrosis via the TGF-β1/Smads Signaling Pathway. J Clin Transl Hepatol 2021;9:917-30. [PMID: 34966655 DOI: 10.14218/JCTH.2021.00032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
82 Lee IC, Huang JY, Chen TC, Yen CH, Chiu NC, Hwang HE, Huang JG, Liu CA, Chau GY, Lee RC, Hung YP, Chao Y, Ho SY, Huang YH. Evolutionary Learning-Derived Clinical-Radiomic Models for Predicting Early Recurrence of Hepatocellular Carcinoma after Resection. Liver Cancer 2021;10:572-82. [PMID: 34950180 DOI: 10.1159/000518728] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
83 Zhang L, Chen D, Tu Y, Sang T, Pan T, Lin H, Cai C, Jin X, Wu F, Xu L, Chen Y. Vitexin attenuates autoimmune hepatitis in mouse induced by syngeneic liver cytosolic proteins via activation of AMPK/AKT/GSK-3β/Nrf2 pathway. Eur J Pharmacol 2021;:174720. [PMID: 34953801 DOI: 10.1016/j.ejphar.2021.174720] [Reference Citation Analysis]
84 Ergen P, Isik B, Arslan F, Karadag FY, Aydin O, Cag Y, Yazici S, Ucisik AC, Vahaboglu MH. Outcomes of Cessation of Antiviral Therapy in Chronic Hepatitis B: A Retrospective Cohort Study. Medeni Med J 2021;36:201-8. [PMID: 34915677 DOI: 10.5222/MMJ.2021.52959] [Reference Citation Analysis]
85 Wang Y, Chen B, Xiao C, Yu J, Bu X, Jiang F, Ding W, Ge Z. Effect of miR-183-5p on Cholestatic Liver Fibrosis by Regulating Fork Head Box Protein O1 Expression. Front Physiol 2021;12:737313. [PMID: 34867446 DOI: 10.3389/fphys.2021.737313] [Reference Citation Analysis]
86 Hwang JH, Kim HJ, Park H, Lee BS, Son HY, Kim YB, Jun SY, Park JH, Lee J, Cho JW. Implementation and Practice of Deep Learning-Based Instance Segmentation Algorithm for Quantification of Hepatic Fibrosis at Whole Slide Level in Sprague-Dawley Rats. Toxicol Pathol 2021;:1926233211057128. [PMID: 34866512 DOI: 10.1177/01926233211057128] [Reference Citation Analysis]
87 Rodríguez MJ, Sabaj M, Tolosa G, Herrera Vielma F, Zúñiga MJ, González DR, Zúñiga-Hernández J. Maresin-1 Prevents Liver Fibrosis by Targeting Nrf2 and NF-κB, Reducing Oxidative Stress and Inflammation. Cells 2021;10:3406. [PMID: 34943914 DOI: 10.3390/cells10123406] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
88 Marti-aguado D, Fernández-patón M, Alfaro-cervello C, Mestre-alagarda C, Bauza M, Gallen-peris A, Merino V, Benlloch S, Pérez-rojas J, Ferrández A, Puglia V, Gimeno-torres M, Aguilera V, Monton C, Escudero-garcía D, Alberich-bayarri Á, Serra MA, Marti-bonmati L. Digital Pathology Enables Automated and Quantitative Assessment of Inflammatory Activity in Patients with Chronic Liver Disease. Biomolecules 2021;11:1808. [DOI: 10.3390/biom11121808] [Reference Citation Analysis]
89 Ghanim AMH, Younis NS, Metwaly HA. Vanillin augments liver regeneration effectively in Thioacetamide induced liver fibrosis rat model. Life Sci 2021;286:120036. [PMID: 34637793 DOI: 10.1016/j.lfs.2021.120036] [Reference Citation Analysis]
90 Wu YN, Zhang R, Song XC, Han XX, Zhang J, Li X. C6orf120 gene knockout in rats mitigates concanavalin A‑induced autoimmune hepatitis via regulating NKT cells. Cell Immunol 2021;371:104467. [PMID: 34896761 DOI: 10.1016/j.cellimm.2021.104467] [Reference Citation Analysis]
91 Abdelhamid AM, Saber S, Youssef ME, Gaafar AGA, Eissa H, Abd-Eldayem MA, Alqarni M, Batiha GE, Obaidullah AJ, Shahien MA, El-Ahwany E, Amin NA, Etman MA, Kaddah MMY, Abd El-Fattah EE. Empagliflozin adjunct with metformin for the inhibition of hepatocellular carcinoma progression: Emerging approach for new application. Biomed Pharmacother 2022;145:112455. [PMID: 34844106 DOI: 10.1016/j.biopha.2021.112455] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
92 Chen YS, Yang SY, Wang PM, Wang CC, Yong CC, Chen DW, Liu YW, Chuang CH, Huang PY, Yao CC, Lin YP, Tsai MC. Concurrent Cholecystectomy Is Associated with a Lower Risk of Recurrence after Curative Resection in Early-Stage Hepatocellular Carcinoma: A 10 Year Observational Single-Center Study. J Pers Med 2021;11:1261. [PMID: 34945733 DOI: 10.3390/jpm11121261] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
93 Westendorf J, Wobeser B, Epp T. IIB or not IIB, part 1: retrospective evaluation of Kenney-Doig categorization of equine endometrial biopsies at a veterinary diagnostic laboratory and comparison with published reports. J Vet Diagn Invest 2021;:10406387211062207. [PMID: 34841986 DOI: 10.1177/10406387211062207] [Reference Citation Analysis]
94 Dou SD, Zhang JN, Xie XL, Liu T, Hu JL, Jiang XY, Wang MM, Jiang HD. MitoQ inhibits hepatic stellate cell activation and liver fibrosis by enhancing PINK1/parkin-mediated mitophagy. Open Med (Wars) 2021;16:1718-27. [PMID: 34825063 DOI: 10.1515/med-2021-0394] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
95 Giadans CG, Ríos DA, Ameigeiras B, Haddad L, De Matteo EN, Valva P, Preciado MV. Intrahepatic immune infiltrate in chronic hepatitis B and chronic hepatitis C: Similar but not the same. J Viral Hepat 2021. [PMID: 34820942 DOI: 10.1111/jvh.13635] [Reference Citation Analysis]
96 Öksüz Z, Üçbilek E, Serin MS, Yaraş S, Temel GÖ, Sezgin O. Possible relationship between IL28B rs12979860 and TLR2 -196 to -174 del/ins polymorphisms and the liver fibrosis stage in hepatitis C patients. Arch Virol 2021. [PMID: 34817649 DOI: 10.1007/s00705-021-05302-9] [Reference Citation Analysis]
97 Huang YJ, Cao J, Lee CY, Wu YM. Umbilical cord blood plasma-derived exosomes as a novel therapy to reverse liver fibrosis. Stem Cell Res Ther 2021;12:568. [PMID: 34772443 DOI: 10.1186/s13287-021-02641-x] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
98 Ravasi G, Pelucchi S, Bertola F, Capelletti MM, Mariani R, Piperno A. Identification of Novel Mutations by Targeted NGS Panel in Patients with Hyperferritinemia. Genes (Basel) 2021;12:1778. [PMID: 34828384 DOI: 10.3390/genes12111778] [Reference Citation Analysis]
99 Tan L, Xu SL, Mo ZS, Liu JR, Gan WQ, Chen JH, Gao ZL, Wu ZQ. The clinical value of serum hepatic parenchyma cell volume-normalized hepatitis B surface antigen levels in hepatitis B e antigen -positive and -negative chronic hepatitis B patients. Ann Transl Med 2021;9:1431. [PMID: 34733983 DOI: 10.21037/atm-21-3846] [Reference Citation Analysis]
100 Hirao H, Ito T, Kadono K, Kojima H, Naini BV, Nakamura K, Kageyama S, Busuttil RW, Kupiec-Weglinski JW, Kaldas FM. Donor Hepatic Occult Collagen Deposition Predisposes to Peritransplant Stress and Impacts Human Liver Transplantation. Hepatology 2021;74:2759-73. [PMID: 34170562 DOI: 10.1002/hep.32030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
101 Chen M, Wu Z, Du Z, Sun S, Wu J, Luo J. Diagnostic Accuracy of Red Blood Cell Distribution Width to Platelet Ratio for Predicting Liver Fibrosis in Patients with Chronic Hepatitis B: A Meta-analysis. Gastroenterol Hepatol 2021:S0210-5705(21)00303-4. [PMID: 34757161 DOI: 10.1016/j.gastrohep.2021.10.001] [Reference Citation Analysis]
102 Ding J, Wen Z. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database. BMC Cancer 2021;21:1157. [PMID: 34715816 DOI: 10.1186/s12885-021-08904-3] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
103 Zhang C, Li JW, Wu Z, Zhao H, Wang GQ. Significant Histologic Changes Are Not Rare in Treatment-naive Hepatitis B Patients with Normal Alanine Aminotransferase Level: A Meta-analysis. J Clin Transl Hepatol 2021;9:615-25. [PMID: 34722176 DOI: 10.14218/JCTH.2020.00136] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Llorens-Revull M, Gregori J, Dopazo C, Rodriguez-Frías F, Garcia-Cehic D, Soria ME, Chen Q, Rando A, Perales C, Esteban JI, Quer J, Bilbao I. Study of Quasispecies Complexity and Liver Damage Progression after Liver Transplantation in Hepatitis C Virus Infected Patients. Genes (Basel) 2021;12:1731. [PMID: 34828337 DOI: 10.3390/genes12111731] [Reference Citation Analysis]
105 Wang G, Duan Z. Guidelines for Prevention and Treatment of Chronic Hepatitis B. J Clin Transl Hepatol 2021;9:769-91. [PMID: 34722192 DOI: 10.14218/JCTH.2021.00209] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
106 Khalili M, King WC, Kleiner DE, Chung RT, Bhan AK, Ghany MG, Sulkowski MS, Lisker-Melman M, Jain MK, Janssen HLA, Hinerman AS, Sanyal AJ, Sterling RK. Evolution of Fatty Liver Disease and Relationship With Lipoproteins and Clinical Outcomes in Hepatitis B/Human Immunodeficiency Virus Coinfection. Clin Infect Dis 2021:ciab764. [PMID: 34698347 DOI: 10.1093/cid/ciab764] [Reference Citation Analysis]
107 Che YQ, Zhang Y, Li HB, Shen D, Cui W. Serum KLKB1 as a Potential Prognostic Biomarker for Hepatocellular Carcinoma Based on Data-Independent Acquisition and Parallel Reaction Monitoring. J Hepatocell Carcinoma 2021;8:1241-52. [PMID: 34676182 DOI: 10.2147/JHC.S325629] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
108 Dwivedi DK, Jena GB. Simultaneous Modulation of NLRP3 Inflammasome and Nrf2/ARE Pathway Rescues Thioacetamide-Induced Hepatic Damage in Mice: Role of Oxidative Stress and Inflammation. Inflammation 2021. [PMID: 34664134 DOI: 10.1007/s10753-021-01571-3] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
109 Ng SWK, Rouhani FJ, Brunner SF, Brzozowska N, Aitken SJ, Yang M, Abascal F, Moore L, Nikitopoulou E, Chappell L, Leongamornlert D, Ivovic A, Robinson P, Butler T, Sanders MA, Williams N, Coorens THH, Teague J, Raine K, Butler AP, Hooks Y, Wilson B, Birtchnell N, Naylor H, Davies SE, Stratton MR, Martincorena I, Rahbari R, Frezza C, Hoare M, Campbell PJ. Convergent somatic mutations in metabolism genes in chronic liver disease. Nature 2021;598:473-8. [PMID: 34646017 DOI: 10.1038/s41586-021-03974-6] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
110 Yim HJ, Kim W, Ahn SH, Jung YK, Um SH, Sohn JH, Jang JY, Kim DJ, Park ES, Jin SY, Kim KH. Besifovir therapy improves hepatic histology and reduces covalently closed circular DNA in chronic hepatitis B patients. J Gastroenterol Hepatol 2021. [PMID: 34653281 DOI: 10.1111/jgh.15710] [Reference Citation Analysis]
111 Xiao S, Deng Y, Shen N, Sun Y, Tang H, Hu P, Ren H, Peng M. Curc-mPEG454, a PEGylated curcumin derivative, as a multi-target anti-fibrotic prodrug. Int Immunopharmacol 2021;101:108166. [PMID: 34628270 DOI: 10.1016/j.intimp.2021.108166] [Reference Citation Analysis]
112 Tai Y, Zhao C, Zhang L, Tang S, Jia X, Tong H, Liu R, Tang C, Gao J. Celecoxib reduces hepatic vascular resistance in portal hypertension by amelioration of endothelial oxidative stress. J Cell Mol Med 2021;25:10389-402. [PMID: 34609050 DOI: 10.1111/jcmm.16968] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
113 Yu T, Ye X, Wen Z, Zhu G, Su H, Han C, Huang K, Qin W, Liao X, Yang C, Liu Z, Wang X, Xu B, Su M, Lv Z, Lau WY, Peng T. Intraoperative Indocyanine Green Retention Test of Left Hemiliver in Decision-Making for Patients With Hepatocellular Carcinoma Undergoing Right Hepatectomy. Front Surg 2021;8:709017. [PMID: 34604294 DOI: 10.3389/fsurg.2021.709017] [Reference Citation Analysis]
114 Yaraş S, Sezgin O, Üçbilek E, Özdoğan O, Altıntaş E. Significant decrease in liver stiffness detected by two dimensional shear-wave elastography after treatment with direct-acting antiviral agents in patients with chronic Hepatitis C. Turk J Gastroenterol 2020;31:142-7. [PMID: 32141823 DOI: 10.5152/tjg.2020.19418] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
115 Cengiz M, Ozenirler S. Serum Peptidyl-prolyl Cis-trans Isomerase NIMA-interacted 1 (Pin1) as a Non-invasive Marker for Liver Fibrosis due to Chronic Hepatitis C Virus. Hepat Mon 2021;21. [DOI: 10.5812/hepatmon.116687] [Reference Citation Analysis]
116 Ma Y, Su H, Yuksel M, Longhi MS, McPhail MJ, Wang P, Bansal S, Wong GW, Graham J, Yang L, J Thompson R, Doherty DG, Hadzic N, Zen Y, Quaglia A, Heneghan MA, Samyn M, Vergani D, Mieli-Vergani G. Human Leukocyte Antigen Profile Predicts Severity of Autoimmune Liver Disease in Children of European Ancestry. Hepatology 2021;74:2032-46. [PMID: 33971035 DOI: 10.1002/hep.31893] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
117 Feng S, Tong H, Gao JH, Tang SH, Yang WJ, Wang GM, Zhou HY, Wen SL. Anti-inflammation treatment for protection of hepatocytes and amelioration of hepatic fibrosis in rats. Exp Ther Med 2021;22:1213. [PMID: 34584558 DOI: 10.3892/etm.2021.10647] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
118 Sorda JA, González Ballerga E, Barreyro FJ, Avagnina A, Carballo P, Paes de Lima A, Daruich J. Bezafibrate therapy in primary biliary cholangitis refractory to ursodeoxycholic acid: a longitudinal study of paired liver biopsies at 5 years of follow up. Aliment Pharmacol Ther 2021;54:1202-12. [PMID: 34587309 DOI: 10.1111/apt.16618] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
119 Erken R, Zaaijer HL, Willemse SB, Bakker E, Takkenberg BB, Reesink HW, Kootstra NA. Hepatitis B core related antigen in relation to intrahepatic and circulating viral markers, before and after combination therapy. Ann Hepatol 2021;26:100540. [PMID: 34583061 DOI: 10.1016/j.aohep.2021.100540] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
120 Cohen CC, Castillo-Leon E, Farris AB, Caltharp SA, Cleeton RL, Sinclair EM, Shevell DE, Karsdal MA, Nielsen MJF, Leeming DJ, Vos MB. PRO-C3, a Serological Marker of Fibrosis, During Childhood and Correlations With Fibrosis in Pediatric NAFLD. Hepatol Commun 2021;5:1860-72. [PMID: 34558828 DOI: 10.1002/hep4.1766] [Reference Citation Analysis]
121 Okdemir S, Cakmak E. A novel non-invasive score for the prediction of advanced fibrosis in patients with chronic hepatitis B. Ann Hepatol 2021;27:100544. [PMID: 34571267 DOI: 10.1016/j.aohep.2021.100544] [Reference Citation Analysis]
122 Yu H, Liu C, Zhang F, Wang J, Han J, Zhou X, Wen Y, Shen T. Efficacy of Zhuyu Pill Intervention in a Cholestasis Rat Model: Mutual Effects on Fecal Metabolism and Microbial Diversity. Front Pharmacol 2021;12:695035. [PMID: 34539394 DOI: 10.3389/fphar.2021.695035] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
123 Behairy OG, El-shimi OS, Shalan NH, Baghdady SM. Association of the killer immunoglobulin-like receptor genes KIR2DS1 and KIR2DS4 with pediatric autoimmune hepatitis type I in Egypt. Egypt Liver Journal 2021;11. [DOI: 10.1186/s43066-021-00145-0] [Reference Citation Analysis]
124 Peng W, Yao M, Zou K, Li C, Wen T, Sun X. Postoperative controlling nutritional status score is an independent risk factor of survival for patients with small hepatocellular carcinoma: a retrospective study. BMC Surg 2021;21:338. [PMID: 34493254 DOI: 10.1186/s12893-021-01334-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
125 Du D, Lv W, Jing X, Ma X, Wuen J, Hasi S. Dietary supplementation of camel whey protein attenuates heat stress-induced liver injury by inhibiting NLRP3 inflammasome activation through the HMGB1/RAGE signalling pathway. Journal of Functional Foods 2021;84:104584. [DOI: 10.1016/j.jff.2021.104584] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
126 Sterling RK, King WC, Khalili M, Chung RT, Sulkowski M, Jain MK, Lisker-Melman M, Ghany MG, Wong DK, Hinerman AS, Bhan AK, Wahed AS, Kleiner DE; HBV-HIV Cohort Study of the Hepatitis B Research Network. A Prospective Study Evaluating Changes in Histology, Clinical and Virologic Outcomes in HBV-HIV Co-infected Adults in North America. Hepatology 2021;74:1174-89. [PMID: 33743541 DOI: 10.1002/hep.31823] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
127 Chen IY, Whitney-Miller CL, Liao X. Congenital hepatic fibrosis and its mimics: a clinicopathologic study of 19 cases at a single institution. Diagn Pathol 2021;16:81. [PMID: 34461951 DOI: 10.1186/s13000-021-01142-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
128 Nielsen MJ, Leeming DJ, Goodman Z, Friedman S, Frederiksen P, Rasmussen DGK, Vig P, Seyedkazemi S, Fischer L, Torstenson R, Karsdal MA, Lefebvre E, Sanyal AJ, Ratziu V. Comparison of ADAPT, FIB-4 and APRI as non-invasive predictors of liver fibrosis and NASH within the CENTAUR screening population. J Hepatol 2021:S0168-8278(21)02011-0. [PMID: 34454994 DOI: 10.1016/j.jhep.2021.08.016] [Reference Citation Analysis]
129 Pandit K, Kumar A, Kaur S, Kumar V, Jain SK, Bhardwaj R, Kaur S. Amelioration of oxidative stress by trans-Anethole via modulating phase I and phase II enzymes against hepatic damage induced by CCl4 in male Wistar rats. Environ Sci Pollut Res Int 2021. [PMID: 34453252 DOI: 10.1007/s11356-021-16070-z] [Reference Citation Analysis]
130 Yang T, Poenisch M, Khanal R, Hu Q, Dai Z, Li R, Song G, Yuan Q, Yao Q, Shen X, Taubert R, Engel B, Jaeckel E, Vogel A, Falk CS, Schambach A, Gerovska D, Araúzo-Bravo MJ, Vondran FWR, Cantz T, Horscroft N, Balakrishnan A, Chevessier F, Ott M, Sharma AD. Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model. J Hepatol 2021:S0168-8278(21)02006-7. [PMID: 34453962 DOI: 10.1016/j.jhep.2021.08.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
131 Zakaria S, El-Sisi AE. Daclatasvir and Sofosbuvir Mitigate Hepatic Fibrosis Through Downregulation of TNF-α / NF-κB Signaling Pathway. Curr Mol Pharmacol 2020;13:318-27. [PMID: 31951178 DOI: 10.2174/1874467213666200116114919] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
132 Lin S, Araujo C, Hall A, Kumar R, Phillips A, Hassan M, Engelmann C, Quaglia A, Jalan R. Prognostic Role of Liver Biopsy in Patients With Severe Indeterminate Acute Hepatitis. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00863-6. [PMID: 34389485 DOI: 10.1016/j.cgh.2021.08.008] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
133 Sabottke CF, Spieler BM, Moawad AW, Elsayes KM. Artificial Intelligence in Imaging of Chronic Liver Diseases: Current Update and Future Perspectives. Magn Reson Imaging Clin N Am 2021;29:451-63. [PMID: 34243929 DOI: 10.1016/j.mric.2021.05.011] [Reference Citation Analysis]
134 Markiewicz-Kijewska M, Szymańska S, Pyzlak M, Kaliciński P, Teisseyre J, Kowalski A, Jankowska I, Czubkowski P, Ismail H. Liver Histopathology in Late Protocol Biopsies after Pediatric Liver Transplantation. Children (Basel) 2021;8:671. [PMID: 34438562 DOI: 10.3390/children8080671] [Reference Citation Analysis]
135 Fujita K, Masaki T. Serum Biomarkers of Liver Fibrosis Staging in the Era of the Concept "Compensated Advanced Chronic Liver Disease". J Clin Med 2021;10:3340. [PMID: 34362121 DOI: 10.3390/jcm10153340] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
136 Lemoinne S, Heurgue A, Bouzbib C, Hanslik B, Gournay J, Nguyen-Khac E, Bureau C, de Lédinghen V, Ganne-Carrié N, Bourlière M. NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF AUTOIMMUNE HEPATITIS. Clin Res Hepatol Gastroenterol 2021;:101772. [PMID: 34332126 DOI: 10.1016/j.clinre.2021.101772] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
137 Lotowska JM, Sobaniec-Lotowska ME, Sobaniec P. Ultrastructural Profile Combined with Immunohistochemistry of a Hepatic Progenitor Cell Line in Pediatric Autoimmune Hepatitis: New Insights into the Morphological Pattern of the Disease. Cells 2021;10:1899. [PMID: 34440668 DOI: 10.3390/cells10081899] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
138 Tai Y, Zhao C, Lan T, Zhang L, Xiao Y, Tong H, Liu R, Tang C, Gao J. Integrated Analysis of Hepatic miRNA and mRNA Expression Profiles in the Spontaneous Reversal Process of Liver Fibrosis. Front Genet 2021;12:706341. [PMID: 34367261 DOI: 10.3389/fgene.2021.706341] [Reference Citation Analysis]
139 Kefalakes H, Horgan XJ, Jung MK, Amanakis G, Kapuria D, Bolte FJ, Kleiner DE, Koh C, Heller T, Rehermann B. Liver-Resident Bystander CD8+ T Cells Contribute to Liver Disease Pathogenesis in Chronic Hepatitis D Virus Infection. Gastroenterology 2021:S0016-5085(21)03278-9. [PMID: 34302839 DOI: 10.1053/j.gastro.2021.07.027] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
140 Zhao J, Ran M, Yang T, Chen L, Ji P, Xu X, Zhang L, Sun S, Liu X, Zhou S, Zhou L, Zhang J. Bicyclol Alleviates Signs of BDL-Induced Cholestasis by Regulating Bile Acids and Autophagy-Mediated HMGB1/p62/Nrf2 Pathway. Front Pharmacol 2021;12:686502. [PMID: 34366845 DOI: 10.3389/fphar.2021.686502] [Reference Citation Analysis]
141 Khedr MA, Salem TA, Boghdadi GM, Elharoun AS, El-Shahaway AA, Atallah HR, Sira MM. Seronegative autoimmune hepatitis in children : A real diagnostic challenge. Wien Klin Wochenschr 2021. [PMID: 34283299 DOI: 10.1007/s00508-021-01907-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
142 Wu L, Huang XQ, Li N, Xie C, Rao SX, Chen SY, Li F. A magnetic resonance imaging modality for non-invasively distinguishing progression of liver fibrosis by visualizing hepatic platelet-derived growth factor receptor-beta expression in mice. J Gastroenterol Hepatol 2021. [PMID: 34278598 DOI: 10.1111/jgh.15628] [Reference Citation Analysis]
143 Liang X, Liangliang X, Peng W, Tao Y, Jinfu Z, Ming Z, Mingqing X. Combined prognostic nutritional index and albumin-bilirubin grade to predict the postoperative prognosis of HBV-associated hepatocellular carcinoma patients. Sci Rep 2021;11:14624. [PMID: 34272447 DOI: 10.1038/s41598-021-94035-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
144 Saldarriaga OA, Dye B, Pham J, Wanninger TG, Millian D, Kueht M, Freiberg B, Utay N, Stevenson HL. Comparison of liver biopsies before and after direct-acting antiviral therapy for hepatitis C and correlation with clinical outcome. Sci Rep 2021;11:14506. [PMID: 34267267 DOI: 10.1038/s41598-021-93881-7] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
145 Abdelhamid AM, Elsheakh AR, Suddek GM, Abdelaziz RR. Telmisartan alleviates alcohol-induced liver injury by activation of PPAR-γ/ Nrf-2 crosstalk in mice. Int Immunopharmacol 2021;99:107963. [PMID: 34273638 DOI: 10.1016/j.intimp.2021.107963] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
146 Shi YW, Yang RX, Fan JG. Chronic hepatitis B infection with concomitant hepatic steatosis: Current evidence and opinion. World J Gastroenterol 2021; 27(26): 3971-3983 [PMID: 34326608 DOI: 10.3748/wjg.v27.i26.3971] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
147 Xiang S, Lu L, Zhong H, Lu M, Mao H. SERS diagnosis of liver fibrosis in the early stage based on gold nanostar liver targeting tags. Biomater Sci 2021;9:5035-44. [PMID: 34110332 DOI: 10.1039/d1bm00013f] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
148 Colucci G, Invernizzi F, Uceda Renteria S, Perbellini R, Degasperi E, D'Ambrosio R, Galmozzi E, Lunghi G, Sguazzini E, Lampertico P, Donato MF. The CCR5 and CXCR3 Pathways in Hepatitis C Virus Liver Transplanted Recipients Treated by a Direct Antiviral Agent Regimen: Informative Kinetics Profiles. Viral Immunol 2021. [PMID: 34252334 DOI: 10.1089/vim.2021.0035] [Reference Citation Analysis]
149 Chang XJ, Shi YW, Wang J, Liu HB, Chen Y, Zhu XN, Chen YP, Yu ZJ, Shang QH, Tan L, Li Q, Jiang L, Xiao GM, Chen L, Lu W, Hu XY, Long QH, An LJ, Zou ZY, Wong VW, Yang YP, Fan JG. Influence of weight management on the prognosis of steatohepatitis in chronic hepatitis B patients during antiviral treatment. Hepatobiliary Pancreat Dis Int 2021:S1499-3872(21)00122-3. [PMID: 34275749 DOI: 10.1016/j.hbpd.2021.06.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
150 Dai X, Zeng Y, Zhang H, Gu Z, Gong Q, Luo K. Advances on Nanomedicines for Diagnosis and Theranostics of Hepatic Fibrosis. Adv NanoBio Res 2021;1:2000091. [DOI: 10.1002/anbr.202000091] [Reference Citation Analysis]
151 Franceschini T, Vasuri F, Muratori P, Muratori L, Guido M, Lenzi M, D'Errico A. A practical histological approach to the diagnosis of autoimmune hepatitis: experience of an Italian tertiary referral center. Virchows Arch 2021. [PMID: 34189631 DOI: 10.1007/s00428-021-03122-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
152 Ehsan N, Sweed D, Elsabaawy M. Evaluation of HCV-related liver fibrosis post-successful DAA therapy. Egypt Liver Journal 2021;11. [DOI: 10.1186/s43066-021-00129-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
153 Kaur P, Shergill R, Mehta RG, Singh B, Arora S. Biofunctional significance of multi-herbal combination against paracetamol-induced hepatotoxicity in Wistar rats. Environ Sci Pollut Res Int 2021. [PMID: 34165748 DOI: 10.1007/s11356-021-15019-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
154 Angelico R, Spada M, Liccardo D, Pedini D, Grimaldi C, Pietrobattista A, Basso MS, Della Corte C, Mosca A, Saffioti MC, Alaggio R, Maggiore G, Candusso M, Francalanci P. Allograft Fibrosis After Pediatric Liver Transplantation: Incidence, Risk Factors, and Evolution. Liver Transpl 2021. [PMID: 34164907 DOI: 10.1002/lt.26218] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
155 Zhan Y, Ward SC, Fiel MI, Teruya-Feldstein J, McKay EM, Dekio F. EpCam is required for maintaining the integrity of the biliary epithelium. Liver Int 2021;41:2132-8. [PMID: 33786975 DOI: 10.1111/liv.14891] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
156 Derben FC, Engel B, Zachou K, Hartl J, Hartleben B, Bantel H, Schramm C, Dalekos GN, Manns MP, Jaeckel E, Taubert R. CK-18 cell death markers improve the prediction of histological remission in autoimmune hepatitis during biochemical remission. Liver Int 2021;41:123-7. [PMID: 33043565 DOI: 10.1111/liv.14699] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
157 Rodriguez-Baez N, Murray KF, Kleiner DE, Ling SC, Rosenthal P, Carlin K, Cooper K, Schwarz KB, Schwarzenberg SJ, Teckman JH, Ghany MG, Alawad AS. Hepatic Histology in Treatment-naïve Children With Chronic Hepatitis B Infection Living in the United States and Canada. J Pediatr Gastroenterol Nutr 2020;71:99-105. [PMID: 32265408 DOI: 10.1097/MPG.0000000000002712] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
158 Behairy OG, Elsadek AE, Behiry EG, Elhenawy IA, Shalan NH, Sayied KR. Clinical Value of Serum Interleukin-33 Biomarker in Infants With Neonatal Cholestasis. J Pediatr Gastroenterol Nutr 2020;70:344-9. [PMID: 31764415 DOI: 10.1097/MPG.0000000000002565] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
159 Kemme S, Stahl M, Brigham D, Lovell MA, Nakano T, Feldman AG, Mack C. Outcomes of Severe Seronegative Hepatitis-associated Aplastic Anemia: A Pediatric Case Series. J Pediatr Gastroenterol Nutr 2021;72:194-201. [PMID: 32925550 DOI: 10.1097/MPG.0000000000002940] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
160 Charchanti A, Kanavaros P, Koniaris E, Kataki A, Glantzounis G, Agnantis NJ, Goussia AC. Expression of Syndecan-1 in Chronic Liver Diseases: Correlation With Hepatic Fibrosis. In Vivo 2021;35:333-9. [PMID: 33402482 DOI: 10.21873/invivo.12264] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
161 Janowski K, Shumbayawonda E, Dennis A, Kelly M, Bachtiar V, DeBrota D, Langford C, Thomaides-Brears H, Pronicki M, Grajkowska W, Wozniak M, Pawliszak P, Chełstowska S, Jurkiewicz E, Banerjee R, Socha P. Multiparametric MRI as a Noninvasive Monitoring Tool for Children With Autoimmune Hepatitis. J Pediatr Gastroenterol Nutr 2021;72:108-14. [PMID: 32925554 DOI: 10.1097/MPG.0000000000002930] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
162 Laschtowitz A, Zachou K, Lygoura V, Pape S, Derben F, Jaeckel E, Oller-Moreno S, Weidemann S, Krech T, Piecha F, Schön G, Liebhoff AM, Al Tarrah M, Heneghan M, Drenth JPH, Dalekos G, Taubert R, Lohse AW, Schramm C. Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis. JHEP Rep 2021;3:100321. [PMID: 34381983 DOI: 10.1016/j.jhepr.2021.100321] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
163 Lackner C, Stauber RE, Davies S, Denk H, Dienes HP, Gnemmi V, Guido M, Miquel R, Paradis V, Schirmacher P, Terracciano L, Berghold A, Pregartner G, Binder L, Douschan P, Rainer F, Sygulla S, Jager M, Rautou PE, Bumbu A, Horhat A, Rusu I, Stefanescu H, Detlefsen S, Krag A, Thiele M, Cortez-Pinto H, Moreno C, Gouw ASH, Tiniakos DG. Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease. J Hepatol 2021:S0168-8278(21)00402-5. [PMID: 34126105 DOI: 10.1016/j.jhep.2021.05.029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
164 Younis NS, Ghanim AMH, Elmorsy MA, Metwaly HA. Taurine ameliorates thioacetamide induced liver fibrosis in rats via modulation of toll like receptor 4/nuclear factor kappa B signaling pathway. Sci Rep 2021;11:12296. [PMID: 34112866 DOI: 10.1038/s41598-021-91666-6] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
165 Ferri F, Carotti S, Carpino G, Mischitelli M, Cantafora A, Molinaro A, Argenziano ME, Parisse S, Corsi A, Riminucci M, Lai Q, Mennini G, Spadetta G, Pugliese F, Rossi M, Morini S, Gaudio E, Ginanni Corradini S. The Propensity of the Human Liver to Form Large Lipid Droplets Is Associated with PNPLA3 Polymorphism, Reduced INSIG1 and NPC1L1 Expression and Increased Fibrogenetic Capacity. Int J Mol Sci 2021;22:6100. [PMID: 34198853 DOI: 10.3390/ijms22116100] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
166 Liu W, He X, Huang F. Analysis of Serum MicroRNA-122 Expression at Different Stages of Chronic Hepatitis B Virus Infection. Biomed Res Int 2021;2021:9957440. [PMID: 34212044 DOI: 10.1155/2021/9957440] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
167 Waldenström J, Hellstrand K, Westin J, Nilsson S, Christensen P, Färkkilä M, Mørch K, Langeland N, Norkrans G, Lagging M. Presence of interferon-λ 4, male gender, absent/mild steatosis and low viral load augment antibody levels to hepatitis C virus. Scand J Gastroenterol 2021;56:849-54. [PMID: 34078234 DOI: 10.1080/00365521.2021.1922750] [Reference Citation Analysis]
168 Lei HJ, Wang SY, Chau IY, Li AF, Chau YP, Hsia CY, Chou SC, Kao YC, Chau GY. Hepatoma upregulated protein and Ki-67 expression in resectable hepatocellular carcinoma. J Chin Med Assoc 2021;84:623-32. [PMID: 33883465 DOI: 10.1097/JCMA.0000000000000540] [Reference Citation Analysis]
169 Covelli C, Sacchi D, Sarcognato S, Cazzagon N, Grillo F, Baciorri F, Fanni D, Cacciatore M, Maffeis V, Guido M. Pathology of autoimmune hepatitis. Pathologica 2021;113:185-93. [PMID: 34294936 DOI: 10.32074/1591-951X-241] [Reference Citation Analysis]
170 Vali Y, Lee J, Boursier J, Spijker R, Verheij J, Brosnan MJ, Anstee QM, Bossuyt PM, Zafarmand MH, On Behalf Of The Litmus Systematic Review Team. FibroTest for Evaluating Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Systematic Review and Meta-Analysis. J Clin Med 2021;10:2415. [PMID: 34072480 DOI: 10.3390/jcm10112415] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
171 Saffioti F, Hall A, de Krijger M, Verheij J, Hübscher SG, Maurice J, Luong TV, Pinzani M, Ponsioen CY, Thorburn D. Collagen proportionate area correlates with histological stage and predicts clinical events in primary sclerosing cholangitis. Liver Int 2021. [PMID: 34051052 DOI: 10.1111/liv.14979] [Reference Citation Analysis]
172 Guo Y, Li C, Zhang R, Zhan Y, Yu J, Tu J, Zheng J. Epigenetically-regulated serum GAS5 as a potential biomarker for patients with chronic hepatitis B virus infection. Cancer Biomark 2021. [PMID: 34092613 DOI: 10.3233/CBM-203169] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
173 Uçmak F, Yılmaz A, Ekin N, Ekinci A, Solmaz İ, Şenateş E. Vitamin D deficiency in patients with chronic hepatitis D viral infection. Clin Exp Hepatol 2021;7:141-8. [PMID: 34295980 DOI: 10.5114/ceh.2021.106505] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
174 Surana P, Hercun J, Takyar V, Kleiner DE, Heller T, Koh C. Platelet count as a screening tool for compensated cirrhosis in chronic viral hepatitis. World J Gastrointest Pathophysiol 2021; 12(3): 40-50 [PMID: 34084591 DOI: 10.4291/wjgp.v12.i3.40] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
175 Zhu X, Ye S, Yu D, Zhang Y, Li J, Zhang M, Leng Y, Yang T, Luo J, Chen X, Zhang H, Kong L. Physalin B attenuates liver fibrosis via suppressing LAP2α-HDAC1-mediated deacetylation of the transcription factor GLI1 and hepatic stellate cell activation. Br J Pharmacol 2021;178:3428-47. [PMID: 33864382 DOI: 10.1111/bph.15490] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
176 Lin MH, Li HQ, Zhu L, Su HY, Peng LS, Wang CY, He CP, Liang XE, Wang Y. Liver Fibrosis in the Natural Course of Chronic Hepatitis B Viral Infection: A Systematic Review with Meta-Analysis. Dig Dis Sci 2021. [PMID: 34008117 DOI: 10.1007/s10620-021-07009-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
177 Chang X, Wang J, Chen Y, Long Q, Song L, Li Q, Liu H, Shang Q, Yu Z, Jiang L, Xiao G, Li L, Chen L, Wang X, Li Z, Chen D, Dong Z, An L, Tan L, Chen Y, Yang Y. A novel nomogram to predict evident histological liver injury in patients with HBeAg-positive chronic hepatitis B virus infection. EBioMedicine 2021;67:103389. [PMID: 34004423 DOI: 10.1016/j.ebiom.2021.103389] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
178 Iannacone M, Guidotti LG. Immunobiology and pathogenesis of hepatitis B virus infection. Nat Rev Immunol 2021. [PMID: 34002067 DOI: 10.1038/s41577-021-00549-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 45] [Article Influence: 4.0] [Reference Citation Analysis]
179 Haep N, Florentino RM, Squires JE, Bell A, Soto-Gutierrez A. The Inside-Out of End-Stage Liver Disease: Hepatocytes are the Keystone. Semin Liver Dis 2021;41:213-24. [PMID: 33992030 DOI: 10.1055/s-0041-1725023] [Reference Citation Analysis]
180 Elshal M, Abu-Elsaad N, El-Karef A, Ibrahim T. Etanercept attenuates immune-mediated hepatitis induced by concanavalin A via differential regulation of the key effector cytokines of CD4+ T cells. Life Sci 2021;277:119618. [PMID: 34004252 DOI: 10.1016/j.lfs.2021.119618] [Reference Citation Analysis]
181 Carrere X, Pinto N, Gene Olaciregui N, Galluzzo L, Rossetti E, Celis Passini V, Salvador Marcos N, Chantada G, Braier J, Lavarino C, Felizzia G. High prevalence of BRAFV600E in patients with cholestasis, sclerosing cholangitis or liver fibrosis secondary to Langerhans cell histiocytosis. Pediatr Blood Cancer 2021;68:e29115. [PMID: 33991404 DOI: 10.1002/pbc.29115] [Reference Citation Analysis]
182 Sun YM, Chen SY, You H. Regression of liver fibrosis: evidence and challenges. Chin Med J (Engl) 2020;133:1696-702. [PMID: 32568866 DOI: 10.1097/CM9.0000000000000835] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
183 Atorrasagasti C, Piccioni F, Borowski S, Tirado-González I, Freitag N, Cantero MJ, Bayo J, Mazzolini G, Alaniz LD, Blois SM, Garcia MG. Acceleration of TAA-Induced Liver Fibrosis by Stress Exposure Is Associated with Upregulation of Nerve Growth Factor and Glycopattern Deviations. Int J Mol Sci 2021;22:5055. [PMID: 34064584 DOI: 10.3390/ijms22105055] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
184 Marella HK, Reddy YK, Jiang Y, Ganguli S, Podila PSB, Snell PD, Kovalic AJ, Cholankeril G, Singal AK, Nair S, Maliakkal B, Satapathy SK. Accuracy of Noninvasive Fibrosis Scoring Systems in African American and White Patients With Nonalcoholic Fatty Liver Disease. Clin Transl Gastroenterol 2020;11:e00165. [PMID: 32352687 DOI: 10.14309/ctg.0000000000000165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
185 Madadi-Sanjani O, Froemmel S, Falk CS, Vieten G, Petersen C, Kuebler JF, Klemann C. Growth Factors Assessed during Kasai Procedure in Liver and Serum Are Not Predictive for the Postoperative Liver Deterioration in Infants with Biliary Atresia. J Clin Med 2021;10:1978. [PMID: 34062967 DOI: 10.3390/jcm10091978] [Reference Citation Analysis]
186 Del Nonno F, Nardacci R, Colombo D, Visco-Comandini U, Cicalini S, Antinori A, Marchioni L, D'Offizi G, Piacentini M, Falasca L. Hepatic Failure in COVID-19: Is Iron Overload the Dangerous Trigger? Cells 2021;10:1103. [PMID: 34064487 DOI: 10.3390/cells10051103] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
187 Bulfoni M, Pravisani R, Dalla E, Cesselli D, Hidaka M, Di Loreto C, Eguchi S, Baccarani U. miRNA expression profiles in liver grafts of HCV and HIV/HCV-infected recipients, 6 months after liver transplantation. J Med Virol 2021;93:4992-5000. [PMID: 33818800 DOI: 10.1002/jmv.26999] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
188 Gowayed MA, Abdel-Bary A, El-Tahan RA. The effective interplay of (non-) selective NSAIDs with neostigmine in animal models of analgesia and inflammation. BMC Pharmacol Toxicol 2021;22:24. [PMID: 33933169 DOI: 10.1186/s40360-021-00488-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
189 Krishna M. Histological Grading and Staging of Chronic Hepatitis. Clin Liver Dis (Hoboken) 2021;17:222-6. [PMID: 33968379 DOI: 10.1002/cld.1014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
190 Yıldız Kaya S, Mete B, Kaya A, Balkan II, Saltoglu N, Tabak ÖF. The role of quantitative HBsAg in patients with HBV DNA between 2000-20,000 IU/ml. Wien Klin Wochenschr 2021;133:647-53. [PMID: 33914152 DOI: 10.1007/s00508-021-01854-7] [Reference Citation Analysis]
191 Kumada T, Toyoda H, Yasuda S, Sone Y, Ogawa S, Takeshima K, Tada T, Ito T, Sumida Y, Tanaka J. Prediction of Hepatocellular Carcinoma by Liver Stiffness Measurements Using Magnetic Resonance Elastography After Eradicating Hepatitis C Virus. Clin Transl Gastroenterol 2021;12:e00337. [PMID: 33888672 DOI: 10.14309/ctg.0000000000000337] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
192 Ma H, Liu J, Du Y, Zhang S, Cao W, Jia Z, Gong W, Zhang A. Estrogen-Related Receptor γ Agonist DY131 Ameliorates Lipopolysaccharide-Induced Acute Liver Injury. Front Pharmacol 2021;12:626166. [PMID: 33967760 DOI: 10.3389/fphar.2021.626166] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
193 Nishimura N, De Battista D, McGivern DR, Engle RE, Tice A, Fares-Gusmao R, Kabat J, Pomerenke A, Nguyen H, Sato S, Bock KW, Moore IN, Kleiner DE, Zamboni F, Alter HJ, Govindarajan S, Farci P. Chitinase 3-like 1 is a profibrogenic factor overexpressed in the aging liver and in patients with liver cirrhosis. Proc Natl Acad Sci U S A 2021;118:e2019633118. [PMID: 33888584 DOI: 10.1073/pnas.2019633118] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
194 Hemeda AA, Ahmad Mohamed A, Aziz RK, Abdel-Hakeem MS, Ali-Tammam M. Impact of IL10, MTP, SOD2, and APOE Gene Polymorphisms on the Severity of Liver Fibrosis Induced by HCV Genotype 4. Viruses 2021;13:714. [PMID: 33924242 DOI: 10.3390/v13040714] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
195 Liang KH, Lai MW, Lin YH, Chu YD, Lin CL, Lin WR, Huang YH, Wang TH, Chien RN, Hu TH, Yeh CT. Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients. BMC Gastroenterol 2021;21:177. [PMID: 33865328 DOI: 10.1186/s12876-021-01761-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
196 van den Brand FF, Snijders RJALM, de Boer YS, Verwer BJ, van Nieuwkerk CMJ, Bloemena E, Kuiken SD, Drenth JPH, Bouma G. Drug withdrawal in patients with autoimmune hepatitis in long-term histological remission: A prospective observational study. Eur J Intern Med 2021;90:30-6. [PMID: 33865679 DOI: 10.1016/j.ejim.2021.03.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
197 Heyens LJM, Busschots D, Koek GH, Robaeys G, Francque S. Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment. Front Med (Lausanne) 2021;8:615978. [PMID: 33937277 DOI: 10.3389/fmed.2021.615978] [Cited by in Crossref: 1] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
198 Ji D, Chen Y, Shang Q, Liu H, Tan L, Wang J, Chen Y, Li Q, Long Q, Song L, Jiang L, Xiao G, Yu Z, Chen L, Hu X, Wang X, Chen D, Li Z, Dong Z, Chen G, Yang Y. Unreliable Estimation of Fibrosis Regression During Treatment by Liver Stiffness Measurement in Patients With Chronic Hepatitis B. Am J Gastroenterol 2021. [PMID: 33840727 DOI: 10.14309/ajg.0000000000001239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
199 Scendoni R, Mirtella D, Froldi R, Valsecchi M, Ferrante L, Cingolani M. Correlation study between anatomopathological data and levels of blood morphine concentrations in heroin-related deaths. Leg Med (Tokyo) 2021;51:101877. [PMID: 33848788 DOI: 10.1016/j.legalmed.2021.101877] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
200 Kuznietsova H, Byelinska I, Dziubenko N, Lynchak O, Milokhov D, Khilya O, Finiuk N, Klyuchivska O, Stoika R, Rybalchenko V. Suppression of systemic inflammation and signs of acute and chronic cholangitis by multi-kinase inhibitor 1-(4-Cl-benzyl)-3-chloro-4-(CF3-phenylamino)-1H-pyrrole-2,5-dione. Mol Cell Biochem 2021;476:3021-35. [PMID: 33792809 DOI: 10.1007/s11010-021-04144-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
201 Islek A, Keskin H. Seronegative autoimmune hepatitis in children: a single-center experience. Acta Gastroenterol Belg 2021;84:305-10. [PMID: 34217180 DOI: 10.51821/84.2.305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
202 Beer A, Dienes HP. Autoimmune hepatitis-is histology conclusive? Ann Transl Med 2021;9:733. [PMID: 33987431 DOI: 10.21037/atm-20-5084] [Reference Citation Analysis]
203 Qu Z, Yang S, Xing F, Tong R, Yang C, Guo R, Huang J, Lu F, Fu C, Yan X, Hectors S, Gillen K, Wang Y, Liu C, Zhan S, Li J. Magnetic resonance quantitative susceptibility mapping in the evaluation of hepatic fibrosis in chronic liver disease: a feasibility study. Quant Imaging Med Surg 2021;11:1170-83. [PMID: 33816158 DOI: 10.21037/qims-20-720] [Reference Citation Analysis]
204 Dutta R, Iqbal A, Das P, Palanichamy JK, Singh A, Mehtab W, Chauhan A, Aggarwal A, Sreenivas V, Ahuja V, Datta Gupta S, Makharia GK. Liver involvement in patients with coeliac disease: proof of causality using IgA/anti-TG2 colocalisation techniques. J Clin Pathol 2021:jclinpath-2020-206735. [PMID: 33789921 DOI: 10.1136/jclinpath-2020-206735] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
205 Deng Z, Jin Z, Qin Y, Wei M, Wang J, Lu T, Zhang L, Zeng J, Bao L, Guo Y, Peng M, Xu B, Wen Z. Efficacy of the association liver partition and portal vein ligation for staged hepatectomy for the treatment of solitary huge hepatocellular carcinoma: a retrospective single-center study. World J Surg Oncol 2021;19:95. [PMID: 33785022 DOI: 10.1186/s12957-021-02199-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
206 Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Gastroenterology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Consensus on the diagnosis and treatment of hepatic fibrosis (2019). J Dig Dis 2020;21:127-38. [PMID: 32108989 DOI: 10.1111/1751-2980.12854] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
207 Kakiuchi T, Takahashi H, Iwane S, Koji A, Matsuo M. Entecavir administration to pregnant Japanese woman with chronic hepatitis B and hepatocellular carcinoma: A case report. Clin Case Rep 2021;9:1752-8. [PMID: 33768929 DOI: 10.1002/ccr3.3896] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
208 Ramot Y, Deshpande A, Morello V, Michieli P, Shlomov T, Nyska A. Microscope-Based Automated Quantification of Liver Fibrosis in Mice Using a Deep Learning Algorithm. Toxicol Pathol 2021;49:1126-33. [PMID: 33769147 DOI: 10.1177/01926233211003866] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
209 Saleh DO, Mansour DF, Fayez AM. Thioacetamide-induced acute hepatic encephalopathy: central vs peripheral effect of Allicin. Metab Brain Dis 2021;36:1331-40. [PMID: 33765229 DOI: 10.1007/s11011-021-00695-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
210 Hassanien KS, El-Sayed EM, Ismail RS, Zakarya ZM, Helal GK. Association between interleukin 28B polymorphism and sustained virological response to sofosbuvir plus daclatasvir in chronic hepatitis C genotype 4 Egyptian patients. J Clin Pharm Ther 2021;46:942-9. [PMID: 33768560 DOI: 10.1111/jcpt.13417] [Reference Citation Analysis]
211 Behairy BE, El-Said HH, Konswa HA, El-Deen AEN, Adawy NM, Sira AM. Predictors of azathioprine toxicity in children with autoimmune hepatitis. Clin Exp Hepatol 2021;7:47-54. [PMID: 34027115 DOI: 10.5114/ceh.2021.104634] [Reference Citation Analysis]
212 Mariani R, Pelucchi S, Paolini V, Belingheri M, di Gennaro F, Faverio P, Riva M, Pesci A, Piperno A. Prolonged exposure to welding fumes as a novel cause of systemic iron overload. Liver Int 2021;41:1600-7. [PMID: 33713383 DOI: 10.1111/liv.14874] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
213 Preti M, Schlott L, Lübbering D, Krzikalla D, Müller AL, Schuran FA, Poch T, Schakat M, Weidemann S, Lohse AW, Weiler-Normann C, Sebode M, Schwinge D, Schramm C, Carambia A, Herkel J. Failure of thymic deletion and instability of autoreactive Tregs drive autoimmunity in immune-privileged liver. JCI Insight 2021;6:141462. [PMID: 33600378 DOI: 10.1172/jci.insight.141462] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
214 Nakamura H, Ara M, Koga H, Miyano G, Okawada M, Doi T, Lane GJ, Okazaki T, Urao M, Yamataka A. Duration from the first pale stool to portoenterostomy is prognostic in biliary atresia. Comparison with age at portoenterostomy. Clin Res Hepatol Gastroenterol 2021;45:101584. [PMID: 33744827 DOI: 10.1016/j.clinre.2020.11.014] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
215 Lindquist DM, Fugate EM, Wang J, Sharma A, Gandhi CR, Dillman JR. MRI Measures of Murine Liver Fibrosis. J Magn Reson Imaging 2021;54:739-49. [PMID: 33738856 DOI: 10.1002/jmri.27601] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
216 Ling Q, Hu X, Jiang R, Liu H, Qiu H, Jiang X, Zubreri A, Zhu H, Wan J, Liu Y. CQMUH-011 mitigates autoimmune hepatitis via inhibiting the function of T lymphocytes. Drug Dev Res 2021. [PMID: 33733518 DOI: 10.1002/ddr.21813] [Reference Citation Analysis]
217 Li J, Wu Z, Wang GQ, Zhao H. Hepatitis B core-related antigen reflects viral replication and protein production in chronic hepatitis B patients. Chin Med J (Engl) 2021;134:1160-7. [PMID: 33734135 DOI: 10.1097/CM9.0000000000001418] [Reference Citation Analysis]
218 Teufel-Schäfer U, Flechtenmacher C, Fichtner A, Hoffmann GF, Schenk JP, Engelmann G. Transient elastography correlated to four different histological fibrosis scores in children with liver disease. Eur J Pediatr 2021;180:2237-44. [PMID: 33704581 DOI: 10.1007/s00431-021-04001-6] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
219 Chen S, Zhou J, Wu X, Meng T, Wang B, Liu H, Wang T, Zhao X, Kong Y, Wu S, Ou X, Jia J, Sun Y, You H. Comparison of fibrosis regression of entecavir alone or combined with pegylated interferon alpha2a in patients with chronic hepatitis B. Hepatol Int 2021;15:611-20. [PMID: 33677771 DOI: 10.1007/s12072-021-10162-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
220 Cho Y, Kabata D, Ehara E, Yamamoto A, Mizuochi T, Mushiake S, Kusano H, Kuwae Y, Suzuki T, Uchida-Kobayashi S, Morikawa H, Amano-Teranishi Y, Kioka K, Jogo A, Isoura Y, Hamazaki T, Murakami Y, Tokuhara D. Assessing liver stiffness with conventional cut-off values overestimates liver fibrosis staging in patients who received the Fontan procedure. Hepatol Res 2021;51:593-602. [PMID: 33677839 DOI: 10.1111/hepr.13627] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
221 Umeshappa CS, Solé P, Surewaard BGJ, Yamanouchi J, Mohapatra S, Uddin MM, Clarke R, Ortega M, Singha S, Mondal D, Yang Y, Vignali DAA, Serra P, Kubes P, Santamaria P. Liver-specific T regulatory type-1 cells program local neutrophils to suppress hepatic autoimmunity via CRAMP. Cell Rep 2021;34:108919. [PMID: 33789099 DOI: 10.1016/j.celrep.2021.108919] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
222 Bekki Y, Marti J, Toshima T, Lewis S, Kamath A, Argiriadi P, Simpson W, Facciuto L, Patel RS, Gunasekaran G, Kim E, Schiano TD, Facciuto ME. A comparative study of portal vein embolization versus radiation lobectomy with Yttrium-90 micropheres in preparation for liver resection for initially unresectable hepatocellular carcinoma. Surgery 2021;169:1044-51. [PMID: 33648768 DOI: 10.1016/j.surg.2020.12.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
223 Li K, Jiang F, Aizpuru M, Larson EL, Xie X, Zhou R, Xiang B. Successful management and technical aspects of major liver resection in children: A retrospective cohort study. Medicine (Baltimore) 2021;100:e24420. [PMID: 33578534 DOI: 10.1097/MD.0000000000024420] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
224 Zhang H, Liu F, Wen N, Li B, Wei Y. Patterns, timing, and predictors of recurrence after laparoscopic liver resection for hepatocellular carcinoma: results from a high-volume HPB center. Surg Endosc 2021. [PMID: 33620568 DOI: 10.1007/s00464-021-08390-5] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
225 Behairy OG, El-Gendy SA, Ibrahim DY, Mansour AI, El-Shimi OS. Mac-2 binding protein glycan isomer as noninvasive tool to assess liver fibrosis in children with chronic liver disease. Hepatol Res 2021;51:277-83. [PMID: 33393720 DOI: 10.1111/hepr.13608] [Reference Citation Analysis]
226 Pu S, Li Y, Liu Q, Zhang X, Chen L, Li R, Zhang J, Wu T, Tang Q, Yang X, Zhang Z, Huang Y, Kuang J, Li H, Zou M, Jiang W, He J. Inhibition of 5-Lipoxygenase in Hepatic Stellate Cells Alleviates Liver Fibrosis. Front Pharmacol 2021;12:628583. [PMID: 33679410 DOI: 10.3389/fphar.2021.628583] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
227 Comeglio P, Sarchielli E, Filippi S, Cellai I, Guarnieri G, Morelli A, Rastrelli G, Maseroli E, Cipriani S, Mello T, Galli A, Bruno BJ, Kim K, Vangara K, Papangkorn K, Chidambaram N, Patel MV, Maggi M, Vignozzi L. Treatment potential of LPCN 1144 on liver health and metabolic regulation in a non-genomic, high fat diet induced NASH rabbit model. J Endocrinol Invest 2021;44:2175-93. [PMID: 33586025 DOI: 10.1007/s40618-021-01522-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
228 Chen YC, Hsu CW, Jeng WJ, Lin CY. Advanced Liver Fibrosis Is Associated with Necroinflammatory Grade but Not Hepatic Steatosis in Chronic Hepatitis B Patients. Dig Dis Sci 2021. [PMID: 33569664 DOI: 10.1007/s10620-020-06761-x] [Reference Citation Analysis]
229 Shaked O, Demetris J, Levitsky J, Feng S, Loza BL, Punch J, Reyes J, Klintmalm G, Jackson W, DesMarais M, Sayre P, Shaked A, Reddy KR. Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation. Transplantation 2021. [PMID: 33982909 DOI: 10.1097/TP.0000000000003681] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
230 Satapathy SK, Tran QT, Kovalic AJ, Bontha SV, Jiang Y, Kedia S, Karri S, Mupparaju V, Podila PSB, Verma R, Maluf D, Mas V, Nair S, Eason JD, Bridges D, Kleiner DE. Clinical and Genetic Risk Factors of Recurrent Nonalcoholic Fatty Liver Disease After Liver Transplantation. Clin Transl Gastroenterol 2021;12:e00302. [PMID: 33555168 DOI: 10.14309/ctg.0000000000000302] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
231 Ting CT, Cheng YY, Tsai TH. Preclinical Pharmacokinetic Interaction and Histopathological Analyses of Hedyotis diffusa on Sorafenib in Rats. ACS Omega 2021;6:3060-7. [PMID: 33553923 DOI: 10.1021/acsomega.0c05461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
232 Li B, Chu F, Lu Q, Wang Y, Lane LA. Alternating stealth polymer coatings between administrations minimizes toxic and antibody immune responses towards nanomedicine treatment regimens. Acta Biomater 2021;121:527-40. [PMID: 33285326 DOI: 10.1016/j.actbio.2020.11.047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
233 Li Y, Yan L, Wang R, Wang Q, You Z, Li B, Zhang J, Huang B, Chen Y, Li Y, Lian M, Tang R, Qiu D, Gershwin ME, Xiao X, Miao Q, Ma X. Serum Immunoglobulin G Levels Predict Biochemical and Histological Remission of Autoimmune Hepatitis Type 1: A Single-Center Experience and Literature Review. Clin Rev Allergy Immunol 2021. [PMID: 33512642 DOI: 10.1007/s12016-021-08833-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
234 Yang L, Hou J, Han E, Qiao G, Liu L, Men X. Decreased Plasma Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Levels are Linked with Disease Severity in Patients with Liver Cirrhosis. Int J Pept Res Ther 2021;27:1229-37. [DOI: 10.1007/s10989-021-10163-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
235 Hsu YC, Chen CY, Chang IW, Chang CY, Wu CY, Lee TY, Wu MS, Bair MJ, Chen JJ, Chen CC, Tseng CH, Tai CM, Huang YT, Ku WH, Mo LR, Lin JT. Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial. Lancet Infect Dis 2021;21:823-33. [PMID: 33524314 DOI: 10.1016/S1473-3099(20)30692-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
236 Zhang Y, Jia Q, Hu C, Han M, Guo Q, Li S, Bo C, Zhang Y, Qi X, Sai L, Peng C. Effects of chlorpyrifos exposure on liver inflammation and intestinal flora structure in mice. Toxicol Res (Camb) 2021;10:141-9. [PMID: 33613981 DOI: 10.1093/toxres/tfaa108] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
237 Huang TH, Lin MT, Wang JH, Chang KC, Yen YH, Kuo FY, Huang CC, Hsiao CC, Chiu SY, Lu SN, Wang CC, Hu TH. Clinical and novel application of FibroScan, FIB-4 and aspartate aminotransferase-to-platelet ratio index in liver fibrosis evaluation in patients with hepatocellular carcinoma and their roles in oesophageal variceal prediction. Int J Clin Pract 2021;75:e13945. [PMID: 33338308 DOI: 10.1111/ijcp.13945] [Reference Citation Analysis]
238 de Moraes LR, Delicato MEA, da Silva Cruz A, Pereira da Silva HTFN, de Vasconcelos Alves CVB, Campos DB, Saraiva EP, Perazzo da Costa F, Guerra RR. Methionine supplementing effects on intestine, liver and uterus morphology, and on positivity and expression of Calbindin-D28k and TRPV6 epithelial calcium carriers in laying quail in thermoneutral conditions and under thermal stress. PLoS One 2021;16:e0245615. [PMID: 33449938 DOI: 10.1371/journal.pone.0245615] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
239 Namisaki T, Fujinaga Y, Moriya K, Yoshiji H. The association of histological progression with biochemical response to ursodeoxycholic acid in primary biliary cholangitis. Hepatol Res 2021;51:31-8. [DOI: 10.1111/hepr.13593] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
240 Mukhtar S, Xiaoxiong Z, Qamer S, Saad M, Mubarik MS, Mahmoud AH, Mohammed OB. Hepatoprotective activity of silymarin encapsulation against hepatic damage in albino rats. Saudi J Biol Sci 2021;28:717-23. [PMID: 33424359 DOI: 10.1016/j.sjbs.2020.10.063] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
241 Muratori P, Granito A, Lenzi M, Muratori L. Limitation of the simplified scoring system for the diagnosis of autoimmune Hepatitis with acute onset. Liver Int 2021;41:529-34. [PMID: 33389800 DOI: 10.1111/liv.14778] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
242 Ballestri S, Mantovani A, Baldelli E, Lugari S, Maurantonio M, Nascimbeni F, Marrazzo A, Romagnoli D, Targher G, Lonardo A. Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease. Diagnostics (Basel) 2021;11:98. [PMID: 33435415 DOI: 10.3390/diagnostics11010098] [Cited by in Crossref: 13] [Cited by in F6Publishing: 26] [Article Influence: 13.0] [Reference Citation Analysis]
243 Iossa D, Vitrone M, Gagliardi M, Falco E, Ragone E, Zampino R, Durante-Mangoni E. Anthropometric parameters and liver histology influence lipid metabolic changes in HCV chronic hepatitis on direct-acting antiviral treatment. Ann Transl Med 2021;9:35. [PMID: 33553328 DOI: 10.21037/atm-20-669] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
244 Weinberg EM, Curry MP, Frenette CT, Regenstein FG, Schiff ER, Goodman ZD, Robinson JM, Chan JL, Imperial JC, Reddy KR. Multicenter, Double-Blind, Randomized Trial of Emricasan in Hepatitis C-Treated Liver Transplant Recipients With Residual Fibrosis or Cirrhosis. Liver Transpl 2021;27:568-79. [PMID: 33164276 DOI: 10.1002/lt.25934] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
245 Atanasova I, Sojoodi M, Leitão HS, Shuvaev S, Geraldes CFGC, Masia R, Guimaraes AS, Tanabe KK, Fuchs BC, Caravan P. Molecular Magnetic Resonance Imaging of Fibrin Deposition in the Liver as an Indicator of Tissue Injury and Inflammation. Invest Radiol 2020;55:209-16. [PMID: 31895219 DOI: 10.1097/RLI.0000000000000631] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
246 Derks TGJ, Peeks F, de Boer F, Fokkert-Wilts M, van der Doef HPJ, van den Heuvel MC, Szymańska E, Rokicki D, Ryan PT, Weinstein DA. The potential of dietary treatment in patients with glycogen storage disease type IV. J Inherit Metab Dis 2021;44:693-704. [PMID: 33332610 DOI: 10.1002/jimd.12339] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
247 Wang Z, Cheng ZX, Abrams ST, Lin ZQ, Yates E, Yu Q, Yu WP, Chen PS, Toh CH, Wang GZ. Extracellular histones stimulate collagen expression in vitro and promote liver fibrogenesis in a mouse model via the TLR4-MyD88 signaling pathway. World J Gastroenterol 2020; 26(47): 7513-7527 [PMID: 33384551 DOI: 10.3748/wjg.v26.i47.7513] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
248 Zhang Y, Li Y, Mu T, Tong N, Cheng P. Hepatic stellate cells specific liposomes with the Toll-like receptor 4 shRNA attenuates liver fibrosis. J Cell Mol Med 2021;25:1299-313. [PMID: 33336563 DOI: 10.1111/jcmm.16209] [Reference Citation Analysis]
249 Ibrahim IM, Haikal A, Ali KM, AlSayed MAL, Barakat TE. Cognitive impairment in children with chronic Hepatitis C Virus: Case control study. Clin Child Psychol Psychiatry 2021;26:381-92. [PMID: 33325269 DOI: 10.1177/1359104520974434] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
250 Wu CJ, Chau GY, Lee IC, Huo TI, Su CW, Hou MC, Huang YH. Early and late recurrence of surgically resected hepatitis B virus-related hepatocellular carcinoma on nucleos(t)ide analogues therapy. J Formos Med Assoc 2021;120:1563-71. [PMID: 33334659 DOI: 10.1016/j.jfma.2020.11.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
251 Beyazal M, Beyazal Polat H, Ertürk A, Bedir R. Noninvasive Assessment of Liver Parenchyma Using Gray-Scale Ultrasound-Based Histogram Analysis in Patients With Chronic Hepatitis B Infection. Ultrasound Q 2020;36:69-73. [PMID: 30855417 DOI: 10.1097/RUQ.0000000000000438] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
252 Zhang L, Li MH, Yi W, Lu Y, Wu S, Hao H, Gao Y, Lu H, Chen Q, Shen G, Chang M, Hu L, Liu R, Sun L, Wan G, Xie Y. AST and HBeAg Level Can Help to Distinguish Non-Minimal Liver Inflammation in Persistently Normal Alanine Aminotransferase of Chronic HBV Infection. Hepat Mon 2020;20. [DOI: 10.5812/hepatmon.99580] [Reference Citation Analysis]
253 Mole DJ, Fallowfield JA, Sherif AE, Kendall T, Semple S, Kelly M, Ridgway G, Connell JJ, McGonigle J, Banerjee R, Brady JM, Zheng X, Hughes M, Neyton L, McClintock J, Tucker G, Nailon H, Patel D, Wackett A, Steven M, Welsh F, Rees M; HepaT1ca Study Group. Quantitative magnetic resonance imaging predicts individual future liver performance after liver resection for cancer. PLoS One 2020;15:e0238568. [PMID: 33264327 DOI: 10.1371/journal.pone.0238568] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
254 Lohse AW, Sebode M, Jørgensen MH, Ytting H, Karlsen TH, Kelly D, Manns MP, Vesterhus M. Second-line and third-line therapy for autoimmune hepatitis: A position statement from the European Reference Network on Hepatological Diseases and the International Autoimmune Hepatitis Group. Journal of Hepatology 2020;73:1496-506. [DOI: 10.1016/j.jhep.2020.07.023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
255 Yassin S, De Lacy R, Pillay K, Goddard E. Characteristics and Outcomes of Autoimmune Hepatitis from a Tertiary Paediatric Centre, Cape Town, South Africa. J Trop Pediatr 2020;66:448-57. [PMID: 31943108 DOI: 10.1093/tropej/fmz088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
256 Chi Z, Zhao W, Li JW, Liu H, Shao C, Zhao H, Gui-Qiang W. Combination of quantitative hepatitis B core antibody (qHBcAb) and aspartate aminotransferase (AST) can accurately diagnose immune tolerance of chronic hepatitis B virus infection based on liver biopsy. Clin Res Hepatol Gastroenterol 2020;:101563. [PMID: 33272888 DOI: 10.1016/j.clinre.2020.10.008] [Reference Citation Analysis]
257 Levy NA, Kern G, Shepshelovich D, Shibolet O, Hershkoviz R, Isakov O. Effect of liver fibrosis on survival in patients with intrahepatic cholangiocarcinoma: a SEER population-based study. Oncotarget 2020;11:4438-47. [PMID: 33315979 DOI: 10.18632/oncotarget.27820] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
258 Rodríguez MJ, Herrera F, Donoso W, Castillo I, Orrego R, González DR, Zúñiga-Hernández J. Pro-Resolving Lipid Mediator Resolvin E1 Mitigates the Progress of Diethylnitrosamine-Induced Liver Fibrosis in Sprague-Dawley Rats by Attenuating Fibrogenesis and Restricting Proliferation. Int J Mol Sci 2020;21:E8827. [PMID: 33266360 DOI: 10.3390/ijms21228827] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
259 Ye L, Kriegl L, Reiter FP, Munker SM, Itzel T, Teufel A, Ziesch A, Török HP, Kirchner T, Gerbes AL, Guba M, Mayerle J, De Toni EN. Prognostic Significance and Functional Relevance of Olfactomedin 4 in Early-Stage Hepatocellular Carcinoma. Clin Transl Gastroenterol 2020;11:e00124. [PMID: 31990698 DOI: 10.14309/ctg.0000000000000124] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
260 Chen H, Cai J, Wang J, Qiu Y, Jiang C, Wang Y, Wang Y, Yi C, Guo Lv, Pan L, Guan Y, Zheng J, Qiu D, Du C, Liu Q, Chen G, Yang Y, Xu Y, Xiang AP, Zhang Q. Targeting Nestin+ hepatic stellate cells ameliorates liver fibrosis by facilitating TβRI degradation. J Hepatol 2021;74:1176-87. [PMID: 33217494 DOI: 10.1016/j.jhep.2020.11.016] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
261 Meerpoel C, Vidal A, Tangni EK, Huybrechts B, Couck L, De Rycke R, De Bels L, De Saeger S, Van den Broeck W, Devreese M, Croubels S. A Study of Carry-Over and Histopathological Effects after Chronic Dietary Intake of Citrinin in Pigs, Broiler Chickens and Laying Hens. Toxins (Basel) 2020;12:E719. [PMID: 33207646 DOI: 10.3390/toxins12110719] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
262 Stein S, Henze L, Poch T, Carambia A, Krech T, Preti M, Schuran FA, Reich M, Keitel V, Fiorotto R, Strazzabosco M, Fischer L, Li J, Müller LM, Wagner J, Gagliani N, Herkel J, Schwinge D, Schramm C. IL-17A/F enable cholangiocytes to restrict T cell-driven experimental cholangitis by upregulating PD-L1 expression. J Hepatol 2021;74:919-30. [PMID: 33197512 DOI: 10.1016/j.jhep.2020.10.035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
263 Sharma S, Agarwal S, Kaushal K, Anand A, Gunjan D, Yadav R, Saraya A. Presence and type of decompensation affects outcomes in autoimmune hepatitis upon treatment with corticosteroids. JGH Open 2021;5:81-90. [PMID: 33490617 DOI: 10.1002/jgh3.12451] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
264 Papic N, Radmanic L, Dusek D, Kurelac I, Zidovec Lepej S, Vince A. Trends of Late Presentation to Care in Patients with Chronic Hepatitis C during a 10-Year Period in Croatia. Infect Dis Rep 2020;12:74-81. [PMID: 33187150 DOI: 10.3390/idr12030016] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
265 Satapathy SK, Banerjee P, Pierre JF, Higgins D, Dutta S, Heda R, Khan SD, Mupparaju VK, Mas V, Nair S, Eason JD, Kleiner DE, Maluf DG. Characterization of Gut Microbiome in Liver Transplant Recipients With Nonalcoholic Steatohepatitis. Transplant Direct 2020;6:e625. [PMID: 33204823 DOI: 10.1097/TXD.0000000000001033] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
266 Ghinolfi D, Dondossola D, Rreka E, Lonati C, Pezzati D, Cacciatoinsilla A, Kersik A, Lazzeri C, Zanella A, Peris A, Maggioni M, Biancofiore G, Reggiani P, Morganti R, De Simone P, Rossi G. Sequential Use of Normothermic Regional and Ex Situ Machine Perfusion in Donation After Circulatory Death Liver Transplant.Liver Transpl. 2021;27:385-402. [PMID: 32949117 DOI: 10.1002/lt.25899] [Cited by in Crossref: 8] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
267 Malekinezhad P, Ellestad LE, Afzali N, Farhangfar SH, Omidi A, Mohammadi A. Evaluation of berberine efficacy in reducing the effects of aflatoxin B1 and ochratoxin A added to male broiler rations. Poult Sci 2021;100:797-809. [PMID: 33518134 DOI: 10.1016/j.psj.2020.10.040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
268 Marti-Aguado D, Rodríguez-Ortega A, Alberich-Bayarri A, Marti-Bonmati L. Magnetic Resonance imaging analysis of liver fibrosis and inflammation: overwhelming gray zones restrict clinical use. Abdom Radiol (NY) 2020;45:3557-68. [PMID: 32857259 DOI: 10.1007/s00261-020-02713-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
269 He W, Ni W, Zhao L, Wang X, Liu L, Fan Z. MicroRNA-125a/VDR axis impaired autophagic flux and contributed to fibrosis in a CCL4-induced mouse model and patients with liver cirrhosis. Life Sci 2021;264:118666. [PMID: 33130085 DOI: 10.1016/j.lfs.2020.118666] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
270 Biewenga M, Inderson A, Tushuizen ME, Crobach ASLP, van Hoek B. Early Predictors of Short-Term Prognosis in Acute and Acute Severe Autoimmune Hepatitis. Liver Transpl 2020;26:1573-81. [PMID: 32997870 DOI: 10.1002/lt.25906] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
271 Munday JS, Ridler A, Aberdein D, Thomson NA, Griffiths K. Chronic facial eczema in sheep: description of gross and histological changes in the liver and association with serum gamma-glutamyltransferase activity at the time of sporidesmin intoxication. N Z Vet J 2021;69:104-12. [PMID: 32981484 DOI: 10.1080/00480169.2020.1823904] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
272 Lensu S, Pariyani R, Mäkinen E, Yang B, Saleem W, Munukka E, Lehti M, Driuchina A, Lindén J, Tiirola M, Lahti L, Pekkala S. Prebiotic Xylo-Oligosaccharides Ameliorate High-Fat-Diet-Induced Hepatic Steatosis in Rats. Nutrients 2020;12:E3225. [PMID: 33105554 DOI: 10.3390/nu12113225] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
273 Li J, Xue J, Ling M, Sun J, Xiao T, Dai X, Sun Q, Cheng C, Xia H, Wei Y, Chen F, Liu Q. MicroRNA-15b in extracellular vesicles from arsenite-treated macrophages promotes the progression of hepatocellular carcinomas by blocking the LATS1-mediated Hippo pathway. Cancer Lett 2021;497:137-53. [PMID: 33080309 DOI: 10.1016/j.canlet.2020.10.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
274 Yang Y, Wang MC, Tian T, Huang J, Yuan SX, Liu L, Zhu P, Gu FM, Fu SY, Jiang BG, Liu FC, Pan ZY, Zhou WP. A High Preoperative Platelet-Lymphocyte Ratio Is a Negative Predictor of Survival After Liver Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma: A Retrospective Study. Front Oncol 2020;10:576205. [PMID: 33178607 DOI: 10.3389/fonc.2020.576205] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
275 Galal SM, Soror SM, Hussien O, Moustafa EF, Hassany SM. Noninvasive assessment of liver fibrosis in children with chronic hepatitis C: Shear wave elastography and APRI versus liver biopsy. Arab J Gastroenterol 2020;21:253-9. [PMID: 33041193 DOI: 10.1016/j.ajg.2020.08.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
276 Rostami T, Monzavi SM, Poustchi H, Khoshdel AR, Behfar M, Hamidieh AA. Analysis of determinant factors of liver fibrosis progression in ex-thalassemic patients. Int J Hematol 2021;113:145-57. [PMID: 33033952 DOI: 10.1007/s12185-020-02998-4] [Reference Citation Analysis]
277 Guo Q, Chen M, Chen Q, Xiao G, Chen Z, Wang X, Huang Y. Silencing p53 inhibits interleukin 10-induced activated hepatic stellate cell senescence and fibrotic degradation in vivo. Exp Biol Med (Maywood) 2021;246:447-58. [PMID: 33028080 DOI: 10.1177/1535370220960391] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
278 Zhang H, Liu M, Liu X, Zhong W, Li Y, Ran Y, Guo L, Chen X, Zhao J, Wang B, Zhou L. Bifidobacterium animalis ssp. Lactis 420 Mitigates Autoimmune Hepatitis Through Regulating Intestinal Barrier and Liver Immune Cells. Front Immunol. 2020;11:569104. [PMID: 33123141 DOI: 10.3389/fimmu.2020.569104] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
279 Tasneem AA, Luck NH. Autoimmune Hepatitis: Clinical Characteristics and Predictors of Biochemical Response to Treatment. J Transl Int Med 2020;8:106-11. [PMID: 32983933 DOI: 10.2478/jtim-2020-0016] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
280 Simoes CC, Thung SN, Fiel MI, Sung MW, Schwartz ME, Ward SC. Morphology of tumor and nontumor tissue in liver resection specimens for hepatocellular carcinoma following nivolumab therapy. Mod Pathol 2021;34:823-33. [PMID: 32989224 DOI: 10.1038/s41379-020-00679-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
281 Lam S, Singh R, Dillman JR, Trout AT, Serai SD, Sharma D, Sheridan R, Su W, Fei L, Karns R, Haramija MM, Ridgway G, Goldfinger M, Squires JE, Denson LA, Hyams JS, Miethke AG. Serum Matrix Metalloproteinase 7 Is a Diagnostic Biomarker of Biliary Injury and Fibrosis in Pediatric Autoimmune Liver Disease. Hepatol Commun 2020;4:1680-93. [PMID: 33163837 DOI: 10.1002/hep4.1589] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
282 Öksüz Z, Üçbilek E, Serin MS, Yaraş S, Temel GO, Sezgin O. Circulating vascular adhesion protein-1(VAP-1): a possible biomarker for liver fibrosis associated with chronic hepatitis B and C. Braz J Microbiol 2020;51:1757-63. [PMID: 32959205 DOI: 10.1007/s42770-020-00379-x] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
283 Khalil R, Shata A, Abd El-Kader EM, Sharaf H, Abdo WS, Amin NA, Saber S. Vildagliptin, a DPP-4 inhibitor, attenuates carbon tetrachloride-induced liver fibrosis by targeting ERK1/2, p38α, and NF-κB signaling. Toxicol Appl Pharmacol 2020;407:115246. [PMID: 32956689 DOI: 10.1016/j.taap.2020.115246] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
284 Zeyada MS, Abdel-Rahman N, El-Karef A, Yahia S, El-Sherbiny IM, Eissa LA. Niclosamide-loaded polymeric micelles ameliorate hepatocellular carcinoma in vivo through targeting Wnt and Notch pathways. Life Sci 2020;261:118458. [PMID: 32961231 DOI: 10.1016/j.lfs.2020.118458] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
285 Hirschfield GM, Beuers U, Kupcinskas L, Ott P, Bergquist A, Färkkilä M, Manns MP, Parés A, Spengler U, Stiess M, Greinwald R, Pröls M, Wendum D, Drebber U, Poupon R. A placebo-controlled randomised trial of budesonide for PBC following an insufficient response to UDCA. J Hepatol 2021;74:321-9. [PMID: 32950590 DOI: 10.1016/j.jhep.2020.09.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
286 Coskun Y, Yuksel I. Serum rheumatoid factor is correlated with liver fibrosis in patients with chronic hepatitis B. Wien Klin Wochenschr 2021;133:432-40. [PMID: 32929574 DOI: 10.1007/s00508-020-01732-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
287 Yan B, Bai DS, Qian JJ, Zhang C, Jin SJ, Wang X, Jiang GQ. Differences in tumour characteristics of Hepatocellular Carcinoma between patients with and without Cirrhosis: A population-based study. J Cancer 2020;11:5812-21. [PMID: 32913474 DOI: 10.7150/jca.46927] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
288 Mada PK, Malus ME, Saldaña Koppel DA, Adley S, Moore M, Alam MJ, Feldman M. Predicting Liver Fibrosis in the Hepatitis C Population: Concordance Analysis Between Noninvasive Scoring Systems and Percutaneous Liver Biopsy. Cureus 2020;12:e10376. [PMID: 33062499 DOI: 10.7759/cureus.10376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
289 Moreau J, Bouzy P, Guillard J, Untereiner V, Garnotel R, Marchal A, Gobinet C, Terryn C, Sockalingum GD, Thiéfin G. Analysis of Hepatic Fibrosis Characteristics in Cirrhotic Patients with and without Hepatocellular Carcinoma by FTIR Spectral Imaging. Molecules 2020;25:E4092. [PMID: 32906799 DOI: 10.3390/molecules25184092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
290 Yao TT, Pan J, Qian JD, Cheng H, Wang Y, Wang GQ. Shear wave elastography may be sensitive and more precise than transient elastography in predicting significant fibrosis. World J Clin Cases 2020; 8(17): 3730-3742 [PMID: 32953849 DOI: 10.12998/wjcc.v8.i17.3730] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
291 Ficht X, Iannacone M. Immune surveillance of the liver by T cells. Sci Immunol. 2020;5:eaba2351. [PMID: 32887842 DOI: 10.1126/sciimmunol.aba2351] [Cited by in Crossref: 3] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
292 Monti L, Salsano M, Candusso M, Avolio AW, Soglia G, Marino M, Francalanci P, Spada M, Toma P. Diagnosis of Acute Rejection of Liver Grafts in Young Children Using Acoustic Radiation Force Impulse Imaging. AJR Am J Roentgenol 2020;215:1229-37. [PMID: 32877250 DOI: 10.2214/AJR.19.22057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
293 Abdelhamid AM, Elsheakh AR, Abdelaziz RR, Suddek GM. Empagliflozin ameliorates ethanol-induced liver injury by modulating NF-κB/Nrf-2/PPAR-γ interplay in mice. Life Sciences 2020;256:117908. [DOI: 10.1016/j.lfs.2020.117908] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
294 Karvar S, Ansa-Addo EA, Suda J, Singh S, Zhu L, Li Z, Rockey DC. Moesin, an Ezrin/Radixin/Moesin Family Member, Regulates Hepatic Fibrosis. Hepatology 2020;72:1073-84. [PMID: 31860744 DOI: 10.1002/hep.31078] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
295 Khalili M, King WC, Kleiner DE, Jain MK, Chung RT, Sulkowski M, Lisker-melman M, Wong DK, Ghany M, Sanyal A, Sterling RK. Fatty Liver Disease in a Prospective North American Cohort of Adults With Human Immunodeficiency Virus and Hepatitis B Virus Coinfection. Clinical Infectious Diseases 2020. [DOI: 10.1093/cid/ciaa1303] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
296 Bahmani M, Ziamajidi N, Hashemnia M, Abbasalipourkabir R. Human umbilical cord-derived mesenchymal stem cells conditioned medium ameliorates CCl 4 -induced liver fibrosis through regulation of expression and activity of liver lysyl oxidase. Toxin Reviews 2021;40:971-84. [DOI: 10.1080/15569543.2020.1813779] [Reference Citation Analysis]
297 Elnfarawy AA, Nashy AE, Abozaid AM, Komber IF, Elweshahy RH, Abdelrahman RS. Vinpocetine attenuates thioacetamide-induced liver fibrosis in rats. Hum Exp Toxicol 2021;40:355-68. [DOI: 10.1177/0960327120947453] [Cited by in Crossref: 2] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
298 Wu Y, Gao S, Yin X, Zhang L, Yao M, Wei D. Hepatic Arterial Blood Flow Index Is Associated with the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B Virus Infection. Hepat Mon 2020;20. [DOI: 10.5812/hepatmon.98323] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
299 Sharma S, Agarwal S, Gopi S, Anand A, Mohta S, Gunjan D, Yadav R, Saraya A. Determinants of Outcomes in Autoimmune Hepatitis Presenting as Acute on Chronic Liver Failure Without Extrahepatic Organ Dysfunction upon Treatment With Steroids. J Clin Exp Hepatol 2021;11:171-80. [PMID: 33746441 DOI: 10.1016/j.jceh.2020.08.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
300 Sutter MA, Cremona TP, Nita I, Cavarra E, Lungarella G, Lewis EC, Schittny JC, Geiser T, Gazdhar A. In Vivo Electroporation-Mediated, Intrahepatic Alpha1 Antitrypsin Gene Transfer Reduces Pulmonary Emphysema in Pallid Mice. Pharmaceutics 2020;12:E793. [PMID: 32825773 DOI: 10.3390/pharmaceutics12090793] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
301 Schulz M, Tacke F. Identifying High-Risk NASH Patients: What We Know so Far. Hepat Med 2020;12:125-38. [PMID: 32982495 DOI: 10.2147/HMER.S265473] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
302 Madadi-Sanjani O, Schukfeh N, Uecker M, Eckmann S, Dingemann J, Ure BM, Petersen C, Kuebler JF. The Intestinal Flora at Kasai Procedure in Children with Biliary Atresia Appears Not to Affect Postoperative Cholangitis. Eur J Pediatr Surg 2021;31:80-5. [PMID: 32820494 DOI: 10.1055/s-0040-1715614] [Reference Citation Analysis]
303 Chen W, Zhang X, Xu M, Jiang L, Zhou M, Liu W, Chen Z, Wang Y, Zou Q, Wang L. Betaine prevented high-fat diet-induced NAFLD by regulating the FGF10/AMPK signaling pathway in ApoE-/- mice. Eur J Nutr 2021;60:1655-68. [PMID: 32808060 DOI: 10.1007/s00394-020-02362-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
304 Xing YF, Wei CS, Zhou TR, Huang DP, Zhong WC, Chen B, Jin H, Hu XY, Yang ZY, He Q, Jiang KP, Jiang JM, Hu ZB, Deng X, Yang F, Li FY, Zhao G, Wang LC, Mi YQ, Gong ZJ, Guo P, Wu JH, Shi WQ, Yang HZ, Zhou DQ, Tong GD. Efficacy of a Chinese herbal formula on hepatitis B e antigen-positive chronic hepatitis B patients. World J Gastroenterol 2020; 26(30): 4501-4522 [PMID: 32874061 DOI: 10.3748/wjg.v26.i30.4501] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
305 Romualdo GR, Prata GB, da Silva TC, Evangelista AF, Reis RM, Vinken M, Moreno FS, Cogliati B, Barbisan LF. The combination of coffee compounds attenuates early fibrosis-associated hepatocarcinogenesis in mice: involvement of miRNA profile modulation. J Nutr Biochem 2020;85:108479. [PMID: 32795656 DOI: 10.1016/j.jnutbio.2020.108479] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
306 Fischer HP, Goltz D. [Autoimmune liver diseases]. Pathologe 2020;41:444-56. [PMID: 32749523 DOI: 10.1007/s00292-020-00807-7] [Reference Citation Analysis]
307 Vali Y, Lee J, Boursier J, Spijker R, Löffler J, Verheij J, Brosnan MJ, Böcskei Z, Anstee QM, Bossuyt PM, Zafarmand MH, Pavlides M, Levick C, Duffin K, Hyde C, Bauer T, Bedossa P, Leeming D, Daly A, Hanf R, Ortiz P, Oresic M, Schuppan D, Hanauer G, Chen Y, Shumbayawonda E, Bjerring PN, Zwinderman K. Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis. Journal of Hepatology 2020;73:252-62. [DOI: 10.1016/j.jhep.2020.03.036] [Cited by in Crossref: 32] [Cited by in F6Publishing: 66] [Article Influence: 16.0] [Reference Citation Analysis]
308 Arase Y, Matsumoto K, Anzai K, Tsuruya K, Sugiyama S, Yoshihara S, Hirose S, Uojima H, Hidaka H, Nakazawa T, Deguchi R, Kojima S, Takashimizu S, Shiraishi K, Shirai T, Kagawa T. Clinicopathological Features of Autoimmune Hepatitis with IgG4-Positive Plasma Cell Infiltration.Dig Dis. 2021;39:225-233. [PMID: 32731217 DOI: 10.1159/000510562] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
309 Afifi NA, Ramadan A, Erian EY, Sedik AA, Amin MM, Hassan A, Saleh DO. Synergistic effect of aminoguanidine and l-carnosine against thioacetamide-induced hepatic encephalopathy in rats: behavioral, biochemical, and ultrastructural evidence. Can J Physiol Pharmacol 2021;99:332-47. [PMID: 32721224 DOI: 10.1139/cjpp-2020-0212] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
310 Crotty R, Taylor MS, Farmer JR, Kakar S, Yilmaz F, Ardeniz Ö, Patil DT, Deshpande V. Spectrum of Hepatic Manifestations of Common Variable Immunodeficiency. Am J Surg Pathol 2020;44:617-25. [PMID: 32187043 DOI: 10.1097/PAS.0000000000001452] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
311 Berumen J, Baglieri J, Kisseleva T, Mekeel K. Liver fibrosis: Pathophysiology and clinical implications. Wiley Interdiscip Rev Syst Biol Med. 2020;e1499. [PMID: 32713091 DOI: 10.1002/wsbm.1499] [Cited by in Crossref: 2] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
312 Skiepko N, Przybylska-Gornowicz B, Gajęcka M, Gajęcki M, Lewczuk B. Effects of Deoxynivalenol and Zearalenone on the Histology and Ultrastructure of Pig Liver. Toxins (Basel) 2020;12:E463. [PMID: 32698427 DOI: 10.3390/toxins12070463] [Cited by in Crossref: 8] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
313 Hatori M, Moriya S, Fujimori M, Kobayashi S, Ikota H, Shirabe K, Yokoo H, Kimura K, Saio M. Phosphomolybdic Acid Prevents Nonspecific Nuclear Staining by Picrosirius Red but Is Converted to Molybdenum Blue by Blue Light. J Histochem Cytochem 2020;68:621-34. [PMID: 32674674 DOI: 10.1369/0022155420942620] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
314 Sun Y, Pan H, Shen S, Xia Z, Yu Z, Li C, Sun P, Xin C. Alisma Shugan Decoction (ASD) Ameliorates Hepatotoxicity and Associated Liver Dysfunction by Inhibiting Oxidative Stress and p65/Nrf2/JunD Signaling Dysregulation In Vivo. Med Sci Monit 2020;26:e921738. [PMID: 32672153 DOI: 10.12659/MSM.921738] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
315 Tsutsui A, Harada K, Tsuneyama K, Nguyen Canh H, Ando M, Nakamura S, Mizobuchi K, Baba N, Senoh T, Nagano T, Shibata H, Aoki T, Takaguchi K. Histopathological analysis of autoimmune hepatitis with "acute" presentation: Differentiation from drug-induced liver injury. Hepatol Res 2020;50:1047-61. [PMID: 32515851 DOI: 10.1111/hepr.13532] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
316 Park SM, Kim JK, Kim EO, Jegal KH, Jung DH, Lee SG, Cho IJ, Kim S, Byun SH, Ku SK, Park CA, Lee CW, An WG, Kim SC, Zhao R. Hepatoprotective Effect of Pericarpium zanthoxyli Extract Is Mediated via Antagonism of Oxidative Stress. Evid Based Complement Alternat Med 2020;2020:6761842. [PMID: 32695211 DOI: 10.1155/2020/6761842] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
317 Lu D, Bai X, Zou Q, Gan Z, Lv Y. Identification of the association between HMMR expression and progression of hepatocellular carcinoma via construction of a co-expression network. Oncol Lett 2020;20:2645-54. [PMID: 32765791 DOI: 10.3892/ol.2020.11844] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
318 Dong W, Yu H, Zhu YY, Xian ZH, Chen J, Wang H, Shi CC, Jin GZ, Dong H, Cong WM. A Novel Pathological Scoring System for Hepatic Cirrhosis with Hepatocellular Carcinoma. Cancer Manag Res 2020;12:5537-47. [PMID: 32753967 DOI: 10.2147/CMAR.S223417] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
319 Torbenson M, Desmet V, Denk H, Callea F, Burt AD, Hübscher SG, Terracciano L, Dienes HP, Goodman ZD, Bedossa P, Wanless IR, Roberts EA, Brunt EM, Clouston AD, Gouw ASH, Kleiner D, Schirmacher P, Tiniakos D. Fifty years of impact on liver pathology: a history of the Gnomes. Virchows Arch 2021;478:191-200. [PMID: 32607686 DOI: 10.1007/s00428-020-02879-5] [Reference Citation Analysis]
320 Döring P, Calvisi DF, Dombrowski F. Nuclear ErbB2 expression in hepatocytes in liver disease. Virchows Arch 2021;478:309-18. [PMID: 32591879 DOI: 10.1007/s00428-020-02871-z] [Reference Citation Analysis]
321 Lenggenhager D, Pawel S, Honcharova-Biletska H, Evert K, Wenzel JJ, Montani M, Furrer E, Fraga M, Moradpour D, Sempoux C, Weber A. The histologic presentation of hepatitis E reflects patients' immune status and pre-existing liver condition. Mod Pathol 2021;34:233-48. [PMID: 32572157 DOI: 10.1038/s41379-020-0593-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
322 Li ZX, Zhao ZM, Liu P, Zheng QS, Liu CH. Treatment of HBV Cirrhosis with Fuzheng Huayu Tablet () and Entecavir: Design of a Randomized, Double-Blind, Parallel and Multicenter Clinical Trial. Chin J Integr Med 2021;27:509-13. [PMID: 32572776 DOI: 10.1007/s11655-020-3257-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
323 Lackner C, Tiniakos D. Fibrosis and alcohol-related liver disease. J Hepatol 2019;70:294-304. [PMID: 30658730 DOI: 10.1016/j.jhep.2018.12.003] [Cited by in Crossref: 61] [Cited by in F6Publishing: 67] [Article Influence: 30.5] [Reference Citation Analysis]
324 Wu Z, Ma AL, Xie Q, Zhang XQ, Cheng J, Zhang DZ, Wang GQ, Zhao H. Significant histological changes and satisfying antiviral efficacy in chronic hepatitis B virus infection patients with normal alanine aminotransferase. Antiviral therapy decision in chronic HBV patients with normal ALT. Clin Res Hepatol Gastroenterol 2021;45:101463. [PMID: 32571749 DOI: 10.1016/j.clinre.2020.05.011] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
325 Itoh S, Uchiyama H, Kawanaka H, Higashi T, Egashira A, Eguchi D, Okuyama T, Tateishi M, Korenaga D, Takenaka K. Characteristic Risk Factors in Cirrhotic Patients for Posthepatectomy Complications: Comparison with Noncirrhotic Patients. The American Surgeon 2014;80:166-70. [DOI: 10.1177/000313481408000225] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
326 Yang L, Ao Q, Zhong Q, Li W, Li W. SIRT1/IGFBPrP1/TGF β1 axis involved in cucurbitacin B ameliorating concanavalin A-induced mice liver fibrosis. Basic Clin Pharmacol Toxicol 2020;127:371-9. [PMID: 32452080 DOI: 10.1111/bcpt.13446] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
327 Hassan HM, Al-Wahaibi LH, Elmorsy MA, Mahran YF. Suppression of Cisplatin-Induced Hepatic Injury in Rats Through Alarmin High-Mobility Group Box-1 Pathway by Ganoderma lucidum: Theoretical and Experimental Study. Drug Des Devel Ther 2020;14:2335-53. [PMID: 32606602 DOI: 10.2147/DDDT.S249093] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
328 Jesper D, Klett D, Schellhaas B, Pfeifer L, Leppkes M, Waldner M, Neurath MF, Strobel D. Ultrasound-Based Attenuation Imaging for the Non-Invasive Quantification of Liver Fat - A Pilot Study on Feasibility and Inter-Observer Variability. IEEE J Transl Eng Health Med 2020;8:1800409. [PMID: 32617199 DOI: 10.1109/JTEHM.2020.3001488] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
329 Cong M, Ou X, Huang J, Long J, Li T, Liu X, Wang Y, Wu X, Zhou J, Sun Y, Shang Q, Chen G, Ma H, Xie W, Piao H, Yang Y, Gao Z, Xu X, Tan Z, Chen C, Zeng N, Wu S, Kong Y, Liu T, Wang P, You H, Jia J, Zhuang H. A Predictive Model Using N-Glycan Biosignatures for Clinical Diagnosis of Early Hepatocellular Carcinoma Related to Hepatitis B Virus. OMICS 2020;24:415-23. [PMID: 32522092 DOI: 10.1089/omi.2020.0055] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
330 Tibuakuu M, Jjingo C, Kirk GD, Thomas DL, Gray R, Ssempijja V, Nalugoda F, Serwadda D, Ocama P, Opio CK, Kleiner DE, Quinn TC, Reynolds SJ. Elevated liver stiffness without histological evidence of liver fibrosis in rural Ugandans. J Viral Hepat 2020;27:1022-31. [PMID: 32388879 DOI: 10.1111/jvh.13320] [Reference Citation Analysis]
331 Degrassi I, Deheragoda M, Creegen D, Mundy H, Mustafa A, Vara R, Hadzic N. Liver histology in children with glycogen storage disorders type VI and IX. Dig Liver Dis 2021;53:86-93. [PMID: 32505569 DOI: 10.1016/j.dld.2020.04.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
332 Sandoval-Rodríguez A, Mena-Enriquez M, García-Bañuelos J, Salazar-Montes A, Fafutis-Morris M, Vázquez-Del Mercado M, Santos-García A, Armendariz-Borunda J. Adenovirus Biodistribution is Modified in Sensitive Animals Compared to Naïve Animals. Mol Biotechnol 2020;62:260-72. [PMID: 32144553 DOI: 10.1007/s12033-020-00247-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
333 Lazzeri C, Bonizzoli M, Fulceri GE, Guetti C, Ghinolfi D, Li Marzi V, Migliaccio ML, Peris A. Utilization rate of uncontrolled donors after circulatory death‐a 3‐year single‐center investigation. Clin Transplant 2020;34. [DOI: 10.1111/ctr.13896] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
334 Khare S, Arora A, Sharma P, Dhawan S, Bansal N, Singla V, Kumar A. Performance of Non-invasive Blood Parameters for Ruling Out Significant Liver Fibrosis in Patients with Chronic Hepatitis B. J Clin Transl Hepatol 2020;8:143-9. [PMID: 32832394 DOI: 10.14218/JCTH.2020.00002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
335 Wedemeyer H, Yurdaydin C, Hardtke S, Caruntu FA, Curescu MG, Yalcin K, Akarca US, Gürel S, Zeuzem S, Erhardt A, Lüth S, Papatheodoridis GV, Keskin O, Port K, Radu M, Celen MK, Idilman R, Weber K, Stift J, Wittkop U, Heidrich B, Mederacke I, von der Leyen H, Dienes HP, Cornberg M, Koch A, Manns MP; HIDIT-II study team. Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial. Lancet Infect Dis 2019;19:275-86. [PMID: 30833068 DOI: 10.1016/S1473-3099(18)30663-7] [Cited by in Crossref: 49] [Cited by in F6Publishing: 18] [Article Influence: 24.5] [Reference Citation Analysis]
336 Levitsky J, Asrani SK, Schiano T, Moss A, Chavin K, Miller C, Guo K, Zhao L, Kandpal M, Bridges N, Brown M, Armstrong B, Kurian S, Demetris AJ, Abecassis M; Clinical Trials in Organ Transplantation - 14 Consortium. Discovery and validation of a novel blood-based molecular biomarker of rejection following liver transplantation. Am J Transplant 2020;20:2173-83. [PMID: 32356368 DOI: 10.1111/ajt.15953] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 10.5] [Reference Citation Analysis]
337 Rong G, Chen Y, Yu Z, Li Q, Bi J, Tan L, Xiang D, Shang Q, Lei C, Chen L, Hu X, Wang J, Liu H, Lu W, Chen Y, Dong Z, Bai W, Yoshida EM, Mendez-Sanchez N, Hu KQ, Qi X, Yang Y. Synergistic Effect of Biejia-Ruangan on Fibrosis Regression in Patients with Chronic Hepatitis B Treated with Entecavir: A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial. J Infect Dis 2020:jiaa266. [PMID: 32437567 DOI: 10.1093/infdis/jiaa266] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
338 Cieciura T, Hryniewiecka E, Perkowska-Ptasińska A, Ciszek M, Pączek L. Shear Wave Elastography Performance in Noninvasive Assessment of Liver Cirrhosis in Liver Transplant Recipients With the Recurrence of Hepatitis C Infection. Transplant Proc 2020;52:2480-3. [PMID: 32446694 DOI: 10.1016/j.transproceed.2020.02.097] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
339 Kandemir B, Ates S, Kurutas EB, Durduran Y, Erayman I, Bitirgen M. GPER-1 in chronic hepatitis B. Journal of Radiation Research and Applied Sciences 2020;13:546-51. [DOI: 10.1080/16878507.2020.1762527] [Reference Citation Analysis]
340 Lin Z, Sun H, Ma Y, Zhou X, Jiang H, Wang X, Song J, Tang Z, Bian Q, Zhang Z, Huang Y, Yu X. Evaluation of immune response to Bacillus subtilis spores expressing Clonorchis sinensis serpin3. Parasitology 2020;147:1080-7. [PMID: 32404215 DOI: 10.1017/S0031182020000797] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
341 Çam H, Yılmaz N. Serum hepcidin levels are related to serum markers for iron metabolism and fibrosis stage in patients with chronic hepatitis B: A cross-sectional study. Arab J Gastroenterol 2020;21:85-90. [PMID: 32423859 DOI: 10.1016/j.ajg.2020.04.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
342 Lim CT, Goh GBB, Li H, Lim TK, Leow WQ, Wan WK, Azhar R, Chow WC, Kumar R. Presence of Hepatic Steatosis Does Not Increase the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Over Long Follow-Up. Microbiol Insights 2020;13:1178636120918878. [PMID: 32435130 DOI: 10.1177/1178636120918878] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
343 Freedman BL, Danford CJ, Patwardhan V, Bonder A. Treatment of Overlap Syndromes in Autoimmune Liver Disease: A Systematic Review and Meta-Analysis. J Clin Med 2020;9:E1449. [PMID: 32414025 DOI: 10.3390/jcm9051449] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
344 Chen YC, Jeng WJ, Hsu CW, Lin CY. Impact of hepatic steatosis on treatment response in nuclesos(t)ide analogue-treated HBeAg-positive chronic hepatitis B: a retrospective study. BMC Gastroenterol 2020;20:146. [PMID: 32397963 DOI: 10.1186/s12876-020-01289-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
345 Lal D, Thakur M, Bihari C. Serum Leptin Serves as an Inflammatory Activity Marker and Predicts Steroid Response in Autoimmune Hepatitis. J Clin Exp Hepatol 2020;10:574-80. [PMID: 33311894 DOI: 10.1016/j.jceh.2020.04.014] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
346 Thapa M, Tedesco D, Gumber S, Elrod EJ, Han JH, Kitchens WH, Magliocca JF, Adams AB, Grakoui A. Blockade of BAFF Reshapes the Hepatic B Cell Receptor Repertoire and Attenuates Autoantibody Production in Cholestatic Liver Disease. J Immunol 2020;204:3117-28. [PMID: 32332110 DOI: 10.4049/jimmunol.1900391] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
347 Viganò L, Lleo A, Muglia R, Gennaro N, Samà L, Colapietro F, Roncalli M, Aghemo A, Chiti A, Di Tommaso L, Solbiati L, Colombo M, Torzilli G. Intrahepatic cholangiocellular carcinoma with radiological enhancement patterns mimicking hepatocellular carcinoma. Updates Surg 2020;72:413-21. [PMID: 32323164 DOI: 10.1007/s13304-020-00750-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
348 Sayan M, Yıldırım FS, Akhan S, Yıldırım AA, Şirin G, Cabalak M, Demir M, Can S, Ersöz G, Altıntaş E, Ensaroğlu F, Akbulut A, Şener A, Deveci A. NS5A resistance - associated substitutions in chronic hepatitis C patients with direct acting antiviral treatment failure in Turkey. Int J Infect Dis 2020;95:84-9. [PMID: 32302766 DOI: 10.1016/j.ijid.2020.03.061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
349 Goertz RS, GaBmann L, Strobel D, Wildner D, Schellhaas B, Neurath MF, Pfeifer L. Acoustic Radiation Force Impulse (ARFI) Elastography in Autoimmune and Cholestatic Liver Diseases. Ann Hepatol 2019;18:23-9. [PMID: 31113596 DOI: 10.5604/01.3001.0012.7858] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
350 Li J, Dong XQ, Wu Z, Ma AL, Xie SB, Zhang XQ, Zhang ZQ, Zhang DZ, Zhao WF, Zhang G, Cheng J, Xie Q, Li J, Zou ZQ, Liu YX, Wang GQ, Zhao H; China Hepatitis B Related Fibrosis Assessment Research Group. Unsatisfying antiviral therapeutic effect in patients with mother-to-child transmissed chronic hepatitis B virus infection: a prospective multi-center clinical study. Chin Med J (Engl) 2019;132:2647-56. [PMID: 31725459 DOI: 10.1097/CM9.0000000000000522] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
351 Gawrieh S, Sethunath D, Cummings OW, Kleiner DE, Vuppalanchi R, Chalasani N, Tuceryan M. Automated quantification and architectural pattern detection of hepatic fibrosis in NAFLD. Ann Diagn Pathol 2020;47:151518. [PMID: 32531442 DOI: 10.1016/j.anndiagpath.2020.151518] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
352 Niu X, Nong S, Gong J, Zhang X, Tang H, Zhou T, Li W. Research on promoting liver fibrosis injury by the targeted regulation of miR-202 for HGF to activate HSC. Ir J Med Sci 2020;189:1295-304. [PMID: 32270431 DOI: 10.1007/s11845-020-02210-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
353 Xu LM, Liu P; Hepatology Committee of Chinese Association of Integrative Medicine, China. Guidelines for diagnosis and treatment of hepatic fibrosis with integrated traditional Chinese and Western medicine (2019 edition). J Integr Med 2020;18:203-13. [PMID: 32331978 DOI: 10.1016/j.joim.2020.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
354 Yousief SW, Bahey-el-din M, Zaghloul TI. Immunization with the basic membrane protein (BMP) family ABC transporter elicits protection against Enterococcus faecium in a murine infection model. Microbes and Infection 2020;22:127-36. [DOI: 10.1016/j.micinf.2019.09.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
355 Chalasani N, Abdelmalek MF, Garcia-tsao G, Vuppalanchi R, Alkhouri N, Rinella M, Noureddin M, Pyko M, Shiffman M, Sanyal A, Allgood A, Shlevin H, Horton R, Zomer E, Irish W, Goodman Z, Harrison SA, Traber PG, Abdelmalek M, Balart L, Borg B, Chalasani N, Charlton M, Conjeevaram H, Fuchs M, Ghalib R, Gholam P, Halegoua-de Marzio D, Harrison S, Jue C, Kemmer N, Kowdley K, Lai M, Lawitz E, Loomba R, Noureddin M, Paredes A, Rinella M, Rockey D, Rodriguez M, Rubin R, Ryan M, Sanyal A, Scanga A, Sepe T, Shiffman M, Shiffman M, Tetri B, Thuluvath P, Torres D, Vierling J, Wattacheril J, Weiland A, Zogg D. Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension. Gastroenterology 2020;158:1334-1345.e5. [DOI: 10.1053/j.gastro.2019.11.296] [Cited by in Crossref: 61] [Cited by in F6Publishing: 102] [Article Influence: 30.5] [Reference Citation Analysis]
356 Bahey-el-din M, Mohamed SA, Sheweita SA, Haroun M, Zaghloul TI. Recombinant N-terminal outer membrane porin (OprF) of Pseudomonas aeruginosa is a promising vaccine candidate against both P. aeruginosa and some strains of Acinetobacter baumannii. International Journal of Medical Microbiology 2020;310:151415. [DOI: 10.1016/j.ijmm.2020.151415] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
357 Klepfish M, Gross T, Vugman M, Afratis NA, Havusha-Laufer S, Brazowski E, Solomonov I, Varol C, Sagi I. LOXL2 Inhibition Paves the Way for Macrophage-Mediated Collagen Degradation in Liver Fibrosis. Front Immunol 2020;11:480. [PMID: 32296422 DOI: 10.3389/fimmu.2020.00480] [Cited by in Crossref: 7] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
358 Vilar CJF, Ribeiro SB, de Araújo AA, Guerra GCB, de Araújo Júnior RF, Brito GAC, Leitão RFC, Pontes DL, Gasparotto LHDS, Oliveira MMB, Viana AD, de Medeiros WMTQ, Bezerra BGP, de Medeiros CACX. Effect of Gold Nanoparticle on 5-Fluorouracil-Induced Experimental Oral Mucositis in Hamsters. Pharmaceutics 2020;12:E304. [PMID: 32230975 DOI: 10.3390/pharmaceutics12040304] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
359 Zen Y, Kondou H, Nakazawa A, Tanikawa K, Hasegawa Y, Bessho K, Imagawa K, Ishige T, Inui A, Suzuki M, Kasahara M, Yamamoto K, Yoshioka T, Kage M, Hayashi H. Proposal of a liver histology-based scoring system for bile salt export pump deficiency. Hepatol Res 2020;50:754-62. [PMID: 32073700 DOI: 10.1111/hepr.13494] [Reference Citation Analysis]
360 Iwanaka T, Yamaza T, Sonoda S, Yoshimaru K, Matsuura T, Yamaza H, Ohga S, Oda Y, Taguchi T. A model study for the manufacture and validation of clinical-grade deciduous dental pulp stem cells for chronic liver fibrosis treatment. Stem Cell Res Ther 2020;11:134. [PMID: 32213198 DOI: 10.1186/s13287-020-01630-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
361 Dale JM, Hood SP, Bowen O, Bright H, Cutler KL, Berry N, Almond N, Goldin R, Karayiannis P, Rose NJ. Development of hepatic pathology in GBV-B-infected red-bellied tamarins (Saguinus labiatus). J Med Virol 2020. [PMID: 32181899 DOI: 10.1002/jmv.25769] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
362 Ghinolfi D, Rreka E, De Tata V, Franzini M, Pezzati D, Fierabracci V, Masini M, Cacciatoinsilla A, Bindi ML, Marselli L, Mazzotti V, Morganti R, Marchetti P, Biancofiore G, Campani D, Paolicchi A, De Simone P. Pilot, Open, Randomized, Prospective Trial for Normothermic Machine Perfusion Evaluation in Liver Transplantation From Older Donors.Liver Transpl. 2019;25:436-449. [PMID: 30362649 DOI: 10.1002/lt.25362] [Cited by in Crossref: 34] [Cited by in F6Publishing: 47] [Article Influence: 17.0] [Reference Citation Analysis]
363 Dkhil MA, Abdel-Gaber R, Alojayri G, Al-Shaebi EM, Qasem MAA, Murshed M, Mares MM, El-Matbouli M, Al-Quraishy S. Biosynthesized silver nanoparticles protect against hepatic injury induced by murine blood-stage malaria infection. Environ Sci Pollut Res Int 2020;27:17762-9. [PMID: 32162231 DOI: 10.1007/s11356-020-08280-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
364 Schorer M, Rakebrandt N, Lambert K, Hunziker A, Pallmer K, Oxenius A, Kipar A, Stertz S, Joller N. TIGIT limits immune pathology during viral infections. Nat Commun 2020;11:1288. [PMID: 32152316 DOI: 10.1038/s41467-020-15025-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
365 Sun Y, Wu X, Zhou J, Meng T, Wang B, Chen S, Liu H, Wang T, Zhao X, Wu S, Kong Y, Ou X, Wee A, Theise ND, Qiu C, Zhang W, Lu F, Jia J, You H. Persistent Low Level of Hepatitis B Virus Promotes Fibrosis Progression During Therapy. Clin Gastroenterol Hepatol. 2020;18:2582-2591.e6. [PMID: 32147592 DOI: 10.1016/j.cgh.2020.03.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
366 Piao D, Hawxby A, Wright H, Rubin EM. Perspective review on solid-organ transplant: needs in point-of-care optical biomarkers. J Biomed Opt 2018;23:1-14. [PMID: 30160078 DOI: 10.1117/1.JBO.23.8.080601] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
367 Maurice J, Pinzani M. The stratification of cirrhosis. Hepatol Res 2020;50:535-41. [PMID: 32072721 DOI: 10.1111/hepr.13493] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
368 Saldarriaga OA, Freiberg B, Krishnan S, Rao A, Burks J, Booth AL, Dye B, Utay N, Ferguson M, Akil A, Yi M, Beretta L, Stevenson HL. Multispectral Imaging Enables Characterization of Intrahepatic Macrophages in Patients With Chronic Liver Disease. Hepatol Commun 2020;4:708-23. [PMID: 32363321 DOI: 10.1002/hep4.1494] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
369 Szekerczés T, Gógl A, Illyés I, Mandl J, Borka K, Kiss A, Schaff Z, Lendvai G, Werling K. Autophagy, Mitophagy and MicroRNA Expression in Chronic Hepatitis C and Autoimmune Hepatitis. Pathol Oncol Res 2020;26:2143-51. [PMID: 32124227 DOI: 10.1007/s12253-020-00799-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
370 Veraldi S, Pietrobattista A, Liccardo D, Basso MS, Mosca A, Alterio T, Cardile S, Benedetti S, Della Corte C, Candusso M. Fat soluble vitamins deficiency in pediatric chronic liver disease: The impact of liver transplantation. Digestive and Liver Disease 2020;52:308-13. [DOI: 10.1016/j.dld.2019.10.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
371 Hartl J, Miquel R, Zachou K, Wong GW, Asghar A, Pape S, Sebode M, Peiseler M, Zenouzi R, Ehlken H, Krech T, Weiler-Normann C, Drenth JPH, Oo YH, Dalekos GN, Heneghan M, Schramm C, Lohse AW. Features and outcome of AIH patients without elevation of IgG. JHEP Rep 2020;2:100094. [PMID: 32280942 DOI: 10.1016/j.jhepr.2020.100094] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
372 Gharibvand MM, Asare M, Motamedfar A, Alavinejad P, Momeni M. Ultrasound shear wave elastography and liver biopsy to determine liver fibrosis in adult patients. J Family Med Prim Care 2020;9:943-9. [PMID: 32318450 DOI: 10.4103/jfmpc.jfmpc_828_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
373 Zhou Z, Gao A, Zhang Q, Wu W, Wu S, Tsui P. Ultrasound Backscatter Envelope Statistics Parametric Imaging for Liver Fibrosis Characterization: A Review. Ultrason Imaging 2020;42:92-109. [DOI: 10.1177/0161734620907886] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
374 Rao A, van de Peppel IP, Gumber S, Karpen SJ, Dawson PA. Attenuation of the Hepatoprotective Effects of Ileal Apical Sodium Dependent Bile Acid Transporter (ASBT) Inhibition in Choline-Deficient L-Amino Acid-Defined (CDAA) Diet-Fed Mice. Front Med (Lausanne) 2020;7:60. [PMID: 32158763 DOI: 10.3389/fmed.2020.00060] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
375 Li L, Ran J, Li L, Chen G, Zhang S, Wang Y. Gli3 is a novel downstream target of miR‑200a with an anti‑fibrotic role for progression of liver fibrosis in vivo and in vitro. Mol Med Rep 2020;21:1861-71. [PMID: 32319630 DOI: 10.3892/mmr.2020.10997] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
376 Dardanelli EP, Orozco ME, Lostra J, Laprida C, Lulkin S, Bosaleh AP, Cernadas C, Lipsich JE. Bidimensional shear-wave elastography for assessing liver fibrosis in children: a proposal of reference values that correlate with the histopathological Knodell-Ishak score. Pediatr Radiol 2020;50:817-26. [PMID: 32072246 DOI: 10.1007/s00247-020-04632-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
377 Dwivedi DK, Jena G, Kumar V. Dimethyl fumarate protects thioacetamide-induced liver damage in rats: Studies on Nrf2, NLRP3, and NF-κB. J Biochem Mol Toxicol 2020;34:e22476. [PMID: 32060995 DOI: 10.1002/jbt.22476] [Cited by in Crossref: 9] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
378 Fang C, Lim A, Sidhu PS. Ultrasound-based liver elastography in the assessment of fibrosis. Clin Radiol 2020;75:822-31. [PMID: 32067699 DOI: 10.1016/j.crad.2020.01.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
379 Eser Karlidag G, Arslan Solmaz O. Are adropin, apelin, elabela, asprosin and betatrophin biomarkers for chronic hepatitis and staging of fibrosis? Biotech Histochem 2020;95:152-9. [PMID: 32011178 DOI: 10.1080/10520295.2020.1714732] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
380 Czaja AJ. Autoimmune Hepatitis: Surviving Crises of Doubt and Elimination. Clin Liver Dis (Hoboken) 2020;15:S72-81. [PMID: 32140216 DOI: 10.1002/cld.917] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
381 Sterling RK, King WC, Wahed AS, Kleiner DE, Khalili M, Sulkowski M, Chung RT, Jain MK, Lisker-Melman M, Wong DK, Ghany MG; HIV-HBV Cohort Study of the Hepatitis B Research Network. Evaluating Noninvasive Markers to Identify Advanced Fibrosis by Liver Biopsy in HBV/HIV Co-infected Adults. Hepatology 2020;71:411-21. [PMID: 31220357 DOI: 10.1002/hep.30825] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
382 Wong DK, Cheng SCY, Mak LL, To EW, Lo RC, Cheung T, Seto W, Fung J, Man K, Lai C, Yuen M. Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No Cirrhosis. Clinical Gastroenterology and Hepatology 2020;18:449-56. [DOI: 10.1016/j.cgh.2019.06.029] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
383 Tan-Garcia A, Lai F, Sheng Yeong JP, Irac SE, Ng PY, Msallam R, Tatt Lim JC, Wai LE, Tham CYL, Choo SP, Lim T, Young DY, D'Ambrosio R, Degasperi E, Perbellini R, Newell E, Le Bert N, Ginhoux F, Bertoletti A, Chen Q, Dutertre CA. Liver fibrosis and CD206+ macrophage accumulation are suppressed by anti-GM-CSF therapy. JHEP Rep 2020;2:100062. [PMID: 32039403 DOI: 10.1016/j.jhepr.2019.11.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
384 Stroffolini T, Sagnelli E, Sagnelli C, Morisco F, Babudieri S, Furlan C, Pirisi M, Russello M, Smedile A, Pisaturo M, Almasio PL. The association between education level and chronic liver disease of any etiology. Eur J Intern Med 2020;75:55-9. [PMID: 31982284 DOI: 10.1016/j.ejim.2020.01.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
385 Helal MG, Samra YA. Irbesartan mitigates acute liver injury, oxidative stress, and apoptosis induced by acetaminophen in mice. J Biochem Mol Toxicol 2020;34. [DOI: 10.1002/jbt.22447] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
386 Xia CH, Han XT, Zhang X, Zhu ZB, Guo J, Cui HL, Jiang HX, Huang WJ, Chen GZ, Liu YN, Liu WJ. Yiqihuoxue Formula Activates Autophagy and Offers Renoprotection in a Rat Model of Adenine-Induced Kidney Disease. Evid Based Complement Alternat Med 2019;2019:3423981. [PMID: 31949466 DOI: 10.1155/2019/3423981] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
387 Sterling RK, Wahed AS, King WC, Kleiner DE, Khalili M, Sulkowski M, Chung RT, Jain MK, Lisker-Melman M, Wong DK, Ghany MG; HIV-HBV Cohort Study of the Hepatitis B Research Network. Spectrum of Liver Disease in Hepatitis B Virus (HBV) Patients Co-infected with Human Immunodeficiency Virus (HIV): Results of the HBV-HIV Cohort Study. Am J Gastroenterol 2019;114:746-57. [PMID: 30410040 DOI: 10.1038/s41395-018-0409-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
388 Soto G, Rodríguez MJ, Fuentealba R, Treuer AV, Castillo I, González DR, Zúñiga-Hernández J. Maresin 1, a Proresolving Lipid Mediator, Ameliorates Liver Ischemia-Reperfusion Injury and Stimulates Hepatocyte Proliferation in Sprague-Dawley Rats. Int J Mol Sci 2020;21:E540. [PMID: 31952110 DOI: 10.3390/ijms21020540] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
389 Jun BG, Lee WC, Jang JY, Jeong SW, Chang Y, Lee SH, Kim YD, Kim SG, Cheon GJ, Kim YS, Kim HS, Jin SY. Relation of fibroblast growth factor receptor 2 expression to hepatocellular carcinoma recurrence after liver resection. PLoS One 2020;15:e0227440. [PMID: 31940413 DOI: 10.1371/journal.pone.0227440] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
390 Li Y, Zhang Y, Chen T, Huang Y, Zhang Y, Geng S, Li X. Role of aldosterone in the activation of primary mice hepatic stellate cell and liver fibrosis via NLRP3 inflammasome. J Gastroenterol Hepatol 2020;35:1069-77. [PMID: 31860730 DOI: 10.1111/jgh.14961] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
391 Kojima H, Nakamura K, Kupiec-Weglinski JW. Therapeutic targets for liver regeneration after acute severe injury: a preclinical overview. Expert Opin Ther Targets 2020;24:13-24. [PMID: 31906729 DOI: 10.1080/14728222.2020.1712361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
392 Alsayed MAL, Elbeah SM, El-Desoky MM, Elziny SM, Megahed A. Polymorphism in Macrophage Migration Inhibitory Factor -173GC in Pediatric Patients with Autoimmune Hepatitis. Pediatr Gastroenterol Hepatol Nutr 2020;23:63-71. [PMID: 31988876 DOI: 10.5223/pghn.2020.23.1.63] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
393 Arjmand A, Tsipouras MG, Tzallas AT, Forlano R, Manousou P, Giannakeas N. Quantification of Liver Fibrosis—A Comparative Study. Applied Sciences 2020;10:447. [DOI: 10.3390/app10020447] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
394 Lei X, Liu Q, Liu Q, Cao Z, Zhang J, Kuang T, Fang Y, Liu G, Qian K, Fu J, Du H, Liu Z, Xiao Z, Li C, Xu X. Camellia oil (Camellia oleifera Abel.) attenuates CCl 4 -induced liver fibrosis via suppressing hepatocyte apoptosis in mice. Food Funct 2020;11:4582-90. [DOI: 10.1039/c9fo02258a] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
395 Li R, Li Z, Feng Y, Yang H, Shi Q, Tao Z, Cheng J, Lu X. PDGFRβ-targeted TRAIL specifically induces apoptosis of activated hepatic stellate cells and ameliorates liver fibrosis. Apoptosis 2020;25:105-19. [DOI: 10.1007/s10495-019-01583-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
396 Young S, Chau G, Lee I, Yeh Y, Chao Y, Huo T, Su C, Lin H, Hou M, Lee M, Huang Y. Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resection. Journal of the Formosan Medical Association 2020;119:218-29. [DOI: 10.1016/j.jfma.2019.04.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
397 Madbouly NA, Nashee H, Elgendy AA, Rabee I, El Amir A. Encapsulation of Low Metronidazole Dose in Poly (D,L-lactide-co-glycolide) (PLGA) Nanoparticles Improves Giardia intestinalis Treatment. Infect Chemother 2020;52:550-61. [PMID: 33377322 DOI: 10.3947/ic.2020.52.4.550] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
398 Tosun M, Onal T, Uslu H, Alparslan B, Çetin Akhan S. Intravoxel incoherent motion imaging for diagnosing and staging the liver fibrosis and inflammation. Abdom Radiol (NY) 2020;45:15-23. [PMID: 31705248 DOI: 10.1007/s00261-019-02300-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
399 Liu J, Kong D, Qiu J, Xie Y, Lu Z, Zhou C, Liu X, Zhang R, Wang Y. Praziquantel ameliorates CCl4 -induced liver fibrosis in mice by inhibiting TGF-β/Smad signalling via up-regulating Smad7 in hepatic stellate cells. Br J Pharmacol 2019;176:4666-80. [PMID: 31412137 DOI: 10.1111/bph.14831] [Cited by in Crossref: 12] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
400 Anstee QM, Neuschwander-Tetri BA, Wong VW, Abdelmalek MF, Younossi ZM, Yuan J, Pecoraro ML, Seyedkazemi S, Fischer L, Bedossa P, Goodman Z, Alkhouri N, Tacke F, Sanyal A. Cenicriviroc for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis: AURORA Phase 3 study design. Contemp Clin Trials 2020;89:105922. [PMID: 31881392 DOI: 10.1016/j.cct.2019.105922] [Cited by in Crossref: 27] [Cited by in F6Publishing: 53] [Article Influence: 9.0] [Reference Citation Analysis]
401 Koblihová E, Mrázová I, Vaňourková Z, Maxová H, Kikerlová S, Husková Z, Ryska M, Froněk J, Vernerová Z. Pharmacological stimulation of Wnt/beta-catenin signaling pathway attenuates the course of thioacetamide-induced acute liver failure. Physiol Res 2020;69:113-26. [PMID: 31852203 DOI: 10.33549/physiolres.934071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
402 Gaggini M, Carli F, Rosso C, Younes R, D'Aurizio R, Bugianesi E, Gastaldelli A. Altered Metabolic Profile and Adipocyte Insulin Resistance Mark Severe Liver Fibrosis in Patients with Chronic Liver Disease. Int J Mol Sci 2019;20:E6333. [PMID: 31888144 DOI: 10.3390/ijms20246333] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
403 Da BL, Surana P, Kleiner DE, Heller T, Koh C. The Delta-4 fibrosis score (D4FS): A novel fibrosis score in chronic hepatitis D. Antiviral Res 2020;174:104691. [PMID: 31837393 DOI: 10.1016/j.antiviral.2019.104691] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
404 Mohseni R, Arab Sadeghabadi Z, Karimi J, Gholami H, Ghasemi H, Ghadimipour HR, Kheiripour N. Chlorella vulgaris supplementation attenuates the progression of liver fibrosis through targeting TGF-β-signaling pathway in the CCl 4 -induced liver fibrosis in rats. Toxin Reviews. [DOI: 10.1080/15569543.2019.1700525] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
405 Shindoh J, Kobayashi Y, Kawamura Y, Akuta N, Kobayashi M, Suzuki Y, Ikeda K, Hashimoto M. Microvascular Invasion and a Size Cutoff Value of 2 cm Predict Long-Term Oncological Outcome in Multiple Hepatocellular Carcinoma: Reappraisal of the American Joint Committee on Cancer Staging System and Validation Using the Surveillance, Epidemiology, and End-Results Database. Liver Cancer 2020;9:156-66. [PMID: 32399430 DOI: 10.1159/000504193] [Cited by in Crossref: 3] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
406 Da BL, Surana P, Takyar V, Kleiner DE, Heller T, Koh C. Vibration-controlled transient elastography for the detection of cirrhosis in chronic hepatitis D infection. J Viral Hepat 2020;27:428-36. [PMID: 31742822 DOI: 10.1111/jvh.13235] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
407 Yoo JJ, Seo YS, Kim YS, Jeong SW, Jang JY, Suh SJ, Yim HJ, Suk KT, Kim DJ, Han KH, Kim SU, Lee B, Kim SG. The Influence of Histologic Inflammation on the Improvement of Liver Stiffness Values Over 1 and 3 Years. J Clin Med 2019;8:E2065. [PMID: 31771253 DOI: 10.3390/jcm8122065] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
408 Kohli R, Ratziu V, Fiel MI, Waldmann E, Wilson DP, Balwani M. Initial assessment and ongoing monitoring of lysosomal acid lipase deficiency in children and adults: Consensus recommendations from an international collaborative working group. Mol Genet Metab 2020;129:59-66. [PMID: 31767214 DOI: 10.1016/j.ymgme.2019.11.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
409 Gupta G, Yakubu I, Bhati CS, Zhang Y, Kang L, Patterson JA, Andrews-Joseph A, Alam A, Ferreira-Gonzalez A, Kumar D, Moinuddin IK, Kamal L, King AL, Levy M, Sharma A, Cotterell A, Reichman TW, Khan A, Kimball P, Stiltner R, Baldecchi M, Brigle N, Gehr T, Sterling RK. Ultra-short duration direct acting antiviral prophylaxis to prevent virus transmission from hepatitis C viremic donors to hepatitis C negative kidney transplant recipients. Am J Transplant 2020;20:739-51. [PMID: 31652392 DOI: 10.1111/ajt.15664] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 16.7] [Reference Citation Analysis]
410 Palom A, Rodríguez-Tajes S, Navascués CA, García-Samaniego J, Riveiro-Barciela M, Lens S, Rodríguez M, Esteban R, Buti M. Long-term clinical outcomes in patients with chronic hepatitis delta: the role of persistent viraemia. Aliment Pharmacol Ther 2020;51:158-66. [PMID: 31721254 DOI: 10.1111/apt.15521] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
411 Huang YH, Chen MH, Guo QL, Chen ZX, Chen QD, Wang XZ. Interleukin-10 induces senescence of activated hepatic stellate cells via STAT3-p53 pathway to attenuate liver fibrosis. Cell Signal 2020;66:109445. [PMID: 31730896 DOI: 10.1016/j.cellsig.2019.109445] [Cited by in Crossref: 17] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
412 Zhou L, Zhang X, Cai J, Yan L, Lv D, Tang X, Liu D, Tang H. HBcAg distribution predicts virologic response to PEG-IFNα therapy in HBeAg-positive CHB with minimally elevated ALT. Future Virology 2019;14:729-37. [DOI: 10.2217/fvl-2019-0127] [Reference Citation Analysis]
413 Lee HW, Na K, Kim SU, Kim BK, Park JY, Nahm JH, Lee JI, Kim DY, Ahn SH, Han KH, Park YN. Predictive validation of qualitative fibrosis staging in patients with chronic hepatitis B on antiviral therapy. Sci Rep 2019;9:15628. [PMID: 31666552 DOI: 10.1038/s41598-019-51638-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
414 Salarian M, Turaga RC, Xue S, Nezafati M, Hekmatyar K, Qiao J, Zhang Y, Tan S, Ibhagui OY, Hai Y, Li J, Mukkavilli R, Sharma M, Mittal P, Min X, Keilholz S, Yu L, Qin G, Farris AB, Liu ZR, Yang JJ. Early detection and staging of chronic liver diseases with a protein MRI contrast agent. Nat Commun 2019;10:4777. [PMID: 31664017 DOI: 10.1038/s41467-019-11984-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 32] [Article Influence: 7.3] [Reference Citation Analysis]
415 Musso M, Mosti S, Gualano G, Mencarini P, Urso R, Ghirga P, Rianda A, Del Nonno F, Goletti D, Palmieri F. Hepatitis C virus infection: a challenge in the complex management of two cases of multidrug-resistant tuberculosis. BMC Infect Dis 2019;19:882. [PMID: 31640579 DOI: 10.1186/s12879-019-4494-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
416 Kirchner VA, Tak E, Kim K, LeCluyse EL, Niedernhofer LJ, Soldatow V, Lee J, Kim J, Tolar J, Song GW, Pruett TL. The evolving microenvironment of the human hepatocyte: Healthy vs. cirrhotic liver vs. isolated cells. Tissue Cell. 2020;62:101310. [PMID: 32433018 DOI: 10.1016/j.tice.2019.101310] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
417 Helsley RN, Varadharajan V, Brown AL, Gromovsky AD, Schugar RC, Ramachandiran I, Fung K, Kabbany MN, Banerjee R, Neumann CK, Finney C, Pathak P, Orabi D, Osborn LJ, Massey W, Zhang R, Kadam A, Sansbury BE, Pan C, Sacks J, Lee RG, Crooke RM, Graham MJ, Lemieux ME, Gogonea V, Kirwan JP, Allende DS, Civelek M, Fox PL, Rudel LL, Lusis AJ, Spite M, Brown JM. Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease. Elife. 2019;8. [PMID: 31621579 DOI: 10.7554/elife.49882] [Cited by in Crossref: 34] [Cited by in F6Publishing: 47] [Article Influence: 11.3] [Reference Citation Analysis]
418 Peng C, Li C, Liu C, Wen T, Yang J, Li B, Yan L. The outcome of the HCC patients underwent ALPPS: Retrospective study. Medicine (Baltimore) 2019;98:e17182. [PMID: 31567959 DOI: 10.1097/MD.0000000000017182] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
419 Hempel F, Roderfeld M, Savai R, Sydykov A, Irungbam K, Schermuly R, Voswinckel R, Köhler K, Churin Y, Kiss L, Bier J, Pons-Kühnemann J, Roeb E. Depletion of Bone Marrow-Derived Fibrocytes Attenuates TAA-Induced Liver Fibrosis in Mice. Cells 2019;8:E1210. [PMID: 31591328 DOI: 10.3390/cells8101210] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
420 Pai RK, Kleiner DE, Hart J, Adeyi OA, Clouston AD, Behling CA, Jain D, Kakar S, Brahmania M, Burgart L, Batts KP, Valasek MA, Torbenson MS, Guindi M, Wang HL, Ajmera V, Adams LA, Parker CE, Feagan BG, Loomba R, Jairath V. Standardising the interpretation of liver biopsies in non-alcoholic fatty liver disease clinical trials. Aliment Pharmacol Ther 2019;50:1100-11. [PMID: 31583739 DOI: 10.1111/apt.15503] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
421 Torgersen J, Taddei TH, Park LS, Carbonari DM, Kallan MJ, Mitchell Richards K, Zhang X, Jhala D, Bräu N, Homer R, D'Addeo K, Mehta R, Skanderson M, Kidwai-Khan F, Justice AC, Lo Re V 3rd. Differences in Pathology, Staging, and Treatment between HIV+ and Uninfected Patients with Microscopically Confirmed Hepatocellular Carcinoma. Cancer Epidemiol Biomarkers Prev 2020;29:71-8. [PMID: 31575557 DOI: 10.1158/1055-9965.EPI-19-0503] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
422 Elshaer RE, Tawfik MK, Nosseir N, El-ghaiesh SH, Toraih EA, Elsherbiny NM, Zaitone SA. Leflunomide-induced liver injury in mice: Involvement of TLR4 mediated activation of PI3K/mTOR/NFκB pathway. Life Sciences 2019;235:116824. [DOI: 10.1016/j.lfs.2019.116824] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
423 Takahashi Y, Yuniartha R, Yamaza T, Sonoda S, Yamaza H, Kirino K, Yoshimaru K, Matsuura T, Taguchi T. Therapeutic potential of spheroids of stem cells from human exfoliated deciduous teeth for chronic liver fibrosis and hemophilia A. Pediatr Surg Int. 2019;35:1379-1388. [PMID: 31552493 DOI: 10.1007/s00383-019-04564-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
424 Chen C, Li X, Wang L. Thymosinβ4 alleviates cholestatic liver fibrosis in mice through downregulating PDGF/PDGFR and TGFβ/Smad pathways. Dig Liver Dis 2020;52:324-30. [PMID: 31542221 DOI: 10.1016/j.dld.2019.08.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
425 Kawaguchi T, Ide T, Kondo R, Nomura Y, Arinaga-Hino T, Kuwahara R, Amano K, Sano T, Akiba J, Ohshima K, Yano H, Torimura T. Histological changes in patients who developed hepatocellular carcinoma after hepatitis C virus eradication by interferon-based therapy. Exp Ther Med 2019;18:3991-4001. [PMID: 31616517 DOI: 10.3892/etm.2019.8024] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
426 Okuno M, Newhook TE, Joechle K, Kawaguchi Y, De Bellis M, Tzeng CD, Chun YS, Aloia TA, Shindoh J, Kaseb AO, Vauthey JN. Characteristics of atypical large well-differentiated hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma? HPB (Oxford) 2020;22:545-52. [PMID: 31533893 DOI: 10.1016/j.hpb.2019.08.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
427 Beime J, Krech T, Hischke S, Grabhorn E, Brinkert F. Tissue inhibitor of metalloproteinase 1 and AST-to-Platelet Ratio Index as noninvasive biomarkers predict allograft fibrosis after pediatric liver transplantation. Clin Transplant 2019;33:e13676. [PMID: 31344272 DOI: 10.1111/ctr.13676] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
428 Abdel-Aziz SA, Sira MM, Gad EH, Ayoub I, Soltan M. Preoperative alkaline phosphatase is a potential predictor of short-term outcome of surgery in infants with biliary atresia. Clin Exp Hepatol 2019;5:155-60. [PMID: 31501792 DOI: 10.5114/ceh.2019.85072] [Reference Citation Analysis]
429 Ahn M, Kim J, Choi Y, Ekanayake P, Chun JY, Yang D, Kim GO, Shin T. Fermented black radish (Raphanus sativus L. var. niger) attenuates methionine and choline deficient diet-induced nonalcoholic fatty liver disease in mice. Food Sci Nutr 2019;7:3327-37. [PMID: 31660146 DOI: 10.1002/fsn3.1200] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
430 Ghinolfi D, Lai Q, Pezzati D, De Simone P, Rreka E, Filipponi F. Use of Elderly Donors in Liver Transplantation: A Paired-match Analysis at a Single Center. Ann Surg. 2018;268:325-331. [PMID: 28549011 DOI: 10.1097/sla.0000000000002305] [Cited by in Crossref: 25] [Cited by in F6Publishing: 36] [Article Influence: 8.3] [Reference Citation Analysis]
431 Dai X, Chen C, Xue J, Xiao T, Mostofa G, Wang D, Chen X, Xu H, Sun Q, Li J, Wei Y, Chen F, Quamruzzaman Q, Zhang A, Liu Q. Exosomal MALAT1 derived from hepatic cells is involved in the activation of hepatic stellate cells via miRNA-26b in fibrosis induced by arsenite. Toxicol Lett 2019;316:73-84. [PMID: 31513886 DOI: 10.1016/j.toxlet.2019.09.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
432 Lobo AR, Gaievski EHS, de Mesquita CH, De Carli E, Teixeira PDS, Pereira RMR, Borelli P, de Sá LRM, Colli C. Increased adiposity by feeding growing rats a high-fat diet results in iron decompartmentalisation. Br J Nutr 2020;123:1094-108. [PMID: 32172712 DOI: 10.1017/S0007114519002320] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
433 Agina HA, Ehsan NA, Abd-Elaziz TA, Abd-Elfatah GA, Said EM, Sira MM. Hepatic expression of programmed death-1 (PD-1) and its ligand, PD-L1, in children with autoimmune hepatitis: relation to treatment response. Clin Exp Hepatol 2019;5:256-64. [PMID: 31598564 DOI: 10.5114/ceh.2019.87642] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
434 Torbenson M, Washington K. Pathology of liver disease: advances in the last 50 years. Hum Pathol 2020;95:78-98. [PMID: 31493428 DOI: 10.1016/j.humpath.2019.08.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
435 Lam JH, Ng HHM, Lim CJ, Sim XN, Malavasi F, Li H, Loh JJH, Sabai K, Kim JK, Ong CCH, Loh T, Leow WQ, Choo SP, Toh HC, Lee SY, Chan CY, Chew V, Lim TS, Yeong J, Lim TKH. Expression of CD38 on Macrophages Predicts Improved Prognosis in Hepatocellular Carcinoma. Front Immunol 2019;10:2093. [PMID: 31552039 DOI: 10.3389/fimmu.2019.02093] [Cited by in Crossref: 16] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
436 Moscoso CG, Steer CJ. "Let my liver rather heat with wine" - a review of hepatic fibrosis pathophysiology and emerging therapeutics. Hepat Med 2019;11:109-29. [PMID: 31565001 DOI: 10.2147/HMER.S213397] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
437 Helmy SA, El-mesery M, El-karef A, Eissa LA, El Gayar AM. Thymoquinone upregulates TRAIL/TRAILR2 expression and attenuates hepatocellular carcinoma in vivo model. Life Sciences 2019;233:116673. [DOI: 10.1016/j.lfs.2019.116673] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
438 Honigbaum S, Zhu Q, Layman A, Anders RA, Schwarz KB. Abundant Expression of Lysyl Oxidase-like 2 Protein in Intrahepatic Bile Ducts of Infants With Biliary Atresia. Journal of Pediatric Gastroenterology & Nutrition 2019;69:344-50. [DOI: 10.1097/mpg.0000000000002414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
439 Wm T, L S, C K, K E, T H, H B, T K, K N, M H, S K. Quantification of Hemodynamic Changes in Chronic Liver Disease: Correlation of Perfusion-CT Data with Histopathologic Staging of Fibrosis. Acad Radiol 2019;26:1174-80. [PMID: 30528750 DOI: 10.1016/j.acra.2018.11.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
440 Chang XJ, Sun C, Chen Y, Li XD, Yu ZJ, Dong Z, Bai WL, Wang XD, Li ZQ, Chen D, Du WJ, Liao H, Jiang QY, Sun LJ, Li YY, Zhang CH, Xu DP, Chen YP, Li Q, Yang YP. On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B. World J Gastroenterol 2019; 25(32): 4764-4778 [PMID: 31528100 DOI: 10.3748/wjg.v25.i32.4764] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
441 Gong WF, Zhong JH, Lu Z, Zhang QM, Zhang ZY, Chen CZ, Liu X, Ma L, Zhang ZM, Xiang BD, Li LQ. Evaluation of liver regeneration and post-hepatectomy liver failure after hemihepatectomy in patients with hepatocellular carcinoma. Biosci Rep 2019;39:BSR20190088. [PMID: 31383787 DOI: 10.1042/BSR20190088] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
442 Loh Z, Fitzsimmons RL, Reid RC, Ramnath D, Clouston A, Gupta PK, Irvine KM, Powell EE, Schroder K, Stow JL, Sweet MJ, Fairlie DP, Iyer A. Inhibitors of class I histone deacetylases attenuate thioacetamide-induced liver fibrosis in mice by suppressing hepatic type 2 inflammation. Br J Pharmacol 2019;176:3775-90. [PMID: 31236923 DOI: 10.1111/bph.14768] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
443 Sajjadi-Jazi SM, Soltani A, Enayati S, Kakavand Hamidi A, Amoli MM. Autoimmune Polyglandular Syndrome Type 1: a case report. BMC Med Genet 2019;20:143. [PMID: 31420020 DOI: 10.1186/s12881-019-0870-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
444 Farmakis SG, Buchanan PM, Guzman MA, Hardy AK, Jain AK, Teckman JH. Shear wave elastography correlates with liver fibrosis scores in pediatric patients with liver disease. Pediatr Radiol 2019;49:1742-53. [DOI: 10.1007/s00247-019-04493-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
445 Elshal M, Abu-Elsaad N, El-Karef A, Ibrahim T. Retinoic acid modulates IL-4, IL-10 and MCP-1 pathways in immune mediated hepatitis and interrupts CD4+ T cells infiltration. Int Immunopharmacol. 2019;75:105808. [PMID: 31419710 DOI: 10.1016/j.intimp.2019.105808] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
446 Andruszkow J, Hartleben B, Schlué J, Ritz T, Knüchel R, Hasan A, Petersen C, Madadi-Sanjani O. [Staging of liver fibrosis in biliary atresia : Comparison of Chevallier and Ishak score as well as automated evaluation]. Pathologe 2019;40:85-92. [PMID: 30617605 DOI: 10.1007/s00292-018-0558-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
447 Ali RO, Moon MS, Townsend EC, Hill K, Zhang GY, Bradshaw A, Guan H, Hamilton D, Kleiner DE, Auh S, Koh C, Heller T. Exploring the Link Between Platelet Numbers and Vascular Homeostasis Across Early and Late Stages of Fibrosis in Hepatitis C. Dig Dis Sci 2020;65:524-33. [PMID: 31407130 DOI: 10.1007/s10620-019-05760-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
448 Luo Y, Zhang J, Fang L, Zhu Y, You Y, Zhang C, Zheng P, Zhang L, Yin L, Xia F, Bie P, Xie C. FBXW10 promotes hepatocarcinogenesis in male patients and mice. Carcinogenesis 2020;41:689-98. [DOI: 10.1093/carcin/bgz138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
449 Czekaj P, Król M, Limanówka Ł, Michalik M, Lorek K, Gramignoli R. Assessment of animal experimental models of toxic liver injury in the context of their potential application as preclinical models for cell therapy. Eur J Pharmacol 2019;861:172597. [PMID: 31408648 DOI: 10.1016/j.ejphar.2019.172597] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
450 Serenari M, Collaud C, Alvarez FA, de Santibañes M, Giunta D, Pekolj J, Ardiles V, de Santibañes E. Interstage Assessment of Remnant Liver Function in ALPPS Using Hepatobiliary Scintigraphy: Prediction of Posthepatectomy Liver Failure and Introduction of the HIBA Index. Ann Surg 2018;267:1141-7. [PMID: 28121683 DOI: 10.1097/SLA.0000000000002150] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 10.7] [Reference Citation Analysis]
451 Xia WY, Gao L, Dai EH, Chen D, Xie EF, Yang L, Zhang SC, Zhang BF, Xu J, Pan SY. Liquid biopsy for non-invasive assessment of liver injury in hepatitis B patients. World J Gastroenterol 2019; 25(29): 3985-3995 [PMID: 31413532 DOI: 10.3748/wjg.v25.i29.3985] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
452 Xu XY, Wang WS, Zhang QM, Li JL, Sun JB, Qin TT, Liu HB. Performance of common imaging techniques vs serum biomarkers in assessing fibrosis in patients with chronic hepatitis B: A systematic review and meta-analysis. World J Clin Cases 2019; 7(15): 2022-2037 [PMID: 31423434 DOI: 10.12998/wjcc.v7.i15.2022] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
453 Warnes T, Roberts S, Smith A, Haboubi N, McMahon RF. Liver biopsy in primary biliary cholangitis: is sinusoidal fibrosis the missing key? J Clin Pathol 2019;72:669-76. [PMID: 31371396 DOI: 10.1136/jclinpath-2019-205958] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
454 Das T, Bergen IM, Koudstaal T, van Hulst JA, van Loo G, Boonstra A, Vanwolleghem T, Leung PS, Gershwin ME, Hendriks RW, Kool M. DNGR1-mediated deletion of A20/Tnfaip3 in dendritic cells alters T and B-cell homeostasis and promotes autoimmune liver pathology. Journal of Autoimmunity 2019;102:167-78. [DOI: 10.1016/j.jaut.2019.05.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
455 Kishanifarahani Z, Ahadi M, Kazeminejad B, Mollasharifi T, Saber Afsharian M, Sadeghi A, Bidari F, Jamali E, Hasanzadeh N, Movafagh A, Dehghan A, Moradi A, Moradi A. Inter-observer Variability in Histomorphological Evaluation of Non-neoplastic Liver Biopsy Tissue and Impact of Clinical Information on Final Diagnosis in Shahid Beheshti University of Medical Sciences Affiliated Hospitals. Iran J Pathol 2019;14:243-7. [PMID: 31583002 DOI: 10.30699/ijp.2019.99566.1985] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
456 Li J, Qureshi M, Gupta A, Anderson SW, Soto J, Li B. Quantification of Degree of Liver Fibrosis Using Fibrosis Area Fraction Based on Statistical Chi-Square Analysis of Heterogeneity of Liver Tissue Texture on Routine Ultrasound Images. Acad Radiol 2019;26:1001-7. [PMID: 30393055 DOI: 10.1016/j.acra.2018.10.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
457 Barakat NH, Barakat SH, Ahmed N. Prediction and Staging of Hepatic Fibrosis in Children with Hepatitis C Virus: A Machine Learning Approach. Healthc Inform Res 2019;25:173-81. [PMID: 31406609 DOI: 10.4258/hir.2019.25.3.173] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
458 Lee IC, Bae JS. Hepatoprotective effects of vicenin-2 and scolymoside through the modulation of inflammatory pathways. J Nat Med 2020;74:90-7. [PMID: 31350693 DOI: 10.1007/s11418-019-01348-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
459 Fang C, Virdee S, Jacob J, Rufai O, Agarwal K, Quaglia A, Quinlan DJ, Sidhu PS. Strain elastography for noninvasive assessment of liver fibrosis: A prospective study with histological comparison. Ultrasound 2019;27:262-71. [PMID: 31762783 DOI: 10.1177/1742271X19862836] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
460 Yang X, Yang C, Qiu Y, Shen S, Kong J, Wang W. A preliminary study of associating liver partition and portal vein ligation for staged hepatectomy in a rat model of liver cirrhosis. Exp Ther Med 2019;18:1203-11. [PMID: 31316615 DOI: 10.3892/etm.2019.7688] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
461 Wei SF, Sun JJ, Zhou N, Li XL, Lin Y, Zhang YD, Zhang YR, Wu LY. Protective effect of RNA interference targeting Ikkβ on hepatic fibrosis in rats. J Cell Biochem 2019;120:18894-900. [PMID: 31297885 DOI: 10.1002/jcb.29209] [Reference Citation Analysis]
462 Tian QJ, Zhao XY, Wang Y, Wee A, Soon GST, Gouw ASH, Li M, Yang RY, Wang L, Wang QY, Duan WJ, Wang Y, Wang XM, Kong YY, Ou XJ, You H, Jia JD. Histologic pattern is better correlated with clinical outcomes than biochemical classification in patients with drug-induced liver injury. Mod Pathol 2019;32:1795-805. [PMID: 31300804 DOI: 10.1038/s41379-019-0314-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
463 Calvente CJ, Tameda M, Johnson CD, Del Pilar H, Lin YC, Adronikou N, De Mollerat Du Jeu X, Llorente C, Boyer J, Feldstein AE. Neutrophils contribute to spontaneous resolution of liver inflammation and fibrosis via microRNA-223. J Clin Invest 2019;129:4091-109. [PMID: 31295147 DOI: 10.1172/JCI122258] [Cited by in Crossref: 49] [Cited by in F6Publishing: 75] [Article Influence: 16.3] [Reference Citation Analysis]
464 Elzamly S, Agina HA, Elbalshy AE, Abuhashim M, Saad E, Abd Elmageed ZY. Integration of VEGF and α-SMA Expression Improves the Prediction Accuracy of Fibrosis in Chronic Hepatitis C Liver Biopsy. Appl Immunohistochem Mol Morphol 2017;25:261-70. [PMID: 26990742 DOI: 10.1097/PAI.0000000000000299] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
465 Pedroza M, To S, Smith J, Agarwal SK. Cadherin-11 contributes to liver fibrosis induced by carbon tetrachloride. PLoS One 2019;14:e0218971. [PMID: 31269038 DOI: 10.1371/journal.pone.0218971] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
466 Franceschini E, Escoffre J, Novell A, Auboire L, Mendes V, Benane YM, Bouakaz A, Basset O. Quantitative Ultrasound in Ex Vivo Fibrotic Rabbit Livers. Ultrasound in Medicine & Biology 2019;45:1777-86. [DOI: 10.1016/j.ultrasmedbio.2019.02.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
467 Elshaarawy O, Alkhatib A, Elhelbawy M, Gomaa A, Allam N, Alsebaey A, Rewisha E, Waked I. Validation of modified albumin-bilirubin-TNM score as a prognostic model to evaluate patients with hepatocellular carcinoma. WJH 2019;11:542-52. [DOI: 10.4254/wjh.v11.i6.542] [Reference Citation Analysis]
468 Elshaarawy O, Alkhatib A, Elhelbawy M, Gomaa A, Allam N, Alsebaey A, Rewisha E, Waked I. Validation of modified albumin-bilirubin-TNM score as a prognostic model to evaluate patients with hepatocellular carcinoma. World J Hepatol 2019; 11(6): 542-552 [PMID: 31293722 DOI: 10.4254/wjh.v11.i6.542] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
469 Cosgun BE, Erdemli ME, Gul M, Gul S, Bag HG, Erdemli Z, Altinoz E. Crocin (active constituent of saffron) improves CCl4-induced liver damage by modulating oxidative stress in rats. Turkish Journal of Biochemistry 2019;44:370-8. [DOI: 10.1515/tjb-2017-0173] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
470 Lin Y, Ren N, Li S, Chen M, Pu P. Novel anti-obesity effect of scutellarein and potential underlying mechanism of actions. Biomed Pharmacother 2019;117:109042. [PMID: 31228804 DOI: 10.1016/j.biopha.2019.109042] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
471 Baiocchini A, Del Nonno F, Taibi C, Visco-Comandini U, D'Offizi G, Piacentini M, Falasca L. Liver sinusoidal endothelial cells (LSECs) modifications in patients with chronic hepatitis C. Sci Rep 2019;9:8760. [PMID: 31217430 DOI: 10.1038/s41598-019-45114-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
472 Ben Yakov G, Sharma D, Alao H, Surana P, Kapuria D, Etzion O, Hsieh MM, Tisdale JF, Fitzhugh CD, Kleiner DE, Levy EB, Chang R, Rivera E, Huang A, Koh C, Heller T. Vibration Controlled Transient Elastography (Fibroscan®) in sickle cell liver disease - could we strike while the liver is hard? Br J Haematol 2019;187:117-23. [PMID: 31218662 DOI: 10.1111/bjh.16047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
473 Beer A, Holzmann H, Pischke S, Behrendt P, Wrba F, Schlue J, Drebber U, Neudert B, Halilbasic E, Kreipe H, Lohse A, Sterneck M, Wedemeyer H, Manns M, Dienes HP. Chronic Hepatitis E is associated with cholangitis. Liver Int 2019;39:1876-83. [PMID: 31102493 DOI: 10.1111/liv.14137] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
474 Abou-Beih S, Masson S, Saunders R, Haugk B, Oakley F, Tiniakos D. Sinusoidal and pericellular fibrosis in adult post-transplant liver biopsies: association with hepatic stellate cell activation and patient outcome. Virchows Arch 2019;475:233-43. [PMID: 31201503 DOI: 10.1007/s00428-019-02585-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
475 Glaser F, John C, Engel B, Höh B, Weidemann S, Dieckhoff J, Stein S, Becker N, Casar C, Schuran FA, Wieschendorf B, Preti M, Jessen F, Franke A, Carambia A, Lohse AW, Ittrich H, Herkel J, Heeren J, Schramm C, Schwinge D. Liver infiltrating T cells regulate bile acid metabolism in experimental cholangitis. J Hepatol 2019;71:783-92. [PMID: 31207266 DOI: 10.1016/j.jhep.2019.05.030] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
476 Madadi-Sanjani O, Kuebler JF, Dippel S, Gigina A, Falk CS, Vieten G, Petersen C, Klemann C. Hepatocyte growth factor levels in livers and serum at Kasai-portoenterostomy are not predictive of clinical outcome in infants with biliary atresia. Growth Factors 2019;37:68-75. [PMID: 31185750 DOI: 10.1080/08977194.2019.1626379] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
477 Simoes CC, Saldarriaga OA, Utay NS, Stueck AE, Merwat SK, Merwat SN, Schiano TD, Fiel MI, Stevenson HL. Direct-Acting Antiviral Treatment of Patients with Hepatitis C Resolves Serologic and Histopathologic Features of Autoimmune Hepatitis. Hepatol Commun 2019;3:1113-23. [PMID: 31388631 DOI: 10.1002/hep4.1388] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
478 Ravichandran G, Neumann K, Berkhout LK, Weidemann S, Langeneckert AE, Schwinge D, Poch T, Huber S, Schiller B, Hess LU, Ziegler AE, Oldhafer KJ, Barikbin R, Schramm C, Altfeld M, Tiegs G. Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice. J Hepatol 2019;71:773-82. [PMID: 31173810 DOI: 10.1016/j.jhep.2019.05.023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
479 El-Raziky ME, Fouad HM, Abd Elkhalak NS, Ghobrial CM, El-Karaksy HM. Paediatric chronic hepatitis B virus infection: are children too tolerant to treat? Acta Paediatr 2019;108:1144-50. [PMID: 30362178 DOI: 10.1111/apa.14626] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
480 Wang W, Dong R, Guo Y, He J, Shao C, Yi P, Yu F, Gu D, Zheng J. CircMTO1 inhibits liver fibrosis via regulation of miR-17-5p and Smad7. J Cell Mol Med 2019;23:5486-96. [PMID: 31148365 DOI: 10.1111/jcmm.14432] [Cited by in Crossref: 22] [Cited by in F6Publishing: 31] [Article Influence: 7.3] [Reference Citation Analysis]
481 Sebode M, Wigger J, Filpe P, Fischer L, Weidemann S, Krech T, Weiler-Normann C, Peiseler M, Hartl J, Tolosa E, Herkel J, Schramm C, Lohse AW, Arrenberg P. Inflammatory Phenotype of Intrahepatic Sulfatide-Reactive Type II NKT Cells in Humans With Autoimmune Hepatitis. Front Immunol 2019;10:1065. [PMID: 31191516 DOI: 10.3389/fimmu.2019.01065] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
482 Komatsu H, Inui A, Kishiki K, Kawai H, Yoshio S, Osawa Y, Kanto T, Fujisawa T. Liver disease secondary to congenital heart disease in children. Expert Review of Gastroenterology & Hepatology 2019;13:651-66. [DOI: 10.1080/17474124.2019.1621746] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
483 Guo Y, Xu C, Fang Y, Wang C, Gao N, Wen Q, Qiao H. High CYP2E1 activity aggravates hepatofibrosis by limiting macrophage polarization towards the M2 phenotype. Mol Carcinog 2019;58:1481-91. [DOI: 10.1002/mc.23029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
484 Surana P, Kapuria D, Broadwell C, Wright EC, Takyar V, Kleiner DE, Ghany MG, Ben-Yakov G, Heller T, Liang TJ, Koh C. Longitudinal effects of Nucleos(t)ide analogue therapy in chronic hepatitis B patients and the utility of non-invasive fibrosis markers during treatment: A single-center experience for up to 17 years. Antiviral Res 2019;168:61-7. [PMID: 31125632 DOI: 10.1016/j.antiviral.2019.05.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
485 Ferreira AR, Queiroz TCN, Vidigal PVT, Ferreira RDP, Wanderley DC, Fagundes EDT. MULTIVARIATE ANALYSIS OF BILIARY FLOW-RELATED FACTORS AND POST-KASAI SURVIVAL IN BILIARY ATRESIA PATIENTS. Arq Gastroenterol 2019;56:71-8. [PMID: 31141068 DOI: 10.1590/S0004-2803.201900000-18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
486 Sanjeev S, Bidanchi RM, Murthy MK, Gurusubramanian G, Roy VK. Influence of ferulic acid consumption in ameliorating the cadmium-induced liver and renal oxidative damage in rats. Environ Sci Pollut Res Int 2019;26:20631-53. [PMID: 31104231 DOI: 10.1007/s11356-019-05420-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 40] [Article Influence: 7.7] [Reference Citation Analysis]
487 Abd-elgawad MM, Baddour NM, Salem MA. Chronic hepatitis C in children: Clinical spectrum and histopathological study. Alexandria Journal of Medicine 2013;49:363-8. [DOI: 10.1016/j.ajme.2013.03.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
488 Umeshappa CS, Singha S, Blanco J, Shao K, Nanjundappa RH, Yamanouchi J, Parés A, Serra P, Yang Y, Santamaria P. Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines. Nat Commun 2019;10:2150. [PMID: 31089130 DOI: 10.1038/s41467-019-09893-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 44] [Article Influence: 12.3] [Reference Citation Analysis]
489 Abdel-Aziz SA, Sira MM, Gad EH, Ayoub I, Soltan M. Preoperative alkaline phosphatase is a potential predictor of short-term outcome of surgery in infants with biliary atresia. Clin Exp Hepatol 2019;5:155-60. [PMID: 31501792 DOI: 10.5114/ceh.2019.85072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
490 Verloh N, Probst U, Utpatel K, Zeman F, Brennfleck F, Werner JM, Fellner C, Stroszczynski C, Evert M, Wiggermann P, Haimerl M. Influence of hepatic fibrosis and inflammation: Correlation between histopathological changes and Gd-EOB-DTPA-enhanced MR imaging. PLoS One 2019;14:e0215752. [PMID: 31083680 DOI: 10.1371/journal.pone.0215752] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
491 Di Giorgio A, D'Adda A, Marseglia A, Sonzogni A, Licini L, Nicastro E, D'Antiga L. Biliary features in liver histology of children with autoimmune liver disease. Hepatol Int 2019;13:510-8. [PMID: 31069759 DOI: 10.1007/s12072-019-09948-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
492 Hsiao CY, Teng X, Su TH, Lee PH, Kao JH, Huang KW. Improved quantitative assessment of HBV-associated liver fibrosis using second-harmonic generation microscopy with feature selection. Clin Res Hepatol Gastroenterol 2020;44:12-20. [PMID: 31076362 DOI: 10.1016/j.clinre.2019.04.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
493 Shalby MM, Ibrahim SA, Behairy OG, Behiry EG, Mahmoud DA. Diagnostic value of serum cytokeratin-18 in children with chronic liver disease. J Paediatr Child Health 2020;56:41-6. [PMID: 31054236 DOI: 10.1111/jpc.14488] [Reference Citation Analysis]
494 Liao Y, Lee L, Yang P, Kuo L, Kuan L, Tseng W, Hwang D. Assessment of liver cirrhosis for patients with Child's A classification before hepatectomy using dynamic contrast-enhanced MRI. Clinical Radiology 2019;74:407.e11-7. [DOI: 10.1016/j.crad.2019.01.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
495 Nastasio S, Sciveres M, Matarazzo L, Malaventura C, Cirillo F, Riva S, Maggiore G. Long-term follow-up of children and young adults with autoimmune hepatitis treated with cyclosporine. Digestive and Liver Disease 2019;51:712-8. [DOI: 10.1016/j.dld.2018.10.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
496 Liu T, Sun Y, Zhou J, Yang F, Zou X, Wang L, Wu X, Chen Y, Piao H, Lu L, Jiang W, Xu Y, Feng B, Nan Y, Xie W, Chen G, Zheng H, Li H, Ding H, Liu H, Wang T, Ou X, Wu S, Kong Y, Wang P, Cong M, Zhang Y, You H, Jia J. On-treatment changes of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein are associated with the regression of liver fibrosis in chronic hepatitis B patients on interferon α add-on therapy. J Med Virol 2019;91:1499-509. [PMID: 30905065 DOI: 10.1002/jmv.25465] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
497 Cai Y, Liu D, Cui J, Sha Y, Zhou H, Tang N, Wang N, Huang A, Xia J. Diagnostic accuracy of red blood cell distribution width to platelet ratio for predicting staging liver fibrosis in chronic liver disease patients: A systematic review and meta-analysis. Medicine (Baltimore) 2019;98:e15096. [PMID: 30946368 DOI: 10.1097/MD.0000000000015096] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
498 Mostafa ME, Shaaban AA, Salem HA. Dimethylfumarate ameliorates hepatic injury and fibrosis induced by carbon tetrachloride. Chemico-Biological Interactions 2019;302:53-60. [DOI: 10.1016/j.cbi.2019.01.029] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
499 Ebadi M, Czaja AJ, Montano-Loza AJ. Letter: vitamin D deficiency and autoimmune hepatitis - from research to treatment-authors' reply. Aliment Pharmacol Ther 2019;49:1104-5. [PMID: 30920035 DOI: 10.1111/apt.15154] [Reference Citation Analysis]
500 El-sisi AE, Zakaria S. Potential Anti-Fibrotic Effect of Direct Acting Antiviral Drugs on CCl4 Induced Hepatic Fibrosis in Rats. Egyptian Journal of Basic and Clinical Pharmacology 2019;9. [DOI: 10.32527/2019/101414] [Reference Citation Analysis]
501 Shen X, Guo H, Xu J, Wang J. Inhibition of lncRNA HULC improves hepatic fibrosis and hepatocyte apoptosis by inhibiting the MAPK signaling pathway in rats with nonalcoholic fatty liver disease. J Cell Physiol 2019;234:18169-79. [PMID: 30908654 DOI: 10.1002/jcp.28450] [Cited by in Crossref: 21] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
502 Rong X, Liu J, Yao X, Jiang T, Wang Y, Xie F. Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/β-catenin pathway. Stem Cell Res Ther 2019;10:98. [PMID: 30885249 DOI: 10.1186/s13287-019-1204-2] [Cited by in Crossref: 64] [Cited by in F6Publishing: 100] [Article Influence: 21.3] [Reference Citation Analysis]
503 Sarıgul F, Sayan M, User U, Oztoprak N. Evaluation of Direct Acting Antivirals Efficiency in Turkish Patients with Chronic Hepatitis C Under Strict Rules. Hepat Mon 2019;In Press. [DOI: 10.5812/hepatmon.62390] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
504 da Costa Ribeiro Barboza S, de Oliveira JS, de Carvalho Souza MT, de Lima Júnior DM, Lima HB, Guerra RR. Ovines submitted to diets containing cassava foliage hay and spineless cactus forage: histological changes in the digestive and renal systems. Trop Anim Health Prod 2019;51:1689-97. [PMID: 30880354 DOI: 10.1007/s11250-019-01863-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
505 Abbasi-Oshaghi E, Mirzaei F, Pourjafar M. NLRP3 inflammasome, oxidative stress, and apoptosis induced in the intestine and liver of rats treated with titanium dioxide nanoparticles: in vivo and in vitro study. Int J Nanomedicine 2019;14:1919-36. [PMID: 30936694 DOI: 10.2147/IJN.S192382] [Cited by in Crossref: 26] [Cited by in F6Publishing: 37] [Article Influence: 8.7] [Reference Citation Analysis]
506 Abu-Elsaad N, El-Karef A. Protection against nonalcoholic steatohepatitis through targeting IL-18 and IL-1alpha by luteolin. Pharmacol Rep 2019;71:688-94. [PMID: 31207429 DOI: 10.1016/j.pharep.2019.03.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
507 Abo El-magd NF, El-karef A, El-shishtawy MM, Eissa LA. Hepatoprotective effects of glycyrrhizin and omega-3 fatty acids on Nuclear Factor-kappa B pathway in thioacetamide-induced fibrosis in rats. Egyptian Journal of Basic and Applied Sciences 2019;2:65-74. [DOI: 10.1016/j.ejbas.2014.12.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
508 Ben Ayed H, Koubaa M, Yaich S, Rekik K, Ben Jemaa T, Maaloul I, Marrekchi C, Damak J, Ben Jemaa M. A new combined predicting model using a non-invasive score for the assessment of liver fibrosis in patients presenting with chronic hepatitis B virus infection. Med Mal Infect 2019;49:607-15. [PMID: 30871816 DOI: 10.1016/j.medmal.2019.02.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
509 Duman DG, Zibandeh N, Ugurlu MU, Celikel C, Akkoc T, Banzragch M, Genc D, Ozdogan O, Akkoc T. Mesenchymal stem cells suppress hepatic fibrosis accompanied by expanded intrahepatic natural killer cells in rat fibrosis model. Mol Biol Rep. 2019;46:2997-3008. [PMID: 30850965 DOI: 10.1007/s11033-019-04736-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
510 Giadans CG, Ríos DA, Ameigeiras B, Pietrantonio AM, Lucatelli NL, Haddad L, Mullen E, Heinrich F, De Matteo E, Flichman D, Valva P, Preciado MV. Chronic hepatitis B: The interplay between intrahepatic lymphocyte population and viral antigens in relation to liver damage. J Viral Hepat 2019;26:727-37. [PMID: 30739377 DOI: 10.1111/jvh.13078] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
511 Hassan I, Ebaid H, Alhazza IM, Al-Tamimi J, Aman S, Abdel-Mageed AM. Copper Mediates Anti-Inflammatory and Antifibrotic Activity of Gleevec in Hepatocellular Carcinoma-Induced Male Rats. Can J Gastroenterol Hepatol 2019;2019:9897315. [PMID: 30941331 DOI: 10.1155/2019/9897315] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
512 Lee C, Yang S, Lee B, Jeong SY, Kim K, Ku S, Bae J. Hepatic protective effects of sulforaphane through the modulation of inflammatory pathways. Journal of Asian Natural Products Research 2020;22:386-96. [DOI: 10.1080/10286020.2019.1581174] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
513 Vega EA, Kutlu OC, Joechle K, De La Cruz N, Ko D, Conrad C. Preoperative Prognosticators of Safe Laparoscopic Hepatocellular Carcinoma Resection in Advanced Cirrhosis: a Propensity Score Matching Population-Based Analysis of 1799 Western Patients. J Gastrointest Surg. 2019;23:1157-1165. [PMID: 30820798 DOI: 10.1007/s11605-019-04139-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
514 Khedr MA, El-Araby HA, Konsowa HA, Sokar SS, Mahmoud MF, Adawy NM, Zakaria HM. Glutathione peroxidase and malondialdehyde in children with chronic hepatitis C. Clin Exp Hepatol 2019;5:81-7. [PMID: 30915411 DOI: 10.5114/ceh.2019.83161] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
515 Zhao Y, Wang Z, Feng D, Zhao H, Lin M, Hu Y, Zhang N, Lv L, Gao Z, Zhai X, Tian X, Yao J. p66Shc Contributes to Liver Fibrosis through the Regulation of Mitochondrial Reactive Oxygen Species. Theranostics 2019;9:1510-22. [PMID: 30867846 DOI: 10.7150/thno.29620] [Cited by in Crossref: 38] [Cited by in F6Publishing: 46] [Article Influence: 12.7] [Reference Citation Analysis]
516 Masuya R, Muraji T, Ohtani H, Mukai M, Onishi S, Harumatsu T, Yamada K, Yamada W, Kawano T, Machigashira S, Nakame K, Kaji T, Ieiri S. Morphometric demonstration of portal vein stenosis and hepatic arterial medial hypertrophy in patients with biliary atresia. Pediatr Surg Int 2019;35:529-37. [DOI: 10.1007/s00383-019-04459-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
517 Kong Y, Sun Y, Zhou J, Wu X, Chen Y, Piao H, Lu L, Ding H, Nan Y, Jiang W, Xu Y, Xie W, Li H, Feng B, Shi G, Chen G, Li H, Zheng H, Cheng J, Wang T, Liu H, Lv F, Shao C, Mao Y, Sun J, Chen T, Han T, Han Y, Wang L, Ou X, Zhang H, Jia J, You H. Early steep decline of liver stiffness predicts histological reversal of fibrosis in chronic hepatitis B patients treated with entecavir. J Viral Hepat. 2019;26:576-585. [PMID: 30624000 DOI: 10.1111/jvh.13058] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
518 Santiago P, Schwartz I, Tamariz L, Levy C. Systematic review with meta-analysis: mycophenolate mofetil as a second-line therapy for autoimmune hepatitis. Aliment Pharmacol Ther. 2019;49:830-839. [PMID: 30761563 DOI: 10.1111/apt.15157] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 8.7] [Reference Citation Analysis]
519 Goel A, Ramakrishna B, Job V, Zachariah U, Eapen CE. Vitamin B12 Deficiency in Patients With Unexplained Portal Hypertension Indicates Absence of Severe Liver Fibrosis. J Clin Gastroenterol 2019;53:e126-7. [PMID: 30742603 DOI: 10.1097/MCG.0000000000000673] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
520 Stift J, Semmler G, Walzel C, Mandorfer M, Schwarzer R, Schwabl P, Paternostro R, Scheiner B, Wöran K, Pinter M, Stättermayer AF, Trauner M, Peck-Radosavljevic M, Ferlitsch A, Reiberger T. Transjugular aspiration liver biopsy performed by hepatologists trained in HVPG measurements is safe and provides important diagnostic information. Dig Liver Dis 2019;51:1144-51. [PMID: 30862438 DOI: 10.1016/j.dld.2019.01.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
521 Barghi M, Ashrafi M, Aminlari M, Namazi F, Nazifi S. The protective effect of Zataria multiflora Boiss essential oil on CCl4 induced liver fibrosis in rats. Drug Chem Toxicol 2021;44:229-37. [PMID: 30746963 DOI: 10.1080/01480545.2019.1571502] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
522 Turan CA, Ozturk TC, Akoglu EU, Ak R, Aygun K, Sahiner A, Sumer E, Somay A, Onur OE. The Role of Intralipid Emulsion in the Rat Model of Digoxin Intoxication. Cardiovasc Toxicol 2018;18:329-36. [PMID: 29397554 DOI: 10.1007/s12012-018-9444-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
523 Mohseni R, Karimi J, Tavilani H, Khodadadi I, Hashemnia M. Carvacrol ameliorates the progression of liver fibrosis through targeting of Hippo and TGF-β signaling pathways in carbon tetrachloride (CCl 4 )-induced liver fibrosis in rats. Immunopharmacology and Immunotoxicology 2019;41:163-71. [DOI: 10.1080/08923973.2019.1566926] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
524 Kontis E, Pantiora E, Melemeni A, Tsaroucha A, Karvouni E, Polydorou A, Vezakis A, Fragulidis GP. Ischemic postconditioning decreases iNOS gene expression but ischemic preconditioning ameliorates histological injury in a swine model of extended liver resection. Transl Gastroenterol Hepatol 2019;4:5. [PMID: 30854492 DOI: 10.21037/tgh.2019.01.04] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
525 Durante-Mangoni E, Parrella A, Pafundi PC, Vitrone M, Ragone E, De Rosa I, Amarelli C, Zampino R. Liver histopathological findings in advanced heart failure: a reappraisal of cardiac cirrhosis concept. Intern Emerg Med 2019;14:931-40. [PMID: 30689135 DOI: 10.1007/s11739-019-02033-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
526 Chang CY, Hsieh WY, Chau GY, Chen PH, Su CW, Hou MC, Lei HJ, Huo TI, Huang YH, Lin HC, Wu JC. Esophageal varices are not predictive of patient prognosis after surgical resection of hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2018;30:1368-77. [PMID: 29994873 DOI: 10.1097/MEG.0000000000001193] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
527 He FL, Li C, Liu FQ, Qi XS. Correlation analysis of collagen proportionate area in Budd-Chiari syndrome: A preliminary clinicopathological study. World J Clin Cases 2019;7:130-6. [PMID: 30705890 DOI: 10.12998/wjcc.v7.i2.130] [Reference Citation Analysis]
528 Amisaki M, Yagyu T, Uchinaka E, Morimoto M, Tokuyasu N, Sakamoto T, Honjo S, Saito H, Fujiwara Y. Impact of postoperative mean arterial pressure on the incidence of postoperative complications after hepatic resection for primary liver malignancy. Surg Today 2019;49:488-97. [PMID: 30637514 DOI: 10.1007/s00595-019-1759-7] [Reference Citation Analysis]
529 Asai R, Tsuchiya H, Amisaki M, Makimoto K, Takenaga A, Sakabe T, Hoi S, Koyama S, Shiota G. CD44 standard isoform is involved in maintenance of cancer stem cells of a hepatocellular carcinoma cell line. Cancer Med. 2019;8:773-782. [PMID: 30636370 DOI: 10.1002/cam4.1968] [Cited by in Crossref: 19] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
530 Ghanem LY, Mansour IM, Abulata N, Akl MM, Demerdash ZA, El Baz HG, Mahmoud SS, Mohamed SH, Mahmoud FS, Hassan ASM. Liver Macrophage Depletion Ameliorates The Effect of Mesenchymal Stem Cell Transplantation in a Murine Model of Injured Liver. Sci Rep 2019;9:35. [PMID: 30631109 DOI: 10.1038/s41598-018-37184-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
531 Hashem MM, Salama MM, Mohammed FF, Tohamy AF, El Deeb KS. Metabolic profile and hepatoprotective effect of Aeschynomene elaphroxylon (Guill. & Perr.). PLoS One 2019;14:e0210576. [PMID: 30629685 DOI: 10.1371/journal.pone.0210576] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
532 Saitou T, Takanezawa S, Ninomiya H, Watanabe T, Yamamoto S, Hiasa Y, Imamura T. Tissue Intrinsic Fluorescence Spectra-Based Digital Pathology of Liver Fibrosis by Marker-Controlled Segmentation. Front Med (Lausanne) 2018;5:350. [PMID: 30619861 DOI: 10.3389/fmed.2018.00350] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
533 Lee GC, Ferrone CR, Vagefi PA, Uppot RN, Tanabe KK, Lillemoe KD, Blaszkowsky LS, Qadan M. Surgical resection versus ablation for early-stage hepatocellular carcinoma: A retrospective cohort analysis. Am J Surg 2019;218:157-63. [PMID: 30635211 DOI: 10.1016/j.amjsurg.2018.12.067] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
534 Wakui N, Nagai H, Matsukiyo Y, Ogino Y, Matsui D, Mukozu T, Kogame M, Matsui T, Daido Y, Momiyama K, Maruyama K, Kudo T, Shinohara M, Ikehara T, Sumino Y, Igarashi Y. Effect of Hepatic Inflammation in Chronic Hepatitis C Infection on Fibrosis Assessment by Arrival Time Parametric Imaging. Ultrasound Q 2018;34:128-32. [PMID: 29634669 DOI: 10.1097/RUQ.0000000000000355] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
535 Yue ZM, Hong DM, Shengdi WM, Peili FM, Zheng LM, Wenjiao ZM, Wenping WM. Histological Reference for Shear Wave Elastography in Liver Fibrosis: Collagen Quantification and Scoring System. Advanced Ultrasound in Diagnosis and Therapy 2019;3:87. [DOI: 10.37015/audt.2019.190815] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
536 Rigopoulou EI, Gyftaki S, Arvaniti P, Tsimourtou V, Koukoulis GK, Hadjigeorgiou G, Dalekos GN. Autoimmune hepatitis in patients with multiple sclerosis: The role of immunomodulatory treatment. Clin Res Hepatol Gastroenterol 2019;43:e25-32. [PMID: 30594597 DOI: 10.1016/j.clinre.2018.12.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
537 Maggi U, Iavarone M, Fabbi M, Yiu D, Fornoni G, Melada E, Dondossola D, Cantù P, Rossi G. Liver Transplantations and Brain Dead Donors With Alcohol Abuse. Transplant Proc 2018;50:3105-10. [PMID: 30577174 DOI: 10.1016/j.transproceed.2018.08.023] [Reference Citation Analysis]
538 Einer C, Leitzinger C, Lichtmannegger J, Eberhagen C, Rieder T, Borchard S, Wimmer R, Denk G, Popper B, Neff F, Polishchuk EV, Polishchuk RS, Hauck SM, von Toerne C, Müller JC, Karst U, Baral BS, DiSpirito AA, Kremer AE, Semrau J, Weiss KH, Hohenester S, Zischka H. A High-Calorie Diet Aggravates Mitochondrial Dysfunction and Triggers Severe Liver Damage in Wilson Disease Rats. Cell Mol Gastroenterol Hepatol 2019;7:571-96. [PMID: 30586623 DOI: 10.1016/j.jcmgh.2018.12.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
539 Stasi C, Tsochatzis EA, Hall A, Rosenberg W, Milani S, Dhillon AP, Pinzani M. Comparison and correlation of fibrosis stage assessment by collagen proportionate area (CPA) and the ELF panel in patients with chronic liver disease. Dig Liver Dis 2019;51:1001-7. [PMID: 30606698 DOI: 10.1016/j.dld.2018.12.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
540 Athwal VS, Pritchett J, Martin K, Llewellyn J, Scott J, Harvey E, Zaitoun AM, Mullan AF, Zeef LAH, Friedman SL, Irving WL, Hanley NA, Guha IN, Piper Hanley K. SOX9 regulated matrix proteins are increased in patients serum and correlate with severity of liver fibrosis. Sci Rep 2018;8:17905. [PMID: 30559459 DOI: 10.1038/s41598-018-36037-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
541 Sakai M, Spee B, Grinwis GCM, Penning LC, van Wolferen ME, van der Laan LJW, Fieten H. Association of circulating microRNA-122 and microRNA-29a with stage of fibrosis and progression of chronic hepatitis in Labrador Retrievers. J Vet Intern Med 2019;33:151-7. [PMID: 30548329 DOI: 10.1111/jvim.15366] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
542 Khouri Chalouhi C, Vernuccio F, Rini F, Duca P, Tuscano B, Brancatelli G, Vanzulli A. Hepatobiliary phase in cirrhotic patients with different Model for End-stage Liver Disease score: comparison of the performance of gadoxetic acid to gadobenate dimeglumine. Eur Radiol 2019;29:3090-9. [PMID: 30547205 DOI: 10.1007/s00330-018-5884-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
543 Mohamed MZ, Hafez HM, Hassan M, Ibrahim MA. PI3K/Akt and Nrf2/HO-1 pathways involved in the hepatoprotective effect of verapamil against thioacetamide toxicity in rats. Hum Exp Toxicol 2019;38:381-8. [PMID: 30526075 DOI: 10.1177/0960327118817099] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
544 Abdel Ghaffar TY, El Naghi S, Abdel Gawad M, Helmy S, Abdel Ghaffar A, Yousef M, Moafy M. Safety and efficacy of combined sofosbuvir/daclatasvir treatment of children and adolescents with chronic hepatitis C Genotype 4. J Viral Hepat. 2019;26:263-270. [PMID: 30380158 DOI: 10.1111/jvh.13032] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
545 Liu K, Wong VWS, Liang LY, Lui GCY, Chan HLY, Wong GLH. Clinical outcomes and management of patients with chronic hepatitis B and liver stiffness measurement in the grey zone. Liver Int 2019;39:494-502. [PMID: 30417579 DOI: 10.1111/liv.14001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
546 Chong CC, Cheung ST, Cheung Y, Chan AW, Chan SL, Yu SC, Lai PB. Novel biomarkers GEP/ABCB5 regulate response to adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2018;17:524-30. [DOI: 10.1016/j.hbpd.2018.10.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
547 Dong XQ, Wu Z, Zhao H, Wang GQ; China HepB-Related Fibrosis Assessment Research Group. Evaluation and comparison of thirty noninvasive models for diagnosing liver fibrosis in chinese hepatitis B patients. J Viral Hepat 2019;26:297-307. [PMID: 30380170 DOI: 10.1111/jvh.13031] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
548 Lee YS, Cho IJ, Kim JW, Lee MK, Ku SK, Choi JS, Lee HJ. Hepatoprotective effects of blue honeysuckle on CCl4-induced acute liver damaged mice. Food Sci Nutr 2019;7:322-38. [PMID: 30680187 DOI: 10.1002/fsn3.893] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
549 Ji SS, Jiang HD, Jiang JC, Li J, Lin ST, Chen B, Xu SH. Applicability of liver stiffness measurement based nomograms to the assessments of hepatitis B related significant fibrosis and cirrhosis. Clin Chim Acta 2019;489:75-82. [PMID: 30471249 DOI: 10.1016/j.cca.2018.11.029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
550 Verloh N, Utpatel K, Zeman F, Fellner C, Schlitt HJ, Müller M, Stroszczynski C, Evert M, Wiggermann P, Haimerl M. Diagnostic performance of Gd-EOB-DTPA-enhanced MRI for evaluation of liver dysfunction: a multivariable analysis of 3T MRI sequences. Oncotarget 2018;9:36371-8. [PMID: 30555635 DOI: 10.18632/oncotarget.26368] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
551 Wu Z, Dong X, Wang G, Zhao H; China HepB-Related Fibrosis Assessment Research Group. Clinical noninvasive markers for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase less than two times upper limit of normal. J Viral Hepat 2019;26:287-96. [PMID: 30380162 DOI: 10.1111/jvh.13030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
552 Mathies F, Steffens N, Kleinschmidt D, Stuhlmann F, Huber FJ, Roy U, Meyer T, Luetgehetmann M, von Petersdorff M, Seiz O, Herkel J, Schramm C, Flavell RA, Gagliani N, Krebs C, Panzer U, Abdullah Z, Strowig T, Bedke T, Huber S. Colitis Promotes a Pathological Condition of the Liver in the Absence of Foxp3+ Regulatory T Cells. J Immunol. 2018;201:3558-3568. [PMID: 30446566 DOI: 10.4049/jimmunol.1800711] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
553 Verloh N, Einspieler I, Utpatel K, Menhart K, Brunner S, Hofheinz F, van den Hoff J, Wiggermann P, Evert M, Stroszczynski C, Hellwig D, Grosse J. In vivo confirmation of altered hepatic glucose metabolism in patients with liver fibrosis/cirrhosis by 18F-FDG PET/CT. EJNMMI Res 2018;8:98. [PMID: 30414009 DOI: 10.1186/s13550-018-0452-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
554 Dong XQ, Wu Z, Li J, Wang GQ, Zhao H; China HepB-Related Fibrosis Assessment Research Group. Declining in liver stiffness cannot indicate fibrosis regression in patients with chronic hepatitis B: A 78-week prospective study. J Gastroenterol Hepatol. 2019;34:755-763. [PMID: 30290019 DOI: 10.1111/jgh.14498] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
555 Liu C, Wang L, Xie H, Zhang L, Wang B, Luo C, Wang S, Tang M, Fu Z, Ruan H, Liu Z, Wei L, Yi W, Xie Y. The relationship between serum hepatitis B virus DNA level and liver histology in patients with chronic HBV infection. PLoS One 2018;13:e0206060. [PMID: 30403735 DOI: 10.1371/journal.pone.0206060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
556 Hwang J, Yoon HM, Kim JR, Lee JS, Jung AY, Kim KM, Cho YA. Diagnostic Performance of Transient Elastography for Liver Fibrosis in Children: A Systematic Review and Meta-Analysis. American Journal of Roentgenology 2018;211:W257-66. [DOI: 10.2214/ajr.18.19535] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
557 Kamarajah SK. Fibrosis score impacts survival following resection for hepatocellular carcinoma (HCC): A Surveillance, End Results and Epidemiology (SEER) database analysis. Asian Journal of Surgery 2018;41:551-61. [DOI: 10.1016/j.asjsur.2018.01.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
558 Saber S, Goda R, El-tanbouly GS, Ezzat D. Lisinopril inhibits nuclear transcription factor kappa B and augments sensitivity to silymarin in experimental liver fibrosis. International Immunopharmacology 2018;64:340-9. [DOI: 10.1016/j.intimp.2018.09.021] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
559 Sobhy A, Fakhry M M, A Azeem H, Ashmawy AM, Omar Khalifa H. Significance of biglycan and osteopontin as non-invasive markers of liver fibrosis in patients with chronic hepatitis B virus and chronic hepatitis C virus. J Investig Med 2019;67:681-5. [PMID: 30385593 DOI: 10.1136/jim-2018-000840] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
560 Yu Y, Wang J, Ng CW, Ma Y, Mo S, Fong ELS, Xing J, Song Z, Xie Y, Si K, Wee A, Welsch RE, So PTC, Yu H. Deep learning enables automated scoring of liver fibrosis stages. Sci Rep. 2018;8:16016. [PMID: 30375454 DOI: 10.1038/s41598-018-34300-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 7.5] [Reference Citation Analysis]
561 Gokce O, Ozenirler S, Atak Yucel A, Oruklu N, Yilmaz Esendagli G, Karahan S. Evaluation of serum procollagen C-proteinase enhancer 1 level as a fibrosis marker in patients with chronic hepatitis B. Eur J Gastroenterol Hepatol 2018;30:918-24. [PMID: 29683980 DOI: 10.1097/MEG.0000000000001123] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
562 Yan JY, Li ZQ, Yu ZJ, Kan QC. Management of individuals with chronic hepatitis B virus infection and persistent normal or mildly elevated aminotransferase levels. J Cell Biochem 2019;120:6632-41. [PMID: 30368885 DOI: 10.1002/jcb.27959] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
563 Somroo GB, Rai AA, Luck NH, Abbas Z. Clinical presentation of autoimmune hepatitis in Pakistani children. Pan Afr Med J 2018;30:117. [PMID: 30364457 DOI: 10.11604/pamj.2018.30.117.12692] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
564 Lee YB, Ha Y, Chon YE, Kim MN, Lee JH, Park H, Kim KI, Kim SH, Rim KS, Hwang SG. Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B. Clin Mol Hepatol. 2019;25:52-64. [PMID: 30360031 DOI: 10.3350/cmh.2018.0040] [Cited by in Crossref: 24] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]
565 Stroffolini T, Sagnelli E, Sagnelli C, Smedile A, Morisco F, Coppola N, Furlan C, Almasio PL. Geographical pattern of chronic liver diseases in Italy: Results from two pooled national surveys. Eur J Intern Med. 2019;61:40-43. [PMID: 30360942 DOI: 10.1016/j.ejim.2018.10.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
566 Iezzoni JC. Diagnostic histochemistry in hepatic pathology. Semin Diagn Pathol 2018;35:381-9. [PMID: 30409459 DOI: 10.1053/j.semdp.2018.10.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
567 Armacki M, Trugenberger AK, Ellwanger AK, Eiseler T, Schwerdt C, Bettac L, Langgartner D, Azoitei N, Halbgebauer R, Groß R, Barth T, Lechel A, Walter BM, Kraus JM, Wiegreffe C, Grimm J, Scheffold A, Schneider MR, Peuker K, Zeißig S, Britsch S, Rose-John S, Vettorazzi S, Wolf E, Tannapfel A, Steinestel K, Reber SO, Walther P, Kestler HA, Radermacher P, Barth TF, Huber-Lang M, Kleger A, Seufferlein T. Thirty-eight-negative kinase 1 mediates trauma-induced intestinal injury and multi-organ failure. J Clin Invest 2018;128:5056-72. [PMID: 30320600 DOI: 10.1172/JCI97912] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
568 Ghinolfi D, Tincani G, Rreka E, Roffi N, Coletti L, Balzano E, Catalano G, Meli S, Carrai P, Petruccelli S, Biancofiore G, Filipponi F, De Simone P. Dual aortic and portal perfusion at procurement prevents ischaemic-type biliary lesions in liver transplantation when using octogenarian donors: a retrospective cohort study. Transpl Int 2019;32:193-205. [PMID: 30198069 DOI: 10.1111/tri.13342] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
569 Day J, Patel P, Parkes J, Rosenberg W. Derivation and Performance of Standardized Enhanced Liver Fibrosis (ELF) Test Thresholds for the Detection and Prognosis of Liver Fibrosis. J Appl Lab Med. 2019;3:815-826. [PMID: 31639756 DOI: 10.1373/jalm.2018.027359] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
570 Pate RT, Paulus Compart DM, Cardoso FC. Aluminosilicate clay improves production responses and reduces inflammation during an aflatoxin challenge in lactating Holstein cows. J Dairy Sci 2018;101:11421-34. [PMID: 30316598 DOI: 10.3168/jds.2018-15024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
571 Ho SY, Liu PH, Hsu CY, Hsia CY, Su CW, He YJ, Lee YH, Huang YH, Hou MC, Huo TI. Current noninvasive liver reserve models do not predict histological fibrosis severity in hepatocellular carcinoma. Sci Rep 2018;8:15074. [PMID: 30305679 DOI: 10.1038/s41598-018-33536-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
572 Sagnelli E, Stroffolini T, Sagnelli C, Cacopardo B, Andriulli A, Babudieri S, Coppola N, Gaeta GB, Almasio PL. Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy. Eur J Gastroenterol Hepatol 2018;30:676-81. [PMID: 29465473 DOI: 10.1097/MEG.0000000000001099] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
573 Strickland JM, Buchweitz JP, Smedley RC, Olstad KJ, Schultz RS, Oliver NB, Langlois DK. Hepatic copper concentrations in 546 dogs (1982-2015). J Vet Intern Med 2018;32:1943-50. [PMID: 30294943 DOI: 10.1111/jvim.15308] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
574 Yu F, Geng W, Dong P, Huang Z, Zheng J. LncRNA-MEG3 inhibits activation of hepatic stellate cells through SMO protein and miR-212. Cell Death Dis 2018;9:1014. [PMID: 30282972 DOI: 10.1038/s41419-018-1068-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 47] [Article Influence: 7.3] [Reference Citation Analysis]
575 Karakecili F, Cikman A, Aydin M, Gulhan B. Asymmetrical Dimethylarginine Levels in Hepatitis B Virus-Positive Patients. Ann Lab Med 2018;38:446-9. [PMID: 29797815 DOI: 10.3343/alm.2018.38.5.446] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
576 Bond A, Hayes S, Abraham A, Teubner A, Farrer K, Pironi L, Lal S. Reversal of intestinal failure associated liver disease fibrosis in a patient receiving long term home parenteral nutrition. Clin Nutr ESPEN. 2018;28:228-231. [PMID: 30390886 DOI: 10.1016/j.clnesp.2018.09.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
577 Stroffolini T, Sagnelli E, Sagnelli C, Morisco F, Babudieri S, Furlan C, Pirisi M, Russello M, Smedile A, Pisaturo M, Almasio PL. Characteristics and Changes over Time of Alcohol-Related Chronic Liver Diseases in Italy. Can J Gastroenterol Hepatol. 2018;2018:9151820. [PMID: 30345260 DOI: 10.1155/2018/9151820] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
578 Yifan T, Ming X, Yifan W, Hanning Y, Guangyi J, Peijian Y, Ke W, Xiujun C. Hepatic regeneration by associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) is feasible but attenuated in rat liver with thioacetamide-induced fibrosis. Surgery 2019;165:345-52. [PMID: 30249433 DOI: 10.1016/j.surg.2018.08.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
579 Liao R, Du CY, Gong JP, Luo F. HBV-DNA Load-Related Peritumoral Inflammation and ALBI Scores Predict HBV Associated Hepatocellular Carcinoma Prognosis after Curative Resection. J Oncol 2018;2018:9289421. [PMID: 30327670 DOI: 10.1155/2018/9289421] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
580 Moudi B, Heidari Z, Mahmoudzadeh-Sagheb H. Study of liver in HBV-related hepatocellular carcinoma: Stereology shows quantitative differences in liver structure. Eur J Histochem 2018;62. [PMID: 30223640 DOI: 10.4081/ejh.2018.2950] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
581 Gao N, Li J, Li MR, Qi B, Wang Z, Wang GJ, Gao J, Qiao HL. Higher Activity of Alcohol Dehydrogenase Is Correlated with Hepatic Fibrogenesis. J Pharmacol Exp Ther 2018;367:473-82. [PMID: 30228113 DOI: 10.1124/jpet.118.249425] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
582 Ibrahim MA, Abdel-Aziz A, El-Sheikh A, Kamel M, Khalil AZ, Abdelhaleem H. Hepatic effect of sofosbuvir and daclatasvir in thioacetamide-induced liver injury in rats. Clin Exp Hepatol 2018;4:175-81. [PMID: 30324142 DOI: 10.5114/ceh.2018.78121] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
583 Viganò L, Procopio F, Mimmo A, Donadon M, Terrone A, Cimino M, Fabbro DD, Torzilli G. Oncologic superiority of anatomic resection of hepatocellular carcinoma by ultrasound-guided compression of the portal tributaries compared with nonanatomic resection: An analysis of patients matched for tumor characteristics and liver function. Surgery 2018;164:1006-13. [PMID: 30195402 DOI: 10.1016/j.surg.2018.06.030] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
584 Grimaldi C, di Francesco F, Chiusolo F, Angelico R, Monti L, Muiesan P, de Ville de Goyet J. Aggressive prevention and preemptive management of vascular complications after pediatric liver transplantation: A major impact on graft survival and long-term outcome. Pediatr Transplant 2018;22:e13288. [DOI: 10.1111/petr.13288] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
585 Bossen L, Gerussi A, Lygoura V, Mells GF, Carbone M, Invernizzi P. Support of precision medicine through risk-stratification in autoimmune liver diseases – histology, scoring systems, and non-invasive markers. Autoimmunity Reviews 2018;17:854-65. [DOI: 10.1016/j.autrev.2018.02.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
586 de Carvalho TG, Garcia VB, de Araújo AA, da Silva Gasparotto LH, Silva H, Guerra GCB, de Castro Miguel E, de Carvalho Leitão RF, da Silva Costa DV, Cruz LJ, Chan AB, de Araújo Júnior RF. Spherical neutral gold nanoparticles improve anti-inflammatory response, oxidative stress and fibrosis in alcohol-methamphetamine-induced liver injury in rats. International Journal of Pharmaceutics 2018;548:1-14. [DOI: 10.1016/j.ijpharm.2018.06.008] [Cited by in Crossref: 31] [Cited by in F6Publishing: 38] [Article Influence: 7.8] [Reference Citation Analysis]
587 Navrotsky AN. [Diagnostic possibilities of methods for the evaluation of liver fibrosis in chronic viral hepatitis]. Ter Arkh 2016;88:149-55. [PMID: 28635835 DOI: 10.17116/terarkh20168811149-155] [Reference Citation Analysis]
588 Yang YQ, Yan XT, Wang K, Tian RM, Lu ZY, Wu LL, Xu HT, Wu YS, Liu XS, Mao W, Xu P, Liu B. Triptriolide Alleviates Lipopolysaccharide-Induced Liver Injury by Nrf2 and NF-κB Signaling Pathways. Front Pharmacol 2018;9:999. [PMID: 30210350 DOI: 10.3389/fphar.2018.00999] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 6.5] [Reference Citation Analysis]
589 Eissa LA, Kenawy HI, El-Karef A, Elsherbiny NM, El-Mihi KA. Antioxidant and anti-inflammatory activities of berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats. Chem Biol Interact. 2018;294:91-100. [PMID: 30138605 DOI: 10.1016/j.cbi.2018.08.016] [Cited by in Crossref: 25] [Cited by in F6Publishing: 35] [Article Influence: 6.3] [Reference Citation Analysis]
590 Calanchini M, Moolla A, Tomlinson JW, Cobbold JF, Grossman A, Fabbri A, Turner HE. Liver biochemical abnormalities in Turner syndrome: A comprehensive characterization of an adult population. Clin Endocrinol 2018;89:667-76. [DOI: 10.1111/cen.13811] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
591 Renand A, Habes S, Mosnier JF, Aublé H, Judor JP, Vince N, Hulin P, Nedellec S, Métairie S, Archambeaud I, Brouard S, Gournay J, Conchon S. Immune Alterations in Patients With Type 1 Autoimmune Hepatitis Persist Upon Standard Immunosuppressive Treatment. Hepatol Commun 2018;2:968-81. [PMID: 30094407 DOI: 10.1002/hep4.1202] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
592 Bashiri H, Hosseini-Chegeni H, Alsadat Sharifi K, Sahebgharani M, Salari AA. Activation of TRPV1 receptors affects memory function and hippocampal TRPV1 and CREB mRNA expression in a rat model of biliary cirrhosis. Neurol Res 2018;40:938-47. [PMID: 30079821 DOI: 10.1080/01616412.2018.1504158] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
593 Zampino R, Marrone A, Rinaldi L, Guerrera B, Nevola R, Boemio A, Iuliano N, Giordano M, Passariello N, Sasso FC. Endotoxinemia contributes to steatosis, insulin resistance and atherosclerosis in chronic hepatitis C: the role of pro-inflammatory cytokines and oxidative stress. Infection. 2018;. [PMID: 30066228 DOI: 10.1007/s15010-018-1185-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
594 Gounder PP, Haering C, Bruden DJT, Townshend-Bulson L, Simons BC, Spradling PR, McMahon BJ. Does Incorporating Change in APRI or FIB-4 Indices Over Time Improve the Accuracy of a Single Index for Identifying Liver Fibrosis in Persons With Chronic Hepatitis C Virus Infection? J Clin Gastroenterol 2018;52:60-6. [PMID: 27875352 DOI: 10.1097/MCG.0000000000000753] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
595 Rong M, Wang P, Qiu Y, Liu Y, Wang Y, Deng H. Metabolomic analysis of serum from rats following long-term intake of Chinese sausage. Food Nutr Res 2018;62. [PMID: 30013460 DOI: 10.29219/fnr.v62.1447] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
596 Etzion O, Takyar V, Novack V, Gharib AM, Canales R, Adebogun A, Matsumoto E, Eccleston JL, Kleiner DE, Rosenzweig SD, Gunay-Aygun M, Uzel G, Fuss I, Childs R, Holland SM, Levy EB, Liang TJ, Heller T, Koh C. Spleen and Liver Volumetrics as Surrogate Markers of Hepatic Venous Pressure Gradient in Patients With Noncirrhotic Portal Hypertension. Hepatol Commun 2018;2:919-28. [PMID: 30094403 DOI: 10.1002/hep4.1198] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
597 Carbone M, Nardi A, Flack S, Carpino G, Varvaropoulou N, Gavrila C, Spicer A, Badrock J, Bernuzzi F, Cardinale V, Ainsworth HF, Heneghan MA, Thorburn D, Bathgate A, Jones R, Neuberger JM, Battezzati PM, Zuin M, Taylor-Robinson S, Donato MF, Kirby J, Mitchell-Thain R, Floreani A, Sampaziotis F, Muratori L, Alvaro D, Marzioni M, Miele L, Marra F, Giannini E, Gaudio E, Ronca V, Bonato G, Cristoferi L, Malinverno F, Gerussi A, Stocken DD, Cordell HJ, Hirschfield GM, Alexander GJ, Sandford RN, Jones DE, Invernizzi P, Mells GF; Italian PBC Study Group and the UK–PBC Consortium. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score. Lancet Gastroenterol Hepatol 2018;3:626-34. [PMID: 30017646 DOI: 10.1016/S2468-1253(18)30163-8] [Cited by in Crossref: 65] [Cited by in F6Publishing: 27] [Article Influence: 16.3] [Reference Citation Analysis]
598 Song X, Liu Z, Zhang J, Yang Q, Ren Z, Zhang C, Liu M, Gao Z, Zhao H, Jia L. Anti-inflammatory and hepatoprotective effects of exopolysaccharides isolated from Pleurotus geesteranus on alcohol-induced liver injury. Sci Rep 2018;8:10493. [PMID: 30002448 DOI: 10.1038/s41598-018-28785-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
599 Lutterkort GL, Wranke A, Hengst J, Yurdaydin C, Stift J, Bremer B, Hardtke S, Keskin O, Idilman R, Manns MP, Dienes HP, Falk C, Wedemeyer H, Heidrich B. Viral dominance patterns in chronic hepatitis delta determine early response to interferon alpha therapy. J Viral Hepat 2018;25:1384-94. [DOI: 10.1111/jvh.12947] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
600 Athwal VS, Pritchett J, Llewellyn J, Martin K, Camacho E, Raza SM, Phythian-Adams A, Birchall LJ, Mullan AF, Su K, Pearmain L, Dolman G, Zaitoun AM, Friedman SL, MacDonald A, Irving WL, Guha IN, Hanley NA, Piper Hanley K. SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis. EMBO Mol Med 2017;9:1696-710. [PMID: 29109128 DOI: 10.15252/emmm.201707860] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
601 Wang H, Liu A, Bo W, Feng X, Hu Y, Tian L, Zhang H, Tang X, Zhang L. Fibrosis-4 Model Influences Results of Patients with Hepatocellular Carcinoma Undergoing Hepatectomy. Biomed Res Int 2018;2018:4305408. [PMID: 30057907 DOI: 10.1155/2018/4305408] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
602 Mik P, Tonar Z, Malečková A, Eberlová L, Liška V, Pálek R, Rosendorf J, Jiřík M, Mírka H, Králíčková M, Witter K. Distribution of Connective Tissue in the Male and Female Porcine Liver: Histological Mapping and Recommendations for Sampling. J Comp Pathol 2018;162:1-13. [PMID: 30060837 DOI: 10.1016/j.jcpa.2018.05.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
603 Sagnelli C, Uberti-Foppa C, Hasson H, Bellini G, Minichini C, Salpietro S, Messina E, Barbanotti D, Merli M, Punzo F, Coppola N, Lazzarin A, Sagnelli E, Rossi F. In vivo evidence that the cannabinoid receptor 2-63 RR variant is associated with the acquisition and/or expansion of HIV infection. HIV Med 2018;19:597-604. [PMID: 29932291 DOI: 10.1111/hiv.12638] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
604 Sahin M, Karayakar F, Koksal AR, Yetim A, İyisoy MS, Şen İ, Alkım H, Alkım C, Colak T. Changes in Liver Tissue Trace Element Concentrations During Hepatitis B Viral Infection Treatment. Biol Trace Elem Res 2019;188:245-50. [PMID: 29926391 DOI: 10.1007/s12011-018-1414-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
605 Mak LY, Wong DK, Cheung KS, Seto WK, Lai CL, Yuen MF. Role of serum M2BPGi levels on diagnosing significant liver fibrosis and cirrhosis in treated patients with chronic hepatitis B virus infection. Clin Transl Gastroenterol. 2018;9:163. [PMID: 29915243 DOI: 10.1038/s41424-018-0020-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
606 Mardpour S, Hassani S, Mardpour S, Sayahpour F, Vosough M, Ai J, Aghdami N, Hamidieh AA, Baharvand H. Extracellular vesicles derived from human embryonic stem cell‐MSCs ameliorate cirrhosis in thioacetamide‐induced chronic liver injury. J Cell Physiol 2018;233:9330-44. [DOI: 10.1002/jcp.26413] [Cited by in Crossref: 39] [Cited by in F6Publishing: 51] [Article Influence: 9.8] [Reference Citation Analysis]
607 Sood V, Lal BB, Rawat D, Khanna R, Rastogi A, Bihari C, Kumar G, Alam S. Spectrum of Pediatric Autoimmune Liver Disease and Validation of Its Diagnostic Scores in Indian Children. J Pediatr Gastroenterol Nutr 2018;67:e65-72. [PMID: 29901555 DOI: 10.1097/MPG.0000000000002050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
608 Coppola N, Onorato L, Panella M, de Stefano G, Mosca N, Minichini C, Messina V, Potenza N, Starace M, Alessio L, Farella N, Sagnelli E, Russo A. Correlation Between the Hepatic Expression of Human MicroRNA hsa-miR-125a-5p and the Progression of Fibrosis in Patients With Overt and Occult HBV Infection. Front Immunol 2018;9:1334. [PMID: 29951066 DOI: 10.3389/fimmu.2018.01334] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
609 Zhong X, Liu H. Honokiol attenuates diet-induced non-alcoholic steatohepatitis by regulating macrophage polarization through activating peroxisome proliferator-activated receptor γ. J Gastroenterol Hepatol 2018;33:524-32. [PMID: 28670854 DOI: 10.1111/jgh.13853] [Cited by in Crossref: 21] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
610 Cheng JL, Zhao H, Yang SG, Chen EM, Chen WQ, Li LJ. Plasma miRNA-122-5p and miRNA-151a-3p identified as potential biomarkers for liver injury among CHB patients with PNALT. Hepatol Int 2018;12:277-87. [PMID: 29881991 DOI: 10.1007/s12072-018-9871-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
611 Junge N, Junge C, Schröder J, Pfister E, Leiskau C, Hohmann D, Beerbaum P, Baumann U. Pediatric cirrhotic cardiomyopathy: Impact on liver transplant outcomes: Junge et al. Liver Transpl 2018;24:820-30. [DOI: 10.1002/lt.25076] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
612 Wandrer F, Han B, Liebig S, Schlue J, Manns MP, Schulze-Osthoff K, Bantel H. Senescence mirrors the extent of liver fibrosis in chronic hepatitis C virus infection. Aliment Pharmacol Ther 2018;48:270-80. [PMID: 29863282 DOI: 10.1111/apt.14802] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
613 Hidaka M, Eguchi S, Hara T, Soyama A, Okada S, Hamada T, Ono S, Adachi T, Kanetaka K, Takatsuki M. A Predictive Formula for Portal Venous Pressure Prior to Liver Resection Using Directly Measured Values. J Invest Surg 2020;33:118-22. [PMID: 29856668 DOI: 10.1080/08941939.2018.1476631] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
614 Selby PJ, Banks RE, Gregory W, Hewison J, Rosenberg W, Altman DG, Deeks JJ, Mccabe C, Parkes J, Sturgeon C, Thompson D, Twiddy M, Bestall J, Bedlington J, Hale T, Dinnes J, Jones M, Lewington A, Messenger MP, Napp V, Sitch A, Tanwar S, Vasudev NS, Baxter P, Bell S, Cairns DA, Calder N, Corrigan N, Del Galdo F, Heudtlass P, Hornigold N, Hulme C, Hutchinson M, Lippiatt C, Livingstone T, Longo R, Potton M, Roberts S, Sim S, Trainor S, Welberry Smith M, Neuberger J, Thorburn D, Richardson P, Christie J, Sheerin N, Mckane W, Gibbs P, Edwards A, Soomro N, Adeyoju A, Stewart GD, Hrouda D. Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCT. Programme Grants Appl Res 2018;6:1-528. [DOI: 10.3310/pgfar06030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
615 Nesbitt H, Sheng Y, Kamila S, Logan K, Thomas K, Callan B, Taylor MA, Love M, O'rourke D, Kelly P, Beguin E, Stride E, Mchale AP, Callan JF. Gemcitabine loaded microbubbles for targeted chemo-sonodynamic therapy of pancreatic cancer. Journal of Controlled Release 2018;279:8-16. [DOI: 10.1016/j.jconrel.2018.04.018] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 13.8] [Reference Citation Analysis]
616 Fang C, Jaffer OS, Yusuf GT, Konstantatou E, Quinlan DJ, Agarwal K, Quaglia A, Sidhu PS. Reducing the Number of Measurements in Liver Point Shear-Wave Elastography: Factors that Influence the Number and Reliability of Measurements in Assessment of Liver Fibrosis in Clinical Practice. Radiology 2018;287:844-52. [DOI: 10.1148/radiol.2018172104] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
617 Schulz L, Sebode M, Weidemann SA, Lohse AW. Variant syndromes of primary biliary cholangitis. Best Practice & Research Clinical Gastroenterology 2018;34-35:55-61. [DOI: 10.1016/j.bpg.2018.06.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
618 Diaz G, Engle RE, Tice A, Melis M, Montenegro S, Rodriguez-Canales J, Hanson J, Emmert-Buck MR, Bock KW, Moore IN, Zamboni F, Govindarajan S, Kleiner DE, Farci P. Molecular Signature and Mechanisms of Hepatitis D Virus-Associated Hepatocellular Carcinoma. Mol Cancer Res. 2018;16:1406-1419. [PMID: 29858376 DOI: 10.1158/1541-7786.mcr-18-0012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
619 Molyvdas A, Georgopoulou U, Lazaridis N, Hytiroglou P, Dimitriadis A, Foka P, Vassiliadis T, Loli G, Phillipidis A, Zebekakis P, Germenis AE, Speletas M, Germanidis G. The role of the NLRP3 inflammasome and the activation of IL-1β in the pathogenesis of chronic viral hepatic inflammation. Cytokine 2018;110:389-96. [PMID: 29803661 DOI: 10.1016/j.cyto.2018.04.032] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
620 Wang B, Sun Y, Zhou J, Wu X, Chen S, Wu S, Liu H, Wang T, Ou X, Jia J, You H. Advanced septa size quantitation determines the evaluation of histological fibrosis outcome in chronic hepatitis B patients. Mod Pathol. 2018;31:1567-1577. [PMID: 29785021 DOI: 10.1038/s41379-018-0059-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
621 Wang L, Li X, Chen C. Inhibition of acetaminophen-induced hepatotoxicity in mice by exogenous thymosinβ4 treatment. Int Immunopharmacol 2018;61:20-8. [PMID: 29793165 DOI: 10.1016/j.intimp.2018.05.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
622 Liao R, Li D, Du C, Li M. Combined Preoperative ALBI and FIB-4 Is Associated with Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy. J Gastrointest Surg 2018;22:1679-87. [DOI: 10.1007/s11605-018-3810-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
623 Shen J, Liu J, Li C, Wen T, Yan L, Yang J. The prognostic significance of serum HBeAg on the recurrence and long-term survival after hepatectomy for hepatocellular carcinoma: A propensity score matching analysis. J Viral Hepat 2018;25:1057-65. [PMID: 29660216 DOI: 10.1111/jvh.12911] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
624 Sethunath D, Morusu S, Tuceryan M, Cummings OW, Zhang H, Yin XM, Vanderbeck S, Chalasani N, Gawrieh S. Automated assessment of steatosis in murine fatty liver. PLoS One 2018;13:e0197242. [PMID: 29746543 DOI: 10.1371/journal.pone.0197242] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
625 Ryu B, Eo KY, Jang JJ, Kim CY, Lee JM, Oh H, Kim U, Kim J, Lee HH, Jung YM, Park JH. A case of active incomplete biliary cirrhosis in an aged female Japanese macaque (Macaca fuscata). J Med Primatol 2018. [PMID: 29726008 DOI: 10.1111/jmp.12347] [Reference Citation Analysis]
626 Jones D, Manns MP, Terracciano L, Torbenson M, Vierling JM. Unmet needs and new models for future trials in autoimmune hepatitis. The Lancet Gastroenterology & Hepatology 2018;3:363-70. [DOI: 10.1016/s2468-1253(18)30043-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
627 Stroffolini T, Sagnelli E, Almasio PL, Andriulli A, Smedile A, Pirisi M, Sagnelli C, Russello M, Coppola N, de Luca M, Pisaturo M, Rosina F, Gaeta GB; EPACRON study group. Etiological factors of chronic hepatitis in Italy: A 2014 national survey. Eur J Gastroenterol Hepatol. 2017;29:994-997. [PMID: 28538268 DOI: 10.1097/meg.0000000000000907] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
628 Wang L, Wang B, You H, Wu X, Zhou J, Ou X, Jia J. Platelets' increase is associated with improvement of liver fibrosis in entecavir-treated chronic hepatitis B patients with significant liver fibrosis. Hepatol Int 2018;12:237-43. [PMID: 29700765 DOI: 10.1007/s12072-018-9864-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
629 Theise ND, Jia J, Sun Y, Wee A, You H. Progression and regression of fibrosis in viral hepatitis in the treatment era: the Beijing classification. Mod Pathol. 2018;31:1191-1200. [PMID: 29700417 DOI: 10.1038/s41379-018-0048-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
630 Ogaly HA, Eltablawy NA, Abd-Elsalam RM. Antifibrogenic Influence of Mentha piperita L. Essential Oil against CCl4-Induced Liver Fibrosis in Rats. Oxid Med Cell Longev 2018;2018:4039753. [PMID: 29849890 DOI: 10.1155/2018/4039753] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
631 Heubi JE, Bove KE, Setchell KDR. Oral Cholic Acid Is Efficacious and Well Tolerated in Patients With Bile Acid Synthesis and Zellweger Spectrum Disorders. J Pediatr Gastroenterol Nutr 2017;65:321-6. [PMID: 28644367 DOI: 10.1097/MPG.0000000000001657] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
632 Verloh N, Utpatel K, Haimerl M, Zeman F, Beyer L, Fellner C, Brennfleck F, Dahlke MH, Stroszczynski C, Evert M, Wiggermann P. Detecting liver fibrosis with Gd-EOB-DTPA-enhanced MRI: A confirmatory study. Sci Rep 2018;8:6207. [PMID: 29670136 DOI: 10.1038/s41598-018-24316-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
633 Sookoian S, Flichman D, Garaycoechea ME, San Martino J, Castaño GO, Pirola CJ. Metastasis-associated lung adenocarcinoma transcript 1 as a common molecular driver in the pathogenesis of nonalcoholic steatohepatitis and chronic immune-mediated liver damage. Hepatol Commun 2018;2:654-65. [PMID: 29881817 DOI: 10.1002/hep4.1184] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
634 Kendall TJ, Dolman GE, Duff CM, Paish EC, Zaitoun A, Irving W, Fallowfield JA, Guha IN. Hepatic elastin content is predictive of adverse outcome in advanced fibrotic liver disease. Histopathology 2018;73:90-100. [PMID: 29464815 DOI: 10.1111/his.13499] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
635 Feng R, Yuan X, Shao C, Ding H, Liebe R, Weng H. Are we any closer to treating liver fibrosis (and if no, why not)? Journal of Digestive Diseases 2018;19:118-26. [DOI: 10.1111/1751-2980.12584] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
636 Vasseur P, Pohin M, Jégou J, Favot L, Venisse N, Mcheik J, Morel F, Lecron J, Silvain C. Liver fibrosis is associated with cutaneous inflammation in the imiquimod-induced murine model of psoriasiform dermatitis. Br J Dermatol 2018;179:101-9. [DOI: 10.1111/bjd.16137] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
637 Verloh N, Utpatel K, Haimerl M, Zeman F, Fellner C, Dahlke M, Renner P, Seyfried T, Müller M, Stroszczynski C, Evert M, Wiggermann P. DWI - histology: a possible means of determining degree of liver fibrosis? Oncotarget 2018;9:20112-8. [PMID: 29732007 DOI: 10.18632/oncotarget.24981] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
638 Al-Shaebi EA, Dkhil MA, Al-Quraishy S. Indigofera oblongifolia regulates the hepatic gene expression profile induced by blood stage malaria. Microb Pathog 2018;119:170-82. [PMID: 29630927 DOI: 10.1016/j.micpath.2018.04.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
639 Lyshchik A, Kono Y, Dietrich CF, Jang HJ, Kim TK, Piscaglia F, Vezeridis A, Willmann JK, Wilson SR. Contrast-enhanced ultrasound of the liver: technical and lexicon recommendations from the ACR CEUS LI-RADS working group. Abdom Radiol (NY) 2018;43:861-79. [PMID: 29151131 DOI: 10.1007/s00261-017-1392-0] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 14.3] [Reference Citation Analysis]
640 Ramzy MM, Abdelghany HM, Zenhom NM, El-tahawy NF. Effect of histone deacetylase inhibitor on epithelial-mesenchymal transition of liver fibrosis: EFFECT OF HDAC INHIBITOR ON EMT. IUBMB Life 2018;70:511-8. [DOI: 10.1002/iub.1742] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
641 Yan L, Deng Y, Zhou J, Zhao H, Wang G; China HepB-Related Fibrosis Assessment Research Group. Serum YKL-40 as a biomarker for liver fibrosis in chronic hepatitis B patients with normal and mildly elevated ALT. Infection 2018;46:385-93. [PMID: 29600444 DOI: 10.1007/s15010-018-1136-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
642 Khalili M, Shuhart MC, Lombardero M, Feld JJ, Kleiner DE, Chung RT, Terrault NA, Lisker-Melman M, Sanyal A, Lok AS; Hepatitis B Research Network (HBRN)., Harvard Consortium. Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B. Diabetes Care 2018;41:1251-9. [PMID: 29599296 DOI: 10.2337/dc18-0040] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
643 Wadhva RK, Haque MM, Luck NH, Tasneem AA, Abbas Z, Mubarak M. Diagnostic Accuracy of Aspartate Aminotransferase to Platelet Ratio Index and Fibrosis 4 Scores in Predicting Advanced Liver Fibrosis in Patients with End-stage Renal Disease and Chronic Viral Hepatitis: Experience from Pakistan. J Transl Int Med 2018;6:38-42. [PMID: 29607303 DOI: 10.2478/jtim-2018-0008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
644 Guzman-Lepe J, Cervantes-Alvarez E, Collin de l'Hortet A, Wang Y, Mars WM, Oda Y, Bekki Y, Shimokawa M, Wang H, Yoshizumi T, Maehara Y, Bell A, Fox IJ, Takeishi K, Soto-Gutierrez A. Liver-enriched transcription factor expression relates to chronic hepatic failure in humans. Hepatol Commun 2018;2:582-94. [PMID: 29761173 DOI: 10.1002/hep4.1172] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
645 Le PH, Liang KH, Chang ML, Hsu CW, Chen YC, Lin CL, Lin WR, Lai MW, Yeh CT. Clinical Predictors for Neutrophil-to-Lymphocyte Ratio Changes in Patients with Chronic Hepatitis B Receiving Peginterferon Treatment. In Vivo. 2017;31:723-729. [PMID: 28652447 DOI: 10.21873/invivo.11121] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
646 Zhang G, Li R, Deng Y, Zhao L. Conditional survival of patients with hepatocellular carcinoma: results from the Surveillance, Epidemiology, and End Results registry. Expert Rev Gastroenterol Hepatol 2018;12:515-23. [PMID: 29543072 DOI: 10.1080/17474124.2018.1453806] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
647 Hamamoto H, Maemura K, Matsuo K, Taniguchi K, Tanaka Y, Futaki S, Takeshita A, Asai A, Hayashi M, Hirose Y, Kondo Y, Uchiyama K. Delta-like 3 is silenced by HBx via histone acetylation in HBV-associated HCCs. Sci Rep 2018;8:4842. [PMID: 29555949 DOI: 10.1038/s41598-018-23318-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
648 Liao R, Peng C, Li M, Li DW, Jiang N, Li PZ, Ding X, Wu Q, Du CY, Gong JP. Comparison and validation of the prognostic value of preoperative systemic immune cells in hepatocellular carcinoma after curative hepatectomy. Cancer Med 2018;7:1170-82. [PMID: 29533004 DOI: 10.1002/cam4.1424] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
649 D'Ambrosio R, Aghemo A, Rumi MG, Degasperi E, Sangiovanni A, Maggioni M, Fraquelli M, Perbellini R, Rosenberg W, Bedossa P, Colombo M, Lampertico P. Persistence of hepatocellular carcinoma risk in hepatitis C patients with a response to IFN and cirrhosis regression. Liver Int. 2018;38:1459-1467. [PMID: 29377616 DOI: 10.1111/liv.13707] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
650 Höhne M, Frese CK, Grahammer F, Dafinger C, Ciarimboli G, Butt L, Binz J, Hackl MJ, Rahmatollahi M, Kann M, Schneider S, Altintas MM, Schermer B, Reinheckel T, Göbel H, Reiser J, Huber TB, Kramann R, Seeger-Nukpezah T, Liebau MC, Beck BB, Benzing T, Beyer A, Rinschen MM. Single-nephron proteomes connect morphology and function in proteinuric kidney disease. Kidney Int 2018;93:1308-19. [PMID: 29530281 DOI: 10.1016/j.kint.2017.12.012] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 7.8] [Reference Citation Analysis]
651 Nirei K, Kanda T, Nakamura H, Matsuoka S, Takayama T, Sugitani M, Moriyama M. Persistent Hepatic Inflammation Plays a Role in Hepatocellular Carcinoma After Sustained Virological Response in Patients with HCV Infection. Int J Med Sci 2018;15:466-74. [PMID: 29559835 DOI: 10.7150/ijms.23147] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
652 Sun H, Lin Z, Zhao L, Chen T, Shang M, Jiang H, Tang Z, Zhou X, Shi M, Zhou L, Ren P, Qu H, Lin J, Li X, Xu J, Huang Y, Yu X. Bacillus subtilis spore with surface display of paramyosin from Clonorchis sinensis potentializes a promising oral vaccine candidate. Parasit Vectors 2018;11:156. [PMID: 29514667 DOI: 10.1186/s13071-018-2757-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
653 Yim SY, Kim TH, Jun SS, Kim ES, Keum B, Seo YS, Yim HJ, Jeen YT, Chun HJ, Lee HS, Um SH, Kim CD, Won NH, Ryu HS. Expression of Hepatocyte Hepatitis B Core Antigen and Hepatitis B Surface Antigen as a Marker in the Management of Chronic Hepatitis B Patients. Gut Liver 2017;11:417-25. [PMID: 28208002 DOI: 10.5009/gnl16148] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
654 Keller S, Aigner A, Zenouzi R, Kim AC, Meijer A, Weidemann SA, Krech T, Lohse AW, Adam G, Schramm C, Yamamura J. Association of gadolinium-enhanced magnetic resonance imaging with hepatic fibrosis and inflammation in primary sclerosing cholangitis. PLoS One. 2018;13:e0193929. [PMID: 29513767 DOI: 10.1371/journal.pone.0193929] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
655 Guido M, Sarcognato S, Russo FP, Cardin R, Piciocchi M, Colloredo G, Farinati F. Focus on histological abnormalities of intrahepatic vasculature in chronic viral hepatitis. Liver Int 2018;38:1770-6. [DOI: 10.1111/liv.13718] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
656 Muratori P, Carbone M, Stangos G, Perini L, Lalanne C, Ronca V, Cazzagon N, Bianchi G, Lenzi M, Floreani A, Invernizzi P, Muratori L. Clinical and prognostic implications of acute onset of Autoimmune Hepatitis: An Italian multicentre study. Dig Liver Dis 2018;50:698-702. [PMID: 29567415 DOI: 10.1016/j.dld.2018.02.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
657 Li H, Lan J, Han C, Guo K, Wang G, Hu J, Gong J, Luo X, Cao Z. Brg1 promotes liver fibrosis via activation of hepatic stellate cells. Experimental Cell Research 2018;364:191-7. [DOI: 10.1016/j.yexcr.2018.02.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
658 Heidari R, Ghanbarinejad V, Mohammadi H, Ahmadi A, Esfandiari A, Azarpira N, Niknahad H. Dithiothreitol supplementation mitigates hepatic and renal injury in bile duct ligated mice: Potential application in the treatment of cholestasis-associated complications. Biomedicine & Pharmacotherapy 2018;99:1022-32. [DOI: 10.1016/j.biopha.2018.01.018] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
659 Vega-magaña N, Delgado-rizo V, García-benavides L, Toro-arreola SD, Segura-ortega J, Morales ASMZ, Zepeda-nuño JS, Escarra-senmarti M, Gutiérrez-franco J, Haramati J, Bueno-topete MR. Bacterial Translocation Is Linked to Increased Intestinal IFN-γ, IL-4, IL-17, and mucin-2 in Cholestatic Rats. Annals of Hepatology 2018;17:318-29. [DOI: 10.5604/01.3001.0010.8663] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
660 Papić N, Budimir J, Kurelac I, Dušek D, Jugović D, Krajcar N, Vince A. Treatment of Elderly Patients with Chronic Hepatitis C: A Retrospective Cohort Study. Acta Clin Croat 2018;57:61-70. [PMID: 30256012 DOI: 10.20471/acc.2018.57.01.07] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
661 Wang Y, Huang W, Li R, Yun Z, Zhu Y, Yang J, Liu H, Liu Z, Feng Q, Hou J. Systematic quantification of histological patterns shows accuracy in reflecting cirrhotic remodeling. J Gastroenterol Hepatol 2017;32:1631-9. [PMID: 28068755 DOI: 10.1111/jgh.13722] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
662 Eraky SM, El-Mesery M, El-Karef A, Eissa LA, El-Gayar AM. Silymarin and caffeine combination ameliorates experimentally-induced hepatic fibrosis through down-regulation of LPAR1 expression. Biomed Pharmacother 2018;101:49-57. [PMID: 29477472 DOI: 10.1016/j.biopha.2018.02.064] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
663 Kramer AS, Latham B, Diepeveen LA, Mou L, Laurent GJ, Elsegood C, Ochoa-Callejero L, Yeoh GC. InForm software: a semi-automated research tool to identify presumptive human hepatic progenitor cells, and other histological features of pathological significance. Sci Rep 2018;8:3418. [PMID: 29467378 DOI: 10.1038/s41598-018-21757-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
664 Wang H, Zhang H, Zhang Y, Wang D, Cheng X, Yang F, Zhang Q, Xue Z, Li Y, Zhang L, Yang L, Miao G, Li D, Guan Z, Da Y, Yao Z, Gao F, Qiao L, Kong L, Zhang R. Plumbagin protects liver against fulminant hepatic failure and chronic liver fibrosis via inhibiting inflammation and collagen production. Oncotarget 2016;7:82864-75. [PMID: 27756878 DOI: 10.18632/oncotarget.12655] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
665 Chen L, Zhu C, Li F, Wang Y, Bao R, Cao Z, Xiang X, Yan L, Lin L, Zhao G, Xie Q, Bao S, Wang H. Correlation between hepatic human males absent on the first (hMOF) and viral persistence in chronic hepatitis B patients. Cell Biosci 2018;8:14. [PMID: 29484170 DOI: 10.1186/s13578-018-0215-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
666 Liu Z, Li J, Chen J, Shan Q, Dai H, Xie H, Zhou L, Xu X, Zheng S. MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression. BMC Cancer 2018;18:200. [PMID: 29463213 DOI: 10.1186/s12885-018-4056-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 59] [Article Influence: 10.0] [Reference Citation Analysis]
667 Karlas T, Petroff D, Sasso M, Fan JG, Mi YQ, de Lédinghen V, Kumar M, Lupsor-Platon M, Han KH, Cardoso AC, Ferraioli G, Chan WK, Wong VW, Myers RP, Chayama K, Friedrich-Rust M, Beaugrand M, Shen F, Hiriart JB, Sarin SK, Badea R, Lee HW, Marcellin P, Filice C, Mahadeva S, Wong GL, Crotty P, Masaki K, Bojunga J, Bedossa P, Keim V, Wiegand J. Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement. Aliment Pharmacol Ther 2018;47:989-1000. [PMID: 29446106 DOI: 10.1111/apt.14529] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 7.3] [Reference Citation Analysis]
668 Putra J, Schiano TD, Fiel MI. Histological assessment of the liver explant in transplanted hepatitis C virus patients achieving sustained virological response with direct-acting antiviral agents. Histopathology. 2018;72:990-996. [PMID: 29235144 DOI: 10.1111/his.13453] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
669 Tedesco D, Thapa M, Chin CY, Ge Y, Gong M, Li J, Gumber S, Speck P, Elrod EJ, Burd EM, Kitchens WH, Magliocca JF, Adams AB, Weiss DS, Mohamadzadeh M, Grakoui A. Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease. Gastroenterology 2018;154:2178-93. [PMID: 29454797 DOI: 10.1053/j.gastro.2018.02.019] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 12.0] [Reference Citation Analysis]
670 Sun Y, Zhou J, Wu X, Chen Y, Piao H, Lu L, Ding H, Nan Y, Jiang W, Wang T, Liu H, Ou X, Wee A, Theise ND, Jia J, You H. Quantitative assessment of liver fibrosis (qFibrosis) reveals precise outcomes in Ishak "stable" patients on anti-HBV therapy. Sci Rep 2018;8:2989. [PMID: 29445243 DOI: 10.1038/s41598-018-21179-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
671 Orlien SMS, Ismael NY, Ahmed TA, Berhe N, Lauritzen T, Roald B, Goldin RD, Stene-Johansen K, Dyrhol-Riise AM, Gundersen SG, Morgan MY, Johannessen A. Unexplained chronic liver disease in Ethiopia: a cross-sectional study. BMC Gastroenterol 2018;18:27. [PMID: 29439653 DOI: 10.1186/s12876-018-0755-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
672 Wadhera V, Harimoto N, Lubezky N, Gomatos I, Facciuto M, Gonzalez D, Stueck A, Fiel MI, Schiano T, Facciuto ME. The impact of donor liver allograft fibrosis on patients undergoing liver transplantation. Clin Transplant 2018;32:e13187. [PMID: 29314293 DOI: 10.1111/ctr.13187] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
673 Arslan FD, Karakoyun I, Tatar B, Pala EE, Yıldırım M, Ulasoglu C, Duman C, Akar H, Kose S, Isbilen Basok B. SHFI: A Novel Noninvasive Predictive Model for Significant Fibrosis in Patients With Chronic Hepatitis B. Hepat Mon 2018;18. [DOI: 10.5812/hepatmon.63310] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
674 Page SJ, Rivera MM, Kleiner DE, Zhao X, Auh S, Remmers EF, Heller T. Three variants in the nicotinamide adenine dinucleotide phosphate oxidase complex are associated with HCV-related liver damage. Hepatol Commun 2017;1:973-82. [PMID: 29404504 DOI: 10.1002/hep4.1103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
675 Jayesh K, Helen LR, Vysakh A, Binil E, Latha MS. Protective Role of Terminalia bellirica (Gaertn.) Roxb Fruits Against CCl4 Induced Oxidative Stress and Liver Injury in Rodent Model. Indian J Clin Biochem 2019;34:155-63. [PMID: 31092988 DOI: 10.1007/s12291-017-0732-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
676 Zen Y, Yeh MM. Hepatotoxicity of immune checkpoint inhibitors: a histology study of seven cases in comparison with autoimmune hepatitis and idiosyncratic drug-induced liver injury. Mod Pathol. 2018;31:965-973. [PMID: 29403081 DOI: 10.1038/s41379-018-0013-y] [Cited by in Crossref: 110] [Cited by in F6Publishing: 127] [Article Influence: 27.5] [Reference Citation Analysis]
677 Di Maira T, Torregrosa A, Navarro V, Sánchez D, Fornés V, Berenguer M. Liver Volume as a Predictor of Functional Improvement Post-DAA Treatment. Transplantation 2018;102:e74-81. [DOI: 10.1097/tp.0000000000001990] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
678 Lee W, Hwang M, Lee Y, Bae J. Protective effects of zingerone on lipopolysaccharide-induced hepatic failure through the modulation of inflammatory pathways. Chemico-Biological Interactions 2018;281:106-10. [DOI: 10.1016/j.cbi.2017.12.031] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
679 Zhou Y, Ru GQ, Yan R, Wang MS, Chen MJ, Yu LL, Wang H. An Inexpensive Digital Image Analysis Technique for Liver Fibrosis Quantification in Chronic Hepatitis B Patients. Ann Hepatol 2017;16:881-7. [PMID: 29055926 DOI: 10.5604/01.3001.0010.5278] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
680 Beal EW, Black SM, Michaels A. Autoimmune Hepatitis in the Liver Transplant Graft. Clin Liver Dis 2017;21:381-401. [PMID: 28364820 DOI: 10.1016/j.cld.2016.12.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
681 Chandel R, Saxena R, Das A, Kaur J. Association of rno‐miR‐183‐96‐182 cluster with diethyinitrosamine induced liver fibrosis in Wistar rats. J Cell Biochem 2018;119:4072-84. [DOI: 10.1002/jcb.26583] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
682 Chamorro-de-Vega E, Gimenez-Manzorro A, Rodriguez-Gonzalez CG, Escudero-Vilaplana V, De Lorenzo-Pinto A, Iglesias-Peinado I, Herranz-Alonso A, Sanjurjo Saez M; GRUviC Study Group. Twelve weeks of ombitasvir/paritaprevir/r and dasabuvir without ribavirin is effective and safe in the treatment of patients with HCV genotype 1b infection and compensated cirrhosis: results from a real-world cohort study. Expert Opin Drug Saf 2018;17:235-41. [PMID: 29325476 DOI: 10.1080/14740338.2018.1424829] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
683 Yan PG, Wang RY, Zhang J, Cong WM, Dong H, Yu HY, Lau WY, Wu MC, Zhou WP. Impact of Preoperative Hepatitis B Virus Levels on Prognosis After Primary and Repeat Hepatectomies for Hepatocellular Carcinoma Patients-a Retrospective Study. J Gastrointest Surg 2018;22:872-83. [PMID: 29313290 DOI: 10.1007/s11605-017-3638-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
684 Tublin ME, Blair R, Martin J, Malik S, Ruppert K, Demetris A. Prospective Study of the Impact of Liver Biopsy Core Size on Specimen Adequacy and Procedural Complications. American Journal of Roentgenology 2018;210:183-8. [DOI: 10.2214/ajr.17.17792] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
685 Papadatos D, Fowler KJ, Kielar AZ, Cui J, Sirlin CB. Cirrhosis and LI-RADS. Abdom Radiol (NY) 2018;43:26-40. [PMID: 29218367 DOI: 10.1007/s00261-017-1425-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
686 Manzia T, Angelico R, Toti L, Grimaldi C, Sforza D, Vella I, Tariciotti L, Lenci I, Breshanaj G, Baiocchi L, Tisone G. Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients. Transplantation Proceedings 2018;50:175-83. [DOI: 10.1016/j.transproceed.2017.12.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
687 Raizner A, Shillingford N, Mitchell PD, Harney S, Raza R, Serino J, Jonas MM, Lee CK. Hepatic Inflammation May Influence Liver Stiffness Measurements by Transient Elastography in Children and Young Adults. J Pediatr Gastroenterol Nutr. 2017;64:512-517. [PMID: 27540711 DOI: 10.1097/mpg.0000000000001376] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
688 Wang Y, Liang X, Yang J, Wang H, Tan D, Chen S, Cheng J, Chen Y, Sun J, Rong F, Yang W, Liu H, Liu Z, Zheng Y, Liang J, Li S, Liu Z, Hou J. Improved performance of quantitative collagen parameters versus standard histology in longitudinal assessment of nonadvanced liver fibrosis for chronic hepatitis B. J Viral Hepat 2018;25:598-607. [PMID: 29193542 DOI: 10.1111/jvh.12835] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
689 Lo RC, Kim H. Histopathological evaluation of liver fibrosis and cirrhosis regression. Clin Mol Hepatol. 2017;23:302-307. [PMID: 29281870 DOI: 10.3350/cmh.2017.0078] [Cited by in Crossref: 40] [Cited by in F6Publishing: 50] [Article Influence: 8.0] [Reference Citation Analysis]
690 Tang J, Hu P, Li Y, Win-Shwe TT, Li C. Ion Imbalance Is Involved in the Mechanisms of Liver Oxidative Damage in Rats Exposed to Glyphosate. Front Physiol 2017;8:1083. [PMID: 29311996 DOI: 10.3389/fphys.2017.01083] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 6.4] [Reference Citation Analysis]
691 Cima L, Riva G, D'Errico A, Casartelli-Liviero M, Capelli P, Tomezzoli A, Montin U, Carraro A, Scarpa A, Ghimenton C, Colombari R, Brunelli M, Eccher A. Fast Chromotrope Aniline Blue Special Stain Is a Useful Tool to Assess Fibrosis on Liver Biopsy During Transplantation. Transplant Proc 2017;49:667-70. [PMID: 28457367 DOI: 10.1016/j.transproceed.2017.02.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
692 Yan L, Chen Y, Zhou J, Zhao H, Zhang H, Wang G. Diagnostic value of circulating cell-free DNA levels for hepatocellular carcinoma. Int J Infect Dis 2018;67:92-7. [PMID: 29229500 DOI: 10.1016/j.ijid.2017.12.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 41] [Article Influence: 5.2] [Reference Citation Analysis]
693 Anand V, Hyun C, Khan QM, Hall C, Hessefort N, Sonnenberg A, Fimmel CJ. Identification and Fibrosis Staging of Hepatitis C Patients Using the Electronic Medical Record System. J Clin Gastroenterol 2016;50:664-9. [PMID: 26974763 DOI: 10.1097/MCG.0000000000000519] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
694 Salloum C, Lim C, Lahat E, Gavara CG, Levesque E, Compagnon P, Azoulay D. Robotic-Assisted Versus Laparoscopic Left Lateral Sectionectomy: Analysis of Surgical Outcomes and Costs by a Propensity Score Matched Cohort Study. World J Surg. 2017;41:516-524. [PMID: 27743071 DOI: 10.1007/s00268-016-3736-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 6.6] [Reference Citation Analysis]
695 Sonderup MW, Afihene M, Ally R, Apica B, Awuku Y, Cunha L, Dusheiko G, Gogela N, Lohouès-kouacou M, Lam P, Lesi O, Mbaye PS, Musabeyezu E, Musau B, Ojo O, Rwegasha J, Scholz B, Shewaye AB, Tzeuton C, Kassianides C, Spearman CW. Hepatitis C in sub-Saharan Africa: the current status and recommendations for achieving elimination by 2030. The Lancet Gastroenterology & Hepatology 2017;2:910-9. [DOI: 10.1016/s2468-1253(17)30249-2] [Cited by in Crossref: 56] [Cited by in F6Publishing: 31] [Article Influence: 11.2] [Reference Citation Analysis]
696 Eulenberg VM, Lidbury JA. Hepatic Fibrosis in Dogs. J Vet Intern Med. 2018;32:26-41. [PMID: 29194760 DOI: 10.1111/jvim.14891] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
697 Liang X, Xie Q, Tan D, Ning Q, Niu J, Bai X, Chen S, Cheng J, Yu Y, Wang H, Xu M, Shi G, Wan M, Chen X, Tang H, Sheng J, Dou X, Shi J, Ren H, Wang M, Zhang H, Gao Z, Chen C, Ma H, Chen Y, Fan R, Sun J, Jia J, Hou J. Interpretation of liver stiffness measurement-based approach for the monitoring of hepatitis B patients with antiviral therapy: A 2-year prospective study. J Viral Hepat. 2018;25:296-305. [PMID: 29080299 DOI: 10.1111/jvh.12814] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
698 Atallah MAA, Elaidy SM, Tawfik MK. Assessment of the possible roles of SB-269970 versus ketanserin on carbon tetrachloride-induced liver fibrosis in rats: Oxidative stress/TGF-β1-induced HSCs activation pathway. Pharmacol Rep 2018;70:509-18. [PMID: 29660654 DOI: 10.1016/j.pharep.2017.11.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
699 Lee IC, Chau GY, Yeh YC, Chao Y, Huo TI, Su CW, Lin HC, Hou MC, Huang YH. Risk of recurrence in chronic hepatitis B patients developing hepatocellular carcinoma with antiviral secondary prevention failure. PLoS One 2017;12:e0188552. [PMID: 29176777 DOI: 10.1371/journal.pone.0188552] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
700 Mamdouh S, Khorshed F, Aboushousha T, Hamdy H, Diab A, Seleem M, Saber M. Evaluation of Mir-224, Mir-215 and Mir-143 as Serum Biomarkers for HCV Associated Hepatocellular Carcinoma. Asian Pac J Cancer Prev. 2017;18:3167-3171. [PMID: 29172295 DOI: 10.22034/apjcp.2017.18.11.3167] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
701 Hartl J, Ehlken H, Sebode M, Peiseler M, Krech T, Zenouzi R, von Felden J, Weiler-Normann C, Schramm C, Lohse AW. Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis. J Hepatol. 2017; Epub ahead of print. [PMID: 29180000 DOI: 10.1016/j.jhep.2017.11.020] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 9.4] [Reference Citation Analysis]
702 Farrar CT, Gale EM, Kennan R, Ramsay I, Masia R, Arora G, Looby K, Wei L, Kalpathy-Cramer J, Bunzel MM, Zhang C, Zhu Y, Akiyama TE, Klimas M, Pinto S, Diyabalanage H, Tanabe KK, Humblet V, Fuchs BC, Caravan P. CM-101: Type I Collagen-targeted MR Imaging Probe for Detection of Liver Fibrosis. Radiology 2018;287:581-9. [PMID: 29156148 DOI: 10.1148/radiol.2017170595] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 5.8] [Reference Citation Analysis]
703 Andersen SB, Ewertsen C, Carlsen JF, Henriksen BM, Nielsen MB. Ultrasound Elastography Is Useful for Evaluation of Liver Fibrosis in Children-A Systematic Review. J Pediatr Gastroenterol Nutr. 2016;63:389-399. [PMID: 26925609 DOI: 10.1097/mpg.0000000000001171] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
704 Ghavamzadeh A, Sotoudeh M, Hashemi Taheri AP, Alimoghaddam K, Pashaiefar H, Jalili M, Shahi F, Jahani M, Yaghmaie M. Liver fibrosis alleviation after co-transplantation of hematopoietic stem cells with mesenchymal stem cells in patients with thalassemia major. Ann Hematol 2018;97:327-34. [PMID: 29150810 DOI: 10.1007/s00277-017-3181-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
705 Sagnelli E, Stroffolini T, Sagnelli C, Pirisi M, Babudieri S, Colloredo G, Russello M, Coppola N, Gaeta GB, Cacopardo B, De Luca M, Almasio PL; EPACRON study group. Gender differences in chronic liver diseases in two cohorts of 2001 and 2014 in Italy. Infection 2018;46:93-101. [PMID: 29150796 DOI: 10.1007/s15010-017-1101-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
706 Gabbia D, Pozza AD, Albertoni L, Lazzari R, Zigiotto G, Carrara M, Baldo V, Baldovin T, Floreani A, Martin SD. Pregnane X receptor and constitutive androstane receptor modulate differently CYP3A-mediated metabolism in early- and late-stage cholestasis. World J Gastroent